##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - SNP quality (QUAL), depth (DP), allele frequency (AF), mean mapping quality of alternate allele (MQM), genotype, depth and allele frequency for child, mother and father (TRIO).
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, NM number, type, impact, exon number, HGVS.c, HGVS.p).
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=1000g=Allele frequency in all populations of 1000g project.
##DESCRIPTION=ExAC=Allele frequency in all populations of ExAC project.
##DESCRIPTION=ExAC_hom=Homoyzgous counts for populations ALL, NFE and AFR of ExAC project.
##DESCRIPTION=Kaviar=Allele frequency in Kaviar database.
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=MetaLR=MetaLR effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=Sift=Sift effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=PP2_HVAR=Polyphen2 (HVAR) effect prediction: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=PP2_HDIV=Polyphen2 (HDIV) effect prediction: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=ihdb_allsys_hom=Homozygous variant counts in NGSD independent of the processing system.
##DESCRIPTION=ihdb_allsys_het=Heterozygous variant counts in NGSD independent of the processing system.
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validated=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Comments from the NGSD. Comments of other samples are listed in brackets!
##DESCRIPTION=gene_info=Gene information from NGSD (inheritance mode, ExAC pLI score).
##FILTER=anno_high_impact=Variant annotated to have high impact by SnpEff.
##FILTER=anno_pathogenic_clinvar=Variant annotated to be pathogenic by ClinVar.
##FILTER=anno_pathogenic_hgmd=Variant annotated to be pathogenic by HGMD.
##FILTER=low_DP=Depth less than 20.
##FILTER=low_MQM=Mean mapping quality of alternate allele less than Q50.
##FILTER=low_QUAL=Variant quality less than Q30.
##FILTER=off-target=Variant outside the panel/exome target region.
##FILTER=phylop_high=PhyloP value higher than 1.6 i.e. highly-conserved base and possibly pathognic.
##FILTER=pred_pathogenic_1=Variant predicted pathogenic by one of the prediction tools.
##FILTER=pred_pathogenic_2=Variant predicted pathogenic by two of the prediction tools.
##FILTER=pred_pathogenic_3=Variant predicted pathogenic by three of the prediction tools.
##FILTER=pred_pathogenic_4=Variant predicted pathogenic by four of the prediction tools.
#chr	start	end	ref	obs	genotype	filter	quality	gene	variant_type	coding_and_splicing	RepeatMasker	dbSNP	1000g	ExAC	ExAC_hom	Kaviar	phyloP	MetaLR	Sift	PP2_HVAR	PP2_HDIV	OMIM	ClinVar	HGMD	COSMIC	ihdb_allsys_hom	ihdb_allsys_het	classification	classification_comment	validated	comment	gene_info
chr1	27682481	27682481	G	A	het	off-target	QUAL=2181;DP=169;AF=0.51;MQM=60	MAP3K6	intron	MAP3K6:NM_004672.4:intron:MODIFIER:exon27/28:c.3711+36C>T:,MAP3K6:NM_001297609.1:intron:MODIFIER:exon26/27:c.3687+36C>T:		rs12569127	0.1903	0.2656	4554/3529/231	0.2588										39	144					MAP3K6 (inh=n/a pLI=0.00)
chr1	27686063	27686063	G	C	hom	off-target	QUAL=6115;DP=198;AF=1.00;MQM=60	MAP3K6	intron	MAP3K6:NM_004672.4:intron:MODIFIER:exon17/28:c.2320-50C>G:,MAP3K6:NM_001297609.1:intron:MODIFIER:exon16/27:c.2296-50C>G:		rs7521552	0.9880	0.9939	58800/32412/4752	0.9558										156	1					MAP3K6 (inh=n/a pLI=0.00)
chr1	27687466	27687466	G	T	het		QUAL=9743;DP=738;AF=0.52;MQM=60	MAP3K6	missense	MAP3K6:NM_004672.4:missense:MODERATE:exon14/29:c.1866C>A:p.Asn622Lys,MAP3K6:NM_001297609.1:missense:MODERATE:exon13/28:c.1842C>A:p.Asn614Lys		rs35659744	0.1220	0.2622	3300/2798/11	0.2145	0.0290	T,T	T,T,T,T,.	B,B,.	B,B,.				COSM1559293, COSM1559292	137	539				bla3	MAP3K6 (inh=n/a pLI=0.00)
chr1	27690359	27690359	T	C	het	off-target	QUAL=1451;DP=111;AF=0.53;MQM=60	MAP3K6	intron	MAP3K6:NM_004672.4:intron:MODIFIER:exon5/28:c.864+49A>G:,MAP3K6:NM_001297609.1:intron:MODIFIER:exon4/27:c.840+49A>G:	MIRb	rs4307592	0.2196	0.2976	1551/1146/215	0.2141										0	0					MAP3K6 (inh=n/a pLI=0.00)
chr1	27690644	27690644	A	G	het	off-target	QUAL=645;DP=89;AF=0.36;MQM=60	MAP3K6	intron	MAP3K6:NM_004672.4:intron:MODIFIER:exon4/28:c.695+51T>C:,MAP3K6:NM_001297609.1:intron:MODIFIER:exon3/27:c.671+51T>C:		rs12727507	0.3548	0.3309	7323/4186/2129	0.3215										52	159					MAP3K6 (inh=n/a pLI=0.00)
chr1	45796269	45796269	G	C	hom	off-target;low_DP	QUAL=264;DP=10;AF=1.00;MQM=60	MUTYH	intron	MUTYH:NM_001128425.1:intron:MODIFIER:exon14/15:c.1477-40C>G:,MUTYH:NM_001048174.1:intron:MODIFIER:exon14/15:c.1393-40C>G:,MUTYH:NM_001293191.1:intron:MODIFIER:exon14/15:c.1426-40C>G:,MUTYH:NM_001293195.1:intron:MODIFIER:exon15/16:c.1393-40C>G:,MUTYH:NM_001048172.1:intron:MODIFIER:exon14/15:c.1396-40C>G:,MUTYH:NM_001048173.1:intron:MODIFIER:exon14/15:c.1393-40C>G:,MUTYH:NM_001293196.1:intron:MODIFIER:exon14/15:c.1117-40C>G:,MUTYH:NM_001048171.1:intron:MODIFIER:exon14/15:c.1435-40C>G:,MUTYH:NM_001293190.1:intron:MODIFIER:exon14/15:c.1438-40C>G:,MUTYH:NM_001293192.1:intron:MODIFIER:exon14/15:c.1117-40C>G:,MUTYH:NM_012222.2:intron:MODIFIER:exon14/15:c.1468-40C>G:		rs3219493	0.9353	0.9245	35987/19433/3346	0.8921						604933 [MUTYH (provisional) Adenomas,multiple colorectal|Gastric cancer,somatic|Colorectal adenomatous polyposis,autosomal recessive,with pilomatricomas];				274	58					MUTYH (inh=AR pLI=0.00)
chr1	45797505	45797505	C	G	het		QUAL=3120;DP=233;AF=0.52;MQM=60	MUTYH	missense	MUTYH:NM_001128425.1:missense:MODERATE:exon12/16:c.1014G>C:p.Gln338His,MUTYH:NM_001048174.1:missense:MODERATE:exon12/16:c.930G>C:p.Gln310His,MUTYH:NM_001293191.1:missense:MODERATE:exon12/16:c.963G>C:p.Gln321His,MUTYH:NM_001293195.1:missense:MODERATE:exon13/17:c.930G>C:p.Gln310His,MUTYH:NM_001048172.1:missense:MODERATE:exon12/16:c.933G>C:p.Gln311His,MUTYH:NM_001048173.1:missense:MODERATE:exon12/16:c.930G>C:p.Gln310His,MUTYH:NM_001293196.1:missense:MODERATE:exon12/16:c.654G>C:p.Gln218His,MUTYH:NM_001048171.1:missense:MODERATE:exon12/16:c.972G>C:p.Gln324His,MUTYH:NM_001293190.1:missense:MODERATE:exon12/16:c.975G>C:p.Gln325His,MUTYH:NM_001293192.1:missense:MODERATE:exon12/16:c.654G>C:p.Gln218His,MUTYH:NM_012222.2:missense:MODERATE:exon12/16:c.1005G>C:p.Gln335His		rs3219489	0.3135	0.2967	4266/1586/319	0.2680	0.0510	T	T,T,T,T,T,T,T,T,T,T,T,T	B,P,B,P,B,B,B	B,B,B,B,B,B,B	604933 [MUTYH (provisional) Adenomas,multiple colorectal|Gastric cancer,somatic|Colorectal adenomatous polyposis,autosomal recessive,with pilomatricomas];	RCV000034684.1 [benign]; RCV000079500.5 [benign]; RCV000131427.2 [benign]; RCV000144634.1 [benign]; 	CM083726 [CLASS=DFP MUT=ALT PHEN="Reduced activity" GENE=MUTYH]; 	COSM3751252	168	1044	1	[1] Ilnaz Sepahi 29-03-2016 batch import			MUTYH (inh=AR pLI=0.00)
chr1	45798555	45798555	T	C	hom	off-target	QUAL=5837;DP=190;AF=1.00;MQM=60	MUTYH	intron	MUTYH:NM_001128425.1:intron:MODIFIER:exon6/15:c.504+35A>G:,MUTYH:NM_001048174.1:intron:MODIFIER:exon6/15:c.420+35A>G:,MUTYH:NM_001293191.1:intron:MODIFIER:exon6/15:c.453+35A>G:,MUTYH:NM_001293195.1:intron:MODIFIER:exon7/16:c.420+35A>G:,MUTYH:NM_001048172.1:intron:MODIFIER:exon6/15:c.423+35A>G:,MUTYH:NM_001048173.1:intron:MODIFIER:exon6/15:c.420+35A>G:,MUTYH:NM_001293196.1:intron:MODIFIER:exon6/15:c.144+35A>G:,MUTYH:NM_001048171.1:intron:MODIFIER:exon6/15:c.462+35A>G:,MUTYH:NM_001293190.1:intron:MODIFIER:exon6/15:c.465+35A>G:,MUTYH:NM_001293192.1:intron:MODIFIER:exon6/15:c.144+35A>G:,MUTYH:NM_012222.2:intron:MODIFIER:exon6/15:c.495+35A>G:		rs3219487	0.9371	0.9255	52022/27990/4842	0.9134						604933 [MUTYH (provisional) Adenomas,multiple colorectal|Gastric cancer,somatic|Colorectal adenomatous polyposis,autosomal recessive,with pilomatricomas];				317	63					MUTYH (inh=AR pLI=0.00)
chr1	62713224	62713224	C	G	hom		QUAL=1165;DP=37;AF=1.00;MQM=60	KANK4	missense	KANK4:NM_181712.4:missense:MODERATE:exon9/10:c.2803G>C:p.Val935Leu		rs2941679	0.9862	0.9744	57571/31015/5111	0.9516	0.6980	T	T,T,T,T	B,B	B,B					1731	139					KANK4 (inh=n/a pLI=0.00)
chr1	62713246	62713246	G	A	het		QUAL=1311;DP=117;AF=0.44;MQM=60	KANK4	synonymous	KANK4:NM_181712.4:synonymous:LOW:exon9/10:c.2781C>T:p.His927His		rs10889315	0.3189	0.3896	9671/6170/528	0.3831									COSM426544	340	915					KANK4 (inh=n/a pLI=0.00)
chr1	62728784	62728784	A	G	hom	phylop_high	QUAL=38237;DP=1208;AF=1.00;MQM=60	KANK4	missense	KANK4:NM_181712.4:missense:MODERATE:exon7/10:c.2519T>C:p.Val840Ala		rs2666472	0.7159	0.7444	33236/17884/1580	0.7324	2.8390	T	T,T,T	B,B	B,B				COSM4144131	1009	718					KANK4 (inh=n/a pLI=0.00)
chr1	62728838	62728838	T	C	hom	phylop_high	QUAL=35339;DP=1140;AF=1.00;MQM=60	KANK4	missense	KANK4:NM_181712.4:missense:MODERATE:exon7/10:c.2465A>G:p.His822Arg		rs2258470	0.7163	0.7426	33613/18068/1595	0.7337	3.3070	T	T,T,T	B,B	B,B					1009	719					KANK4 (inh=n/a pLI=0.00)
chr1	62728861	62728861	T	C	hom		QUAL=35802;DP=1143;AF=1.00;MQM=60	KANK4	synonymous	KANK4:NM_181712.4:synonymous:LOW:exon7/10:c.2442A>G:p.Lys814Lys		rs2260581	0.7163	0.7426	33625/18069/1593	0.7336										1009	720					KANK4 (inh=n/a pLI=0.00)
chr1	62728918	62728918	G	A	hom		QUAL=5593;DP=187;AF=1.00;MQM=60	KANK4	synonymous	KANK4:NM_181712.4:synonymous:LOW:exon7/10:c.2385C>T:p.Pro795Pro		rs2262110	0.7161	0.7437	33830/18192/1608	0.7345										1011	721					KANK4 (inh=n/a pLI=0.00)
chr1	62729015	62729015	G	A	hom	off-target	QUAL=7385;DP=225;AF=1.00;MQM=60	KANK4	intron	KANK4:NM_181712.4:intron:MODIFIER:exon6/9:c.2320-32C>T:		rs2262106	0.7095	0.7535	25643/13969/1095	0.7083										91	59					KANK4 (inh=n/a pLI=0.00)
chr1	62732421	62732421	T	C	het	phylop_high	QUAL=11284;DP=889;AF=0.52;MQM=60	KANK4	missense	KANK4:NM_181712.4:missense:MODERATE:exon6/10:c.2302A>G:p.Thr768Ala		rs11207949	0.3055	0.2850	6079/2111/253	0.2813	2.3800	T	T,T,T	B,B	B,B					96	680					KANK4 (inh=n/a pLI=0.00)
chr1	62733939	62733939	G	A	het	off-target	QUAL=1676;DP=152;AF=0.46;MQM=60	KANK4	splice_region&intron	KANK4:NM_181712.4:splice_region&intron:LOW:exon5/9:c.2231+20C>T:		rs11207950	0.4669	0.4324	11564/5648/1676	0.4145										120	334					KANK4 (inh=n/a pLI=0.00)
chr1	62738904	62738904	T	C	hom		QUAL=2015;DP=76;AF=0.99;MQM=60	KANK4	synonymous	KANK4:NM_181712.4:synonymous:LOW:exon3/10:c.1872A>G:p.Pro624Pro		rs7516290	0.8005	0.7470	30811/15109/3422	0.7022										915	768					KANK4 (inh=n/a pLI=0.00)
chr1	62739198	62739198	G	A	het		QUAL=1755;DP=140;AF=0.49;MQM=60	KANK4	synonymous	KANK4:NM_181712.4:synonymous:LOW:exon3/10:c.1578C>T:p.Ser526Ser		rs17855078	0.2506	0.3085	6308/3987/186	0.3023										215	870					KANK4 (inh=n/a pLI=0.00)
chr1	62740065	62740065	A	G	het		QUAL=1450;DP=128;AF=0.48;MQM=60	KANK4	synonymous	KANK4:NM_181712.4:synonymous:LOW:exon3/10:c.711T>C:p.Gly237Gly		rs12127930	0.4822	0.4515	12895/6511/1987	0.4422									COSM4144132	379	962					KANK4 (inh=n/a pLI=0.00)
chr1	62740446	62740446	T	C	hom		QUAL=7384;DP=239;AF=1.00;MQM=60	KANK4	synonymous	KANK4:NM_181712.4:synonymous:LOW:exon3/10:c.330A>G:p.Pro110Pro		rs2666506	0.8045	0.7448	33966/15906/3719	0.7091										916	768					KANK4 (inh=n/a pLI=0.00)
chr1	62740449	62740449	T	C	hom		QUAL=7384;DP=239;AF=1.00;MQM=60	KANK4	synonymous	KANK4:NM_181712.4:synonymous:LOW:exon3/10:c.327A>G:p.Ser109Ser		rs2666507	0.7810	0.7374	33241/15890/3051	0.7198										914	769					KANK4 (inh=n/a pLI=0.00)
chr1	62740781	62740781	A	-	het	off-target	QUAL=265;DP=121;AF=0.20;MQM=60	KANK4	intron	KANK4:NM_181712.4:intron:MODIFIER:exon2/9:c.17-22delT:		rs761923018	0.0000	0.1967	0/0/0	0.1312										0	0					KANK4 (inh=n/a pLI=0.00)
chr1	78578177	78578177	T	C	het		QUAL=4972;DP=413;AF=0.46;MQM=60	GIPC2	intron	GIPC2:NM_017655.5:intron:MODIFIER:exon3/5:c.608-6900T>C:,GIPC2:NM_001304725.1:intron:MODIFIER:exon3/5:c.386-6900T>C:		rs6666954	0.4489	0.3224	6753/2474/1523	0.3067										101	360					GIPC2 (inh=n/a pLI=0.00)
chr1	120458004	120458004	A	T	het		QUAL=1768;DP=133;AF=0.55;MQM=60	NOTCH2	synonymous	NOTCH2:NM_024408.3:synonymous:LOW:exon34/34:c.7341T>A:p.Gly2447Gly		rs6685892	0.1925	0.1293	1431/359/637	0.1249						600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];				17	399					NOTCH2 (inh=n/a pLI=1.00)
chr1	120471857	120471857	C	T	het	off-target	QUAL=525;DP=29;AF=0.69;MQM=60	NOTCH2	intron	NOTCH2:NM_024408.3:intron:MODIFIER:exon22/33:c.3656-22G>A:		rs2493392	0.1925	0.1290	1405/346/625	0.1247						600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];				5	101					NOTCH2 (inh=n/a pLI=1.00)
chr1	120477998	120477998	C	A	het	off-target;low_DP	QUAL=286;DP=19;AF=0.63;MQM=60	NOTCH2	3'UTR,intron	NOTCH2:NM_001200001.1:3'UTR:MODIFIER:exon22/22:c.*44G>T:,NOTCH2:NM_024408.3:intron:MODIFIER:exon22/33:c.3655+97G>T:		rs2453056	0.3013	0.1872	2978/490/1358	0.1774						600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];				4	35					NOTCH2 (inh=n/a pLI=1.00)
chr1	120478285	120478285	T	C	het	off-target	QUAL=11662;DP=892;AF=0.51;MQM=60	NOTCH2	intron	NOTCH2:NM_024408.3:intron:MODIFIER:exon21/33:c.3523-58A>G:,NOTCH2:NM_001200001.1:intron:MODIFIER:exon21/21:c.3523-58A>G:		rs5025718	0.6044	0.0000	0/0/0	0.1451						600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];				118	33					NOTCH2 (inh=n/a pLI=1.00)
chr1	120484421	120484421	G	A	het	off-target	QUAL=762;DP=65;AF=0.49;MQM=60	NOTCH2	intron	NOTCH2:NM_024408.3:intron:MODIFIER:exon17/33:c.2753-44C>T:,NOTCH2:NM_001200001.1:intron:MODIFIER:exon17/21:c.2753-44C>T:		rs2493420	0.2714	0.1844	2345/431/880	0.1685						600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];				6	81					NOTCH2 (inh=n/a pLI=1.00)
chr1	120496119	120496119	A	T	het	off-target	QUAL=7154;DP=639;AF=0.45;MQM=60	NOTCH2	intron	NOTCH2:NM_024408.3:intron:MODIFIER:exon14/33:c.2365+47T>A:,NOTCH2:NM_001200001.1:intron:MODIFIER:exon14/21:c.2365+47T>A:		rs7534585	0.1923	0.1284	1418/354/631	0.1236						600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];				0	30					NOTCH2 (inh=n/a pLI=1.00)
chr1	120496127	120496127	A	C	het	off-target	QUAL=7123;DP=638;AF=0.45;MQM=60	NOTCH2	intron	NOTCH2:NM_024408.3:intron:MODIFIER:exon14/33:c.2365+39T>G:,NOTCH2:NM_001200001.1:intron:MODIFIER:exon14/21:c.2365+39T>G:		rs7534586	0.1923	0.1283	1417/353/631	0.1236						600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];				0	30					NOTCH2 (inh=n/a pLI=1.00)
chr1	120512104	120512104	T	C	hom	off-target	QUAL=18002;DP=571;AF=1.00;MQM=60	NOTCH2	intron	NOTCH2:NM_024408.3:intron:MODIFIER:exon6/33:c.1108+30A>G:,NOTCH2:NM_001200001.1:intron:MODIFIER:exon6/21:c.1108+30A>G:		rs2493409	0.9786	0.9929	54659/30854/4055	0.9472						600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];				0	0					NOTCH2 (inh=n/a pLI=1.00)
chr1	120529750	120529750	A	C	het	off-target	QUAL=11339;DP=925;AF=0.48;MQM=60	NOTCH2	intron	NOTCH2:NM_024408.3:intron:MODIFIER:exon4/33:c.752-45T>G:,NOTCH2:NM_001200001.1:intron:MODIFIER:exon4/21:c.752-45T>G:		rs2453040	0.1907	0.1274	1359/328/608	0.1222						600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];				0	30					NOTCH2 (inh=n/a pLI=1.00)
chr1	120539331	120539331	C	T	het	low_MQM	QUAL=25003;DP=1918;AF=0.52;MQM=49	NOTCH2	intron	NOTCH2:NM_024408.3:intron:MODIFIER:exon4/33:c.751+289G>A:,NOTCH2:NM_001200001.1:intron:MODIFIER:exon4/21:c.751+289G>A:		rs2124109	0.0000	0.4411	0/0/0	0.0101						600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];			COSM248829	0	1537					NOTCH2 (inh=n/a pLI=1.00)
chr1	120611496	120611496	C	A	het	low_MQM	QUAL=276;DP=41;AF=0.49;MQM=47	NOTCH2	intron	NOTCH2:NM_024408.3:intron:MODIFIER:exon1/33:c.73+452G>T:,NOTCH2:NM_001200001.1:intron:MODIFIER:exon1/21:c.73+452G>T:		rs2794164	0.0000	0.0662	12/1/1	0.0088						600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];				21	494					NOTCH2 (inh=n/a pLI=1.00)
chr1	120611960	120611960	C	T	het	low_MQM	QUAL=4582;DP=1978;AF=0.21;MQM=47	NOTCH2	missense	NOTCH2:NM_024408.3:missense:MODERATE:exon1/34:c.61G>A:p.Ala21Thr,NOTCH2:NM_001200001.1:missense:MODERATE:exon1/22:c.61G>A:p.Ala21Thr		rs2603926	0.0000	0.3634	0/0/0	0.0029	0.4330	T	T	B,B	B,B	600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];			COSM1600651	0	807					NOTCH2 (inh=n/a pLI=1.00)
chr1	120611964	120611964	G	C	het		QUAL=16593;DP=1978;AF=0.38;MQM=59	NOTCH2	missense	NOTCH2:NM_024408.3:missense:MODERATE:exon1/34:c.57C>G:p.Cys19Trp,NOTCH2:NM_001200001.1:missense:MODERATE:exon1/22:c.57C>G:p.Cys19Trp		rs11810554	0.0000	0.4493	3/1/2	0.0210	0.7660	T,T	.,T	.,B,B	.,B,B	600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];			COSM132738	6	2080					NOTCH2 (inh=n/a pLI=1.00)
chr1	120612003	120612004	GG	-	het	low_MQM;anno_high_impact	QUAL=3950;DP=2047;AF=0.20;MQM=48	NOTCH2	frameshift	NOTCH2:NM_024408.3:frameshift:HIGH:exon1/34:c.17_18delCC:p.Pro6fs,NOTCH2:NM_001200001.1:frameshift:HIGH:exon1/22:c.17_18delCC:p.Pro6fs		rs864309621	0.0000	0.4057	0/0/0	0.0088						600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];	RCV000202675.1 [benign]; 		COSM132830	0	877	2	[3] old entry - no details available [2] ahdoeha1 12.08.2016		n/a (wahrscheinlich durch Pseudogen)	NOTCH2 (inh=n/a pLI=1.00)
chr1	120612006	120612006	G	A	het		QUAL=18605;DP=2048;AF=0.39;MQM=58	NOTCH2	synonymous	NOTCH2:NM_024408.3:synonymous:LOW:exon1/34:c.15C>T:p.Arg5Arg,NOTCH2:NM_001200001.1:synonymous:LOW:exon1/22:c.15C>T:p.Arg5Arg		rs4021006	0.3940	0.4638	259/151/10	0.0257	1.0740					600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];	RCV000173523.1 [uncertain significance]; 		COSM1320072	4	2074					NOTCH2 (inh=n/a pLI=1.00)
chr1	120612034	120612034	T	G	het	low_MQM	QUAL=3549;DP=2046;AF=0.20;MQM=47	NOTCH2	5'UTR	NOTCH2:NM_024408.3:5'UTR:MODIFIER:exon1/34:c.-14A>C:,NOTCH2:NM_001200001.1:5'UTR:MODIFIER:exon1/22:c.-14A>C:	(CGC)n	rs201668322	0.0000	0.2585	0/0/0	0.0010										0	533					NOTCH2 (inh=n/a pLI=1.00)
chr2	17941423	17941423	T	G	hom	off-target	QUAL=1007;DP=33;AF=1.00;MQM=60	GEN1	intron	GEN1:NM_001130009.1:intron:MODIFIER:exon2/13:c.161+52T>G:,GEN1:NM_182625.3:intron:MODIFIER:exon2/13:c.161+52T>G:		rs2555072	0.7089	0.6821	28034/12149/1142	0.6596										64	74					GEN1 (inh=n/a pLI=0.00)
chr2	17942775	17942775	T	A	hom		QUAL=3038;DP=92;AF=1.00;MQM=60	GEN1	missense	GEN1:NM_001130009.1:missense:MODERATE:exon3/14:c.274T>A:p.Ser92Thr,GEN1:NM_182625.3:missense:MODERATE:exon3/14:c.274T>A:p.Ser92Thr		rs1812152	0.8137	0.7138	31946/12878/3045	0.6928	0.5670	T	T,T,T,T	B	B					752	865					GEN1 (inh=n/a pLI=0.00)
chr2	17954027	17954027	G	A	hom		QUAL=972;DP=30;AF=1.00;MQM=60	GEN1	missense	GEN1:NM_001130009.1:missense:MODERATE:exon8/14:c.929G>A:p.Ser310Asn,GEN1:NM_182625.3:missense:MODERATE:exon8/14:c.929G>A:p.Ser310Asn		rs300175	0.9770	0.9932	59666/33260/4705	0.9644	-2.1950	T	T,T,T	B	B					1873	1					GEN1 (inh=n/a pLI=0.00)
chr2	17954421	17954421	C	G	hom	off-target	QUAL=3002;DP=93;AF=1.00;MQM=60	GEN1	intron	GEN1:NM_001130009.1:intron:MODIFIER:exon9/13:c.990+22C>G:,GEN1:NM_182625.3:intron:MODIFIER:exon9/13:c.990+22C>G:		rs300177	0.8115	0.7165	31145/12559/2772	0.6891										238	237					GEN1 (inh=n/a pLI=0.00)
chr2	17962450	17962450	A	G	hom		QUAL=3083;DP=96;AF=1.00;MQM=60	GEN1	synonymous	GEN1:NM_001130009.1:synonymous:LOW:exon14/14:c.1971A>G:p.Glu657Glu,GEN1:NM_182625.3:synonymous:LOW:exon14/14:c.1971A>G:p.Glu657Glu		rs300168	0.5739	0.5758	22044/8822/268	0.5699										510	942					GEN1 (inh=n/a pLI=0.00)
chr2	17962518	17962518	C	T	hom		QUAL=3598;DP=112;AF=1.00;MQM=60	GEN1	missense	GEN1:NM_001130009.1:missense:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile,GEN1:NM_182625.3:missense:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile		rs300169	0.7580	0.6981	30600/12834/1870	0.6714	0.1800	T	T,T,T	B	B					753	860					GEN1 (inh=n/a pLI=0.00)
chr2	47601106	47601106	T	C	het		QUAL=747;DP=42;AF=0.71;MQM=60	EPCAM	missense	EPCAM:NM_002354.2:missense:MODERATE:exon3/9:c.344T>C:p.Met115Thr		rs1126497	0.6661	0.5198	17704/6502/3641	0.5132	0.0400	T	T,T,T	B,B	B,B	185535 [EPCAM (confirmed) Diarrhea 5,with tufting enteropathy,congenital|Colorectal cancer,hereditary nonpolyposis,type 8];	RCV000162369.1 [benign]; 	CM1110060 [CLASS=DP MUT=REF PHEN="Breast cancer increased risk association with" GENE=EPCAM]; 	COSM3927762	455	1143	1	[1] Ilnaz Sepahi 29-03-2016 batch import			EPCAM (inh=n/a pLI=0.00)
chr2	47635523	47635523	-	T	het	off-target;low_QUAL;low_DP	QUAL=28;DP=19;AF=0.32;MQM=60	MSH2	splice_region&intron	MSH2:NM_000251.2:splice_region&intron:LOW:exon1/15:c.212-4dupT:,MSH2:NM_001258281.1:splice_region&intron:LOW:exon2/16:c.14-4dupT:		rs757515274	0.0000	0.1446	0/0/0	0.0955						609309 [MSH2 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 1|Muir-Torre syndrome|Mismatch repair cancer syndrome];				0	7					MSH2 (inh=n/a pLI=0.87)
chr2	48010488	48010488	G	A	het	low_DP;phylop_high;pred_pathogenic_1	QUAL=143;DP=14;AF=0.50;MQM=60	MSH6	missense,5'UTR	MSH6:NM_000179.2:missense:MODERATE:exon1/10:c.116G>A:p.Gly39Glu,MSH6:NM_001281492.1:missense:MODERATE:exon1/8:c.116G>A:p.Gly39Glu,MSH6:NM_001281493.1:5'UTR:MODIFIER:exon1/9:c.-621G>A:		rs1042821	0.2009	0.2141	1894/1004/189	0.1731	1.7010	T	T,D,T	B,B,B	B,B,B	600678 [MSH6 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 5|Endometrial cancer,familial|Mismatch repair cancer syndrome];	RCV000030258.3 [benign]; RCV000034489.1 [benign]; RCV000035318.7 [benign]; RCV000132091.2 [benign]; RCV000144626.1 [benign]; 	CM092149 [CLASS=DP MUT=ALT PHEN="Colorectal cancer association with" GENE=MSH6]; 	COSM3749667	123	802	2	[2] old entry - no details available			MSH6 (inh=AD pLI=n/a)
chr2	48018030	48018030	A	G	het	off-target	QUAL=10785;DP=929;AF=0.46;MQM=60	MSH6	intron	MSH6:NM_000179.2:intron:MODIFIER:exon1/9:c.261-36A>G:,MSH6:NM_001281492.1:intron:MODIFIER:exon1/7:c.237+7421A>G:,MSH6:NM_001281493.1:intron:MODIFIER:exon1/8:c.-476-36A>G:,MSH6:NM_001281494.1:intron:MODIFIER:exon1/9:c.-642-36A>G:		rs1800931	0.0220	0.0373	107/87/0	0.0375						600678 [MSH6 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 5|Endometrial cancer,familial|Mismatch repair cancer syndrome];	RCV000074766.2 [benign]; 			1	22					MSH6 (inh=AD pLI=n/a)
chr2	48022981	48022981	G	T	het	off-target	QUAL=281;DP=26;AF=0.46;MQM=60	MSH6	intron	MSH6:NM_000179.2:intron:MODIFIER:exon2/9:c.458-52G>T:,MSH6:NM_001281492.1:intron:MODIFIER:exon1/7:c.238-2769G>T:,MSH6:NM_001281493.1:intron:MODIFIER:exon2/8:c.-279-2769G>T:,MSH6:NM_001281494.1:intron:MODIFIER:exon2/9:c.-445-52G>T:	FLAM_C	rs1800934	0.2244	0.0000	0/0/0	0.0354						600678 [MSH6 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 5|Endometrial cancer,familial|Mismatch repair cancer syndrome];	RCV000075001.2 [benign]; 			18	107					MSH6 (inh=AD pLI=n/a)
chr2	48030692	48030692	T	A	het	low_DP	QUAL=247;DP=17;AF=0.65;MQM=60	MSH6	synonymous	MSH6:NM_000179.2:synonymous:LOW:exon5/10:c.3306T>A:p.Thr1102Thr,MSH6:NM_001281492.1:synonymous:LOW:exon3/8:c.2916T>A:p.Thr972Thr,MSH6:NM_001281493.1:synonymous:LOW:exon4/9:c.2400T>A:p.Thr800Thr,MSH6:NM_001281494.1:synonymous:LOW:exon5/10:c.2400T>A:p.Thr800Thr		rs2020910	0.0493	0.0204	196/0/0	0.0227						600678 [MSH6 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 5|Endometrial cancer,familial|Mismatch repair cancer syndrome];	RCV000030267.3 [benign]; RCV000078313.5 [benign]; RCV000162391.1 [benign]; 			2	25	1	[1] Ilnaz Sepahi 29-03-2016 batch import			MSH6 (inh=AD pLI=n/a)
chr2	48030838	48030838	A	T	het	off-target	QUAL=2490;DP=238;AF=0.49;MQM=60	MSH6	splice_region&intron	MSH6:NM_000179.2:splice_region&intron:LOW:exon5/9:c.3438+14A>T:,MSH6:NM_001281492.1:splice_region&intron:LOW:exon3/7:c.3048+14A>T:,MSH6:NM_001281493.1:splice_region&intron:LOW:exon4/8:c.2532+14A>T:,MSH6:NM_001281494.1:splice_region&intron:LOW:exon5/9:c.2532+14A>T:		rs2020911	0.4010	0.4043	10612/4778/173	0.3966						600678 [MSH6 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 5|Endometrial cancer,familial|Mismatch repair cancer syndrome];	RCV000035324.8 [benign]; RCV000074853.2 [benign]; 			125	449					MSH6 (inh=AD pLI=n/a)
chr2	48032875	48032878	CTAT	-	het	off-target	QUAL=603;DP=44;AF=0.59;MQM=60	MSH6	intron	MSH6:NM_000179.2:intron:MODIFIER:exon7/9:c.3646+35_3646+38delATCT:,MSH6:NM_001281492.1:intron:MODIFIER:exon5/7:c.3256+35_3256+38delATCT:,MSH6:NM_001281493.1:intron:MODIFIER:exon6/8:c.2740+35_2740+38delATCT:,MSH6:NM_001281494.1:intron:MODIFIER:exon7/9:c.2740+35_2740+38delATCT:		rs2234731;rs3136358;rs606231384	0.7622	0.6925	29410/15213/3345	0.6503						600678 [MSH6 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 5|Endometrial cancer,familial|Mismatch repair cancer syndrome];	RCV000074897.2 [benign]; RCV000078317.4,RCV000074897.2 [benign,benign]; RCV000078317.4,RCV000074897.2 [benign,benign]; RCV000078317.4 [benign]; 			141	149					MSH6 (inh=AD pLI=n/a)
chr2	48033551	48033551	C	G	hom	off-target	QUAL=1514;DP=48;AF=1.00;MQM=60	MSH6	intron	MSH6:NM_000179.2:intron:MODIFIER:exon8/9:c.3802-40C>G:,MSH6:NM_001281492.1:intron:MODIFIER:exon6/7:c.3412-40C>G:,MSH6:NM_001281493.1:intron:MODIFIER:exon7/8:c.2896-40C>G:,MSH6:NM_001281494.1:intron:MODIFIER:exon8/9:c.2896-40C>G:		rs3136367	0.8091	0.7426	33739/17563/4350	0.7296						600678 [MSH6 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 5|Endometrial cancer,familial|Mismatch repair cancer syndrome];	RCV000030272.3 [benign]; RCV000202099.1 [benign]; 			158	142					MSH6 (inh=AD pLI=n/a)
chr2	48033891	48033891	T	-	het	off-target	QUAL=298;DP=38;AF=0.45;MQM=60	MSH6	splice_region&intron	MSH6:NM_000179.2:splice_region&intron:LOW:exon9/9:c.4002-10delT:,MSH6:NM_001281492.1:splice_region&intron:LOW:exon7/7:c.3612-10delT:,MSH6:NM_001281493.1:splice_region&intron:LOW:exon8/8:c.3096-10delT:,MSH6:NM_001281494.1:splice_region&intron:LOW:exon9/9:c.3096-10delT:	(T)n	rs775865491;rs869223687	0.0000	0.4245	82/55/7	0.2520						600678 [MSH6 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 5|Endometrial cancer,familial|Mismatch repair cancer syndrome];	RCV000074976.2,RCV000074976.2 [likely benign,likely benign]; 			19	13					MSH6 (inh=AD pLI=n/a)
chr2	147596973	147596973	A	G	het		QUAL=10840;DP=818;AF=0.51;MQM=60	PABPC1P2-ACVR2A	intergenic_region	PABPC1P2-ACVR2A:PABPC1P2-ACVR2A:intergenic_region:MODIFIER::n.147596973A>G:		rs4411641	0.5090	0.4661	11314/4775/1636	0.4172										181	420					PABPC1P2-ACVR2A (inh=n/a pLI=n/a)
chr2	190670539	190670539	-	A	het	off-target	QUAL=45;DP=44;AF=0.20;MQM=60	PMS1	intron	PMS1:NM_000534.4:intron:MODIFIER:exon4/12:c.418+70dupA:,PMS1:NM_001128143.1:intron:MODIFIER:exon4/11:c.418+70dupA:,PMS1:NM_001128144.1:intron:MODIFIER:exon4/11:c.418+70dupA:,PMS1:NM_001289408.1:intron:MODIFIER:exon3/11:c.-111+9873dupA:,PMS1:NM_001289409.1:intron:MODIFIER:exon2/10:c.-110-12193dupA:,PMS1:NR_110332.1:intron:MODIFIER:exon5/12:n.1044+70dupA:		rs3214425;rs397751218;rs555414470	0.2153	0.2434	527/220/112	0.1498										26	178					PMS1 (inh=n/a pLI=0.00)
chr2	215595164	215595164	G	A	het	phylop_high;pred_pathogenic_2	QUAL=261;DP=27;AF=0.44;MQM=60	BARD1	missense,non_coding_exon	BARD1:NM_000465.3:missense:MODERATE:exon10/11:c.1972C>T:p.Arg658Cys,BARD1:NM_001282543.1:missense:MODERATE:exon9/10:c.1915C>T:p.Arg639Cys,BARD1:NM_001282545.1:missense:MODERATE:exon6/7:c.619C>T:p.Arg207Cys,BARD1:NM_001282548.1:missense:MODERATE:exon5/6:c.562C>T:p.Arg188Cys,BARD1:NM_001282549.1:missense:MODERATE:exon4/5:c.433C>T:p.Arg145Cys,BARD1:NR_104212.1:non_coding_exon:MODIFIER:exon9/10:n.1965C>T:,BARD1:NR_104215.1:non_coding_exon:MODIFIER:exon8/9:n.1908C>T:,BARD1:NR_104216.1:non_coding_exon:MODIFIER:exon9/10:n.1164C>T:		rs3738888	0.0054	0.0079	4/2/0	0.0077	5.1650	T	D,D,D,D	P,D	B,B	601593 [BARD1 (confirmed) Breast cancer,susceptibility to];	RCV000130975.4 [benign]; RCV000205691.1 [benign]; 	CM067650 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=BARD1]; 	COSM3782110, COSM3782109	0	33	2	[2] Ilnaz Sepahi 29-03-2016 batch import	n/a (1xTP, 0xFP)		BARD1 (inh=n/a pLI=0.00)
chr2	215610638	215610638	A	G	het	off-target	QUAL=3825;DP=272;AF=0.51;MQM=60	BARD1	intron	BARD1:NM_000465.3:intron:MODIFIER:exon7/10:c.1678-60T>C:,BARD1:NM_001282543.1:intron:MODIFIER:exon6/9:c.1621-60T>C:,BARD1:NM_001282545.1:intron:MODIFIER:exon3/6:c.325-60T>C:,BARD1:NM_001282548.1:intron:MODIFIER:exon2/5:c.268-60T>C:,BARD1:NM_001282549.1:intron:MODIFIER:exon3/4:c.365-15406T>C:,BARD1:NR_104212.1:intron:MODIFIER:exon6/9:n.1671-60T>C:,BARD1:NR_104215.1:intron:MODIFIER:exon5/8:n.1614-60T>C:,BARD1:NR_104216.1:intron:MODIFIER:exon6/9:n.870-60T>C:		rs4986842	0.0030	0.0000	0/0/0	0.0013						601593 [BARD1 (confirmed) Breast cancer,susceptibility to];				0	0					BARD1 (inh=n/a pLI=0.00)
chr2	215632155	215632155	T	C	het	off-target	QUAL=1539;DP=109;AF=0.57;MQM=60	BARD1	intron	BARD1:NM_000465.3:intron:MODIFIER:exon6/10:c.1568+51A>G:,BARD1:NM_001282543.1:intron:MODIFIER:exon5/9:c.1511+51A>G:,BARD1:NM_001282545.1:intron:MODIFIER:exon2/6:c.216-14876A>G:,BARD1:NM_001282548.1:intron:MODIFIER:exon1/5:c.159-14876A>G:,BARD1:NM_001282549.1:intron:MODIFIER:exon3/4:c.364+24866A>G:,BARD1:NR_104212.1:intron:MODIFIER:exon5/9:n.1561+51A>G:,BARD1:NR_104215.1:intron:MODIFIER:exon4/8:n.1504+51A>G:,BARD1:NR_104216.1:intron:MODIFIER:exon5/9:n.760+51A>G:		rs5031009	0.3662	0.3737	8118/4428/670	0.3614						601593 [BARD1 (confirmed) Breast cancer,susceptibility to];				0	0					BARD1 (inh=n/a pLI=0.00)
chr2	215632192	215632192	G	A	het	off-target	QUAL=1787;DP=114;AF=0.57;MQM=60	BARD1	splice_region&intron,intron	BARD1:NM_000465.3:splice_region&intron:LOW:exon6/10:c.1568+14C>T:,BARD1:NM_001282543.1:splice_region&intron:LOW:exon5/9:c.1511+14C>T:,BARD1:NR_104212.1:splice_region&intron:LOW:exon5/9:n.1561+14C>T:,BARD1:NR_104215.1:splice_region&intron:LOW:exon4/8:n.1504+14C>T:,BARD1:NR_104216.1:splice_region&intron:LOW:exon5/9:n.760+14C>T:,BARD1:NM_001282545.1:intron:MODIFIER:exon2/6:c.216-14913C>T:,BARD1:NM_001282548.1:intron:MODIFIER:exon1/5:c.159-14913C>T:,BARD1:NM_001282549.1:intron:MODIFIER:exon3/4:c.364+24829C>T:		rs5031011	0.3522	0.3614	8067/4322/639	0.3527						601593 [BARD1 (confirmed) Breast cancer,susceptibility to];				119	436					BARD1 (inh=n/a pLI=0.00)
chr2	215632255	215632255	C	T	het		QUAL=3044;DP=110;AF=0.55;MQM=60	BARD1	missense,intron,non_coding_exon	BARD1:NM_000465.3:missense:MODERATE:exon6/11:c.1519G>A:p.Val507Met,BARD1:NM_001282543.1:missense:MODERATE:exon5/10:c.1462G>A:p.Val488Met,BARD1:NM_001282545.1:intron:MODIFIER:exon2/6:c.216-14976G>A:,BARD1:NM_001282548.1:intron:MODIFIER:exon1/5:c.159-14976G>A:,BARD1:NM_001282549.1:intron:MODIFIER:exon3/4:c.364+24766G>A:,BARD1:NR_104212.1:non_coding_exon:MODIFIER:exon5/10:n.1512G>A:,BARD1:NR_104215.1:non_coding_exon:MODIFIER:exon4/9:n.1455G>A:,BARD1:NR_104216.1:non_coding_exon:MODIFIER:exon5/10:n.711G>A:		rs2070094	0.3662	0.3783	8892/4897/739	0.3305	-5.2640	T	T,T	B,B	B,B	601593 [BARD1 (confirmed) Breast cancer,susceptibility to];	RCV000128872.2 [benign]; 	CM034384 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=BARD1]; 	COSM3757929, COSM3757930	356	1275	1	[1] Ilnaz Sepahi 29-03-2016 batch import			BARD1 (inh=n/a pLI=0.00)
chr2	215632256	215632256	A	G	hom		QUAL=3044;DP=110;AF=0.55;MQM=60	BARD1	synonymous,intron,non_coding_exon	BARD1:NM_000465.3:synonymous:LOW:exon6/11:c.1518T>C:p.His506His,BARD1:NM_001282543.1:synonymous:LOW:exon5/10:c.1461T>C:p.His487His,BARD1:NM_001282545.1:intron:MODIFIER:exon2/6:c.216-14977T>C:,BARD1:NM_001282548.1:intron:MODIFIER:exon1/5:c.159-14977T>C:,BARD1:NM_001282549.1:intron:MODIFIER:exon3/4:c.364+24765T>C:,BARD1:NR_104212.1:non_coding_exon:MODIFIER:exon5/10:n.1511T>C:,BARD1:NR_104215.1:non_coding_exon:MODIFIER:exon4/9:n.1454T>C:,BARD1:NR_104216.1:non_coding_exon:MODIFIER:exon5/10:n.710T>C:		rs2070093	0.7706	0.8134	40550/21983/1885	0.7319						601593 [BARD1 (confirmed) Breast cancer,susceptibility to];	RCV000162380.1 [benign]; 			1716	848	1	[1] Ilnaz Sepahi 29-03-2016 batch import			BARD1 (inh=n/a pLI=0.00)
chr2	215634055	215634055	C	T	het	off-target	QUAL=2564;DP=270;AF=0.47;MQM=60	BARD1	splice_region&intron,intron	BARD1:NM_000465.3:splice_region&intron:LOW:exon4/10:c.1315-19G>A:,BARD1:NM_001282543.1:splice_region&intron:LOW:exon3/9:c.1258-19G>A:,BARD1:NR_104212.1:splice_region&intron:LOW:exon3/9:n.1308-19G>A:,BARD1:NR_104215.1:splice_region&intron:LOW:exon2/8:n.1251-19G>A:,BARD1:NR_104216.1:splice_region&intron:LOW:exon3/9:n.507-19G>A:,BARD1:NM_001282545.1:intron:MODIFIER:exon2/6:c.216-16776G>A:,BARD1:NM_001282548.1:intron:MODIFIER:exon1/5:c.159-16776G>A:,BARD1:NM_001282549.1:intron:MODIFIER:exon3/4:c.364+22966G>A:		rs6704780	0.3652	0.3818	8670/4748/730	0.3699						601593 [BARD1 (confirmed) Breast cancer,susceptibility to];				139	472					BARD1 (inh=n/a pLI=0.00)
chr2	215645464	215645464	C	G	het		QUAL=1090;DP=79;AF=0.53;MQM=60	BARD1	missense,intron,non_coding_exon	BARD1:NM_000465.3:missense:MODERATE:exon4/11:c.1134G>C:p.Arg378Ser,BARD1:NM_001282543.1:missense:MODERATE:exon3/10:c.1077G>C:p.Arg359Ser,BARD1:NM_001282545.1:intron:MODIFIER:exon2/6:c.215+16321G>C:,BARD1:NM_001282548.1:intron:MODIFIER:exon1/5:c.159-28185G>C:,BARD1:NM_001282549.1:intron:MODIFIER:exon3/4:c.364+11557G>C:,BARD1:NR_104216.1:intron:MODIFIER:exon3/9:n.507-11428G>C:,BARD1:NR_104212.1:non_coding_exon:MODIFIER:exon3/10:n.1127G>C:,BARD1:NR_104215.1:non_coding_exon:MODIFIER:exon2/9:n.1070G>C:		rs2229571	0.4593	0.5487	19001/12920/845	0.5442	-0.6010	T	T,T	B,B	B,B	601593 [BARD1 (confirmed) Breast cancer,susceptibility to];	RCV000132162.2 [benign]; 	CM076014 [CLASS=DP MUT=ALT PHEN="Breast cancer reduced risk association with" GENE=BARD1]; 	COSM3757932, COSM3757931	947	1311	1	[1] Ilnaz Sepahi 29-03-2016 batch import			BARD1 (inh=n/a pLI=0.00)
chr2	215674090	215674090	T	G	hom	off-target	QUAL=3891;DP=122;AF=1.00;MQM=60	BARD1	intron	BARD1:NM_000465.3:intron:MODIFIER:exon1/10:c.158+46A>C:,BARD1:NM_001282543.1:intron:MODIFIER:exon1/9:c.158+46A>C:,BARD1:NM_001282545.1:intron:MODIFIER:exon1/6:c.158+46A>C:,BARD1:NM_001282548.1:intron:MODIFIER:exon1/5:c.158+46A>C:,BARD1:NM_001282549.1:intron:MODIFIER:exon1/4:c.158+46A>C:,BARD1:NR_104212.1:intron:MODIFIER:exon1/9:n.300+46A>C:,BARD1:NR_104215.1:intron:MODIFIER:exon1/8:n.300+46A>C:,BARD1:NR_104216.1:intron:MODIFIER:exon1/9:n.300+46A>C:		rs35933323	0.7448	0.7387	28663/14756/2178	0.6932						601593 [BARD1 (confirmed) Breast cancer,susceptibility to];				185	125					BARD1 (inh=n/a pLI=0.00)
chr2	215674224	215674224	G	A	het	pred_pathogenic_1	QUAL=8572;DP=821;AF=0.50;MQM=60	BARD1	missense,non_coding_exon	BARD1:NM_000465.3:missense:MODERATE:exon1/11:c.70C>T:p.Pro24Ser,BARD1:NM_001282543.1:missense:MODERATE:exon1/10:c.70C>T:p.Pro24Ser,BARD1:NM_001282545.1:missense:MODERATE:exon1/7:c.70C>T:p.Pro24Ser,BARD1:NM_001282548.1:missense:MODERATE:exon1/6:c.70C>T:p.Pro24Ser,BARD1:NM_001282549.1:missense:MODERATE:exon1/5:c.70C>T:p.Pro24Ser,BARD1:NR_104212.1:non_coding_exon:MODIFIER:exon1/10:n.212C>T:,BARD1:NR_104215.1:non_coding_exon:MODIFIER:exon1/9:n.212C>T:,BARD1:NR_104216.1:non_coding_exon:MODIFIER:exon1/10:n.212C>T:		rs1048108	0.3313	0.4377	7357/4010/154	0.3459	0.9680	T	T,D	B	B	601593 [BARD1 (confirmed) Breast cancer,susceptibility to];	RCV000162363.1 [benign]; 	CM076015 [CLASS=DP MUT=ALT PHEN="Breast cancer reduced risk association with" GENE=BARD1]; 	COSM442275, COSM1482743	363	1300	1	[1] Ilnaz Sepahi 29-03-2016 batch import			BARD1 (inh=n/a pLI=0.00)
chr2	215674323	215674323	C	G	hom	off-target	QUAL=3254;DP=107;AF=1.00;MQM=60	BARD1	5'UTR,non_coding_exon	BARD1:NM_000465.3:5'UTR:MODIFIER:exon1/11:c.-30G>C:,BARD1:NM_001282543.1:5'UTR:MODIFIER:exon1/10:c.-30G>C:,BARD1:NM_001282545.1:5'UTR:MODIFIER:exon1/7:c.-30G>C:,BARD1:NM_001282548.1:5'UTR:MODIFIER:exon1/6:c.-30G>C:,BARD1:NM_001282549.1:5'UTR:MODIFIER:exon1/5:c.-30G>C:,BARD1:NR_104212.1:non_coding_exon:MODIFIER:exon1/10:n.113G>C:,BARD1:NR_104215.1:non_coding_exon:MODIFIER:exon1/9:n.113G>C:,BARD1:NR_104216.1:non_coding_exon:MODIFIER:exon1/10:n.113G>C:		rs1129804	0.7446	0.7072	3938/1466/266	0.4951										139	88					BARD1 (inh=n/a pLI=0.00)
chr2	215674341	215674341	A	G	hom	off-target	QUAL=3159;DP=106;AF=1.00;MQM=60	BARD1	5'UTR,non_coding_exon	BARD1:NM_000465.3:5'UTR:MODIFIER:exon1/11:c.-48T>C:,BARD1:NM_001282543.1:5'UTR:MODIFIER:exon1/10:c.-48T>C:,BARD1:NM_001282545.1:5'UTR:MODIFIER:exon1/7:c.-48T>C:,BARD1:NM_001282548.1:5'UTR:MODIFIER:exon1/6:c.-48T>C:,BARD1:NM_001282549.1:5'UTR:MODIFIER:exon1/5:c.-48T>C:,BARD1:NR_104212.1:non_coding_exon:MODIFIER:exon1/10:n.95T>C:,BARD1:NR_104215.1:non_coding_exon:MODIFIER:exon1/9:n.95T>C:,BARD1:NR_104216.1:non_coding_exon:MODIFIER:exon1/10:n.95T>C:		rs17489363	0.7450	0.6895	3139/1035/182	0.4398										137	88					BARD1 (inh=n/a pLI=0.00)
chr2	220415596	220415597	GA	-	hom	off-target	QUAL=4914;DP=162;AF=0.99;MQM=60	OBSL1	intron	OBSL1:NM_015311.2:intron:MODIFIER:exon20/20:c.5684-33_5684-32delTC:		rs869062633	0.3840	0.4172	8518/5164/579	0.3859						610991 [OBSL1 (confirmed) 3-M syndrome 2];				66	185					OBSL1 (inh=n/a pLI=0.00)
chr2	220416570	220416570	C	T	hom	off-target;low_DP	QUAL=341;DP=13;AF=1.00;MQM=60	OBSL1	intron	OBSL1:NM_015311.2:intron:MODIFIER:exon19/20:c.5414-50G>A:		rs4672931	0.9287	0.9787	44431/26796/1921	0.8666						610991 [OBSL1 (confirmed) 3-M syndrome 2];				327	4					OBSL1 (inh=n/a pLI=0.00)
chr2	220416803	220416803	A	T	hom	off-target	QUAL=37811;DP=1170;AF=1.00;MQM=60	OBSL1	intron	OBSL1:NM_015311.2:intron:MODIFIER:exon19/20:c.5413+31T>A:		rs4672933	0.9782	0.9943	30079/17103/2024	0.9093						610991 [OBSL1 (confirmed) 3-M syndrome 2];				330	2					OBSL1 (inh=n/a pLI=0.00)
chr2	220416942	220416942	G	C	hom		QUAL=1045;DP=34;AF=1.00;MQM=60	OBSL1	splice_region&intron	OBSL1:NM_015311.2:splice_region&intron:LOW:exon18/20:c.5309-4C>G:		rs34490902	0.3876	0.4668	7360/4539/456	0.3865						610991 [OBSL1 (confirmed) 3-M syndrome 2];	RCV000175465.1 [benign]; 			414	1120					OBSL1 (inh=n/a pLI=0.00)
chr2	220417228	220417228	G	T	hom	off-target	QUAL=2391;DP=80;AF=1.00;MQM=60	OBSL1	intron	OBSL1:NM_015311.2:intron:MODIFIER:exon18/20:c.5308+30C>A:		rs60549465	0.3391	0.4657	7246/4585/138	0.3556						610991 [OBSL1 (confirmed) 3-M syndrome 2];				33	84					OBSL1 (inh=n/a pLI=0.00)
chr2	220417266	220417266	C	T	hom	phylop_high;pred_pathogenic_3	QUAL=4448;DP=147;AF=1.00;MQM=60	OBSL1	missense	OBSL1:NM_015311.2:missense:MODERATE:exon18/21:c.5300G>A:p.Arg1767Gln		rs59332477	0.3766	0.4683	9523/5689/497	0.3862	3.5850	T	D,T	D	D	610991 [OBSL1 (confirmed) 3-M syndrome 2];			COSM3757971	406	1118					OBSL1 (inh=n/a pLI=0.00)
chr2	220419236	220419236	T	C	hom		QUAL=14236;DP=471;AF=1.00;MQM=60	OBSL1	synonymous	OBSL1:NM_015311.2:synonymous:LOW:exon15/21:c.4836A>G:p.Thr1612Thr		rs10932813	0.9852	0.9961	59432/32960/4475	0.9293						610991 [OBSL1 (confirmed) 3-M syndrome 2];				2282	4					OBSL1 (inh=n/a pLI=0.00)
chr2	220419339	220419339	T	C	hom		QUAL=21638;DP=704;AF=1.00;MQM=60	OBSL1	missense	OBSL1:NM_015311.2:missense:MODERATE:exon15/21:c.4733A>G:p.Gln1578Arg		rs10932814	0.9611	0.9859	57479/32224/3674	0.9502	0.1950	T	T,T	B	B	610991 [OBSL1 (confirmed) 3-M syndrome 2];				2271	14					OBSL1 (inh=n/a pLI=0.00)
chr2	220420956	220420956	A	G	hom	pred_pathogenic_1	QUAL=1398;DP=55;AF=1.00;MQM=60	OBSL1	synonymous	OBSL1:NM_015311.2:synonymous:LOW:exon14/21:c.4395T>C:p.Asp1465Asp,OBSL1:NM_001173431.1:synonymous:LOW:exon14/14:c.4395T>C:p.Asp1465Asp		rs10932816	0.9637	0.9901	56732/32015/3610	0.9212	-3.7700	T	D,.			610991 [OBSL1 (confirmed) 3-M syndrome 2];			COSM4133493	2289	5					OBSL1 (inh=n/a pLI=0.00)
chr2	220421417	220421417	C	G	hom		QUAL=23446;DP=736;AF=1.00;MQM=60	OBSL1	missense	OBSL1:NM_015311.2:missense:MODERATE:exon13/21:c.4095G>C:p.Glu1365Asp,OBSL1:NM_001173431.1:missense:MODERATE:exon13/14:c.4095G>C:p.Glu1365Asp		rs1983210	0.7246	0.7461	32983/18089/1813	0.7293	0.9020	T,T	T,T,T,T,.	P,P,B,.	B,P,B,.	610991 [OBSL1 (confirmed) 3-M syndrome 2];			COSM442368	1326	845					OBSL1 (inh=n/a pLI=0.00)
chr2	220421456	220421456	C	A	hom	off-target	QUAL=22661;DP=688;AF=1.00;MQM=60	OBSL1	splice_region&intron	OBSL1:NM_015311.2:splice_region&intron:LOW:exon12/20:c.4067-11G>T:,OBSL1:NM_001173431.1:splice_region&intron:LOW:exon12/13:c.4067-11G>T:		rs1983211	0.1170	0.1859	1511/912/3	0.1576						610991 [OBSL1 (confirmed) 3-M syndrome 2];				32	186					OBSL1 (inh=n/a pLI=0.00)
chr2	220422029	220422029	G	A	hom	off-target	QUAL=4770;DP=167;AF=1.00;MQM=60	OBSL1	intron	OBSL1:NM_015311.2:intron:MODIFIER:exon12/20:c.4066+36C>T:,OBSL1:NM_001173431.1:intron:MODIFIER:exon12/13:c.4066+36C>T:		rs55873563	0.1188	0.1828	158/124/3	0.0863						610991 [OBSL1 (confirmed) 3-M syndrome 2];				17	85					OBSL1 (inh=n/a pLI=0.00)
chr2	220422400	220422400	C	G	hom	off-target	QUAL=10361;DP=382;AF=1.00;MQM=60	OBSL1	intron	OBSL1:NM_015311.2:intron:MODIFIER:exon11/20:c.3791-60G>C:,OBSL1:NM_001173431.1:intron:MODIFIER:exon11/13:c.3791-60G>C:		rs2278200	0.4087	0.0000	0/0/0	0.0836						610991 [OBSL1 (confirmed) 3-M syndrome 2];				0	0					OBSL1 (inh=n/a pLI=0.00)
chr2	220422686	220422686	C	T	het	pred_pathogenic_2	QUAL=539;DP=64;AF=0.44;MQM=60	OBSL1	missense	OBSL1:NM_015311.2:missense:MODERATE:exon11/21:c.3649G>A:p.Glu1217Lys,OBSL1:NM_001173431.1:missense:MODERATE:exon11/14:c.3649G>A:p.Glu1217Lys		rs72957510	0.0070	0.0061	1/1/0	0.0053	0.5010	T	T,D,T,T	P,B,D,B	P,B,P,B	610991 [OBSL1 (confirmed) 3-M syndrome 2];	RCV000174131.1 [benign]; 			2	38					OBSL1 (inh=n/a pLI=0.00)
chr2	220422774	220422774	A	G	hom		QUAL=24045;DP=760;AF=1.00;MQM=60	OBSL1	synonymous	OBSL1:NM_015311.2:synonymous:LOW:exon11/21:c.3561T>C:p.Pro1187Pro,OBSL1:NM_001173431.1:synonymous:LOW:exon11/14:c.3561T>C:p.Pro1187Pro		rs2278201	0.4191	0.4303	11375/6202/1290	0.4221	-4.6180	T				610991 [OBSL1 (confirmed) 3-M syndrome 2];			COSM3757974	377	1131					OBSL1 (inh=n/a pLI=0.00)
chr2	220428381	220428381	A	T	het	off-target	QUAL=3406;DP=282;AF=0.45;MQM=60	OBSL1	intron	OBSL1:NM_015311.2:intron:MODIFIER:exon6/20:c.2408-32T>A:,OBSL1:NM_001173431.1:intron:MODIFIER:exon6/13:c.2408-32T>A:,OBSL1:NM_001173408.1:intron:MODIFIER:exon6/8:c.2408-32T>A:		rs2303543	0.5567	0.6462	25389/15212/464	0.6306						610991 [OBSL1 (confirmed) 3-M syndrome 2];				147	144					OBSL1 (inh=n/a pLI=0.00)
chr2	220430203	220430203	C	T	hom		QUAL=23697;DP=741;AF=1.00;MQM=60	OBSL1	missense	OBSL1:NM_015311.2:missense:MODERATE:exon6/21:c.2168G>A:p.Arg723Lys,OBSL1:NM_001173431.1:missense:MODERATE:exon6/14:c.2168G>A:p.Arg723Lys,OBSL1:NM_001173408.1:missense:MODERATE:exon6/9:c.2168G>A:p.Arg723Lys		rs1039898	0.7927	0.8655	45551/27067/1985	0.8544	-0.1200	T	T,T,T,T,T	B,B,B,B	B,B,B,B	610991 [OBSL1 (confirmed) 3-M syndrome 2];			COSM4133496, COSM4133495	1843	407					OBSL1 (inh=n/a pLI=0.00)
chr2	220432709	220432709	A	T	het	off-target	QUAL=9152;DP=726;AF=0.48;MQM=60	OBSL1	splice_region&intron	OBSL1:NM_015311.2:splice_region&intron:LOW:exon2/20:c.1283-18T>A:,OBSL1:NM_001173431.1:splice_region&intron:LOW:exon2/13:c.1283-18T>A:,OBSL1:NM_001173408.1:splice_region&intron:LOW:exon2/8:c.1283-18T>A:		rs2292360	0.3678	0.4234	11346/6780/170	0.4181						610991 [OBSL1 (confirmed) 3-M syndrome 2];				142	301					OBSL1 (inh=n/a pLI=0.00)
chr2	220435034	220435034	A	G	hom		QUAL=20377;DP=650;AF=1.00;MQM=60	OBSL1	synonymous	OBSL1:NM_015311.2:synonymous:LOW:exon1/21:c.921T>C:p.Leu307Leu,OBSL1:NM_001173431.1:synonymous:LOW:exon1/14:c.921T>C:p.Leu307Leu,OBSL1:NM_001173408.1:synonymous:LOW:exon1/9:c.921T>C:p.Leu307Leu		rs10180675	0.7833	0.8644	44374/26362/1758	0.8423						610991 [OBSL1 (confirmed) 3-M syndrome 2];	RCV000173448.1 [benign]; 		COSM4133504, COSM4133503	1845	403					OBSL1 (inh=n/a pLI=0.00)
chr2	220435375	220435375	G	A	het	low_DP	QUAL=376;DP=19;AF=0.84;MQM=60	OBSL1	synonymous	OBSL1:NM_015311.2:synonymous:LOW:exon1/21:c.580C>T:p.Leu194Leu,OBSL1:NM_001173431.1:synonymous:LOW:exon1/14:c.580C>T:p.Leu194Leu,OBSL1:NM_001173408.1:synonymous:LOW:exon1/9:c.580C>T:p.Leu194Leu		rs1061399	0.3588	0.4448	1102/271/4	0.1661						610991 [OBSL1 (confirmed) 3-M syndrome 2];			COSM4133505, COSM442371	475	1052					OBSL1 (inh=n/a pLI=0.00)
chr3	10076843	10076844	TT	-	het	off-target	QUAL=1941;DP=168;AF=0.45;MQM=60	FANCD2	splice_region&intron	FANCD2:NM_033084.3:splice_region&intron:LOW:exon5/42:c.378-6_378-5delTT:,FANCD2:NM_001018115.1:splice_region&intron:LOW:exon5/43:c.378-6_378-5delTT:		rs397897610;rs55973240	0.2115	0.2080	2296/839/957	0.1594						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];				26	182					FANCD2 (inh=AR pLI=0.00)
chr3	10076975	10076975	A	C	het	off-target	QUAL=1279;DP=99;AF=0.48;MQM=60	FANCD2	intron	FANCD2:NM_033084.3:intron:MODIFIER:exon6/42:c.438+58A>C:,FANCD2:NM_001018115.1:intron:MODIFIER:exon6/43:c.438+58A>C:		rs17032276	0.1811	0.0000	0/0/0	0.0318						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];				8	88					FANCD2 (inh=AR pLI=0.00)
chr3	10077955	10077955	A	G	het	off-target	QUAL=553;DP=46;AF=0.63;MQM=60	FANCD2	splice_region&intron	FANCD2:NM_033084.3:splice_region&intron:LOW:exon6/42:c.439-16A>G:,FANCD2:NM_001018115.1:splice_region&intron:LOW:exon6/43:c.439-16A>G:		rs17032278	0.1821	0.1662	1918/849/580	0.1617						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];				25	183					FANCD2 (inh=AR pLI=0.00)
chr3	10081545	10081545	G	C	het	off-target	QUAL=5185;DP=484;AF=0.47;MQM=60	FANCD2	splice_region&intron	FANCD2:NM_033084.3:splice_region&intron:LOW:exon9/42:c.695+16G>C:,FANCD2:NM_001018115.1:splice_region&intron:LOW:exon9/43:c.695+16G>C:		rs17032283	0.1821	0.1659	1907/843/573	0.1627						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];				29	225					FANCD2 (inh=AR pLI=0.00)
chr3	10084224	10084224	C	T	het	off-target	QUAL=14505;DP=1027;AF=0.54;MQM=60	FANCD2	splice_region&intron	FANCD2:NM_033084.3:splice_region&intron:LOW:exon10/42:c.784-19C>T:,FANCD2:NM_001018115.1:splice_region&intron:LOW:exon10/43:c.784-19C>T:		rs9879080	0.2107	0.1743	2300/854/954	0.1686						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];				23	171					FANCD2 (inh=AR pLI=0.00)
chr3	10085130	10085130	C	G	het	off-target;low_DP	QUAL=62;DP=10;AF=0.40;MQM=60	FANCD2	intron	FANCD2:NM_033084.3:intron:MODIFIER:exon12/42:c.990-38C>G:,FANCD2:NM_001018115.1:intron:MODIFIER:exon12/43:c.990-38C>G:		rs9809061	0.2117	0.1758	2122/785/871	0.1665						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];				8	87					FANCD2 (inh=AR pLI=0.00)
chr3	10085536	10085536	A	G	het		QUAL=2144;DP=294;AF=0.43;MQM=60	FANCD2	synonymous	FANCD2:NM_033084.3:synonymous:LOW:exon14/43:c.1122A>G:p.Val374Val,FANCD2:NM_001018115.1:synonymous:LOW:exon14/44:c.1122A>G:p.Val374Val		rs34046352	0.0000	0.1239	37/0/37	0.0074						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];			COSM3759562, COSM3759563	0	780	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCD2 (inh=AR pLI=0.00)
chr3	10089723	10089723	G	A	het	low_MQM	QUAL=90;DP=145;AF=0.21;MQM=39	FANCD2	synonymous	FANCD2:NM_033084.3:synonymous:LOW:exon16/43:c.1401G>A:p.Thr467Thr,FANCD2:NM_001018115.1:synonymous:LOW:exon16/44:c.1401G>A:p.Thr467Thr		rs12330369	0.0000	0.4495	0/0/0	0.0059						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];			COSM4157098, COSM4157099	0	1992	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCD2 (inh=AR pLI=0.00)
chr3	10089773	10089773	A	C	het	off-target	QUAL=1152;DP=117;AF=0.42;MQM=60	FANCD2	intron	FANCD2:NM_033084.3:intron:MODIFIER:exon16/42:c.1413+38A>C:,FANCD2:NM_001018115.1:intron:MODIFIER:exon16/43:c.1413+38A>C:		rs7615646	0.1791	0.1404	234/75/40	0.0306						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];				0	65					FANCD2 (inh=AR pLI=0.00)
chr3	10094206	10094206	-	T	het	off-target	QUAL=110;DP=25;AF=0.36;MQM=60	FANCD2	intron	FANCD2:NM_033084.3:intron:MODIFIER:exon18/42:c.1656+38dupT:,FANCD2:NM_001018115.1:intron:MODIFIER:exon18/43:c.1656+38dupT:		rs544799101	0.0000	0.1695	52/15/29	0.1123						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];				2	45					FANCD2 (inh=AR pLI=0.00)
chr3	10106532	10106532	C	T	het		QUAL=1274;DP=76;AF=0.63;MQM=60	FANCD2	missense	FANCD2:NM_033084.3:missense:MODERATE:exon23/43:c.2141C>T:p.Pro714Leu,FANCD2:NM_001018115.1:missense:MODERATE:exon23/44:c.2141C>T:p.Pro714Leu		rs3864017	0.0000	0.1545	988/525/211	0.0161	-0.1810	T	T,T,T,T	B,B	B,B	613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];	RCV000120989.1 [not provided]; 			59	709	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCD2 (inh=AR pLI=0.00)
chr3	10107520	10107520	G	T	het	off-target	QUAL=12200;DP=1013;AF=0.48;MQM=60	FANCD2	intron	FANCD2:NM_033084.3:intron:MODIFIER:exon24/42:c.2270-28G>T:,FANCD2:NM_001018115.1:intron:MODIFIER:exon24/43:c.2270-28G>T:		rs34608006	0.1753	0.1729	1736/780/494	0.1566						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];				5	46					FANCD2 (inh=AR pLI=0.00)
chr3	10119917	10119917	T	C	het	off-target	QUAL=741;DP=72;AF=0.46;MQM=60	FANCD2	intron	FANCD2:NM_033084.3:intron:MODIFIER:exon30/42:c.2976+36T>C:,FANCD2:NM_001018115.1:intron:MODIFIER:exon30/43:c.2976+36T>C:		rs6805869	0.2115	0.1750	2309/845/954	0.1714						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];				8	89					FANCD2 (inh=AR pLI=0.00)
chr3	10128965	10128965	-	TT	het	off-target	QUAL=132;DP=42;AF=0.10;MQM=60	FANCD2,FANCD2OS	intron	FANCD2:NM_033084.3:intron:MODIFIER:exon34/42:c.3466+35_3466+36dupTT:,FANCD2:NM_001018115.1:intron:MODIFIER:exon34/43:c.3466+35_3466+36dupTT:,FANCD2OS:NM_173472.1:intron:MODIFIER:exon2/2:c.*44-5752_*44-5751dupAA:		rs371321981	0.0000	0.0230	49/13/22	0.0189						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];				1	0					FANCD2 (inh=AR pLI=0.00), FANCD2OS (inh=n/a pLI=0.05)
chr3	10132127	10132127	A	T	het	off-target;low_QUAL	QUAL=14;DP=28;AF=0.21;MQM=57	FANCD2,FANCD2OS	intron	FANCD2:NM_033084.3:intron:MODIFIER:exon37/42:c.3777+58A>T:,FANCD2:NM_001018115.1:intron:MODIFIER:exon37/43:c.3777+58A>T:,FANCD2OS:NM_173472.1:intron:MODIFIER:exon2/2:c.*44-8912T>A:			0.0000	0.0000	0/0/0	0.0001						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];				0	0					FANCD2 (inh=AR pLI=0.00), FANCD2OS (inh=n/a pLI=0.05)
chr3	10133949	10133949	A	G	het	off-target	QUAL=2575;DP=178;AF=0.55;MQM=60	FANCD2,FANCD2OS	splice_region&intron,intron	FANCD2:NM_033084.3:splice_region&intron:LOW:exon38/42:c.3849+13A>G:,FANCD2:NM_001018115.1:splice_region&intron:LOW:exon38/43:c.3849+13A>G:,FANCD2OS:NM_173472.1:intron:MODIFIER:exon2/2:c.*44-10734T>C:		rs9811771	0.2542	0.1918	2872/852/1283	0.1877						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];				26	190					FANCD2 (inh=AR pLI=0.00), FANCD2OS (inh=n/a pLI=0.05)
chr3	10138069	10138069	T	G	het		QUAL=9089;DP=785;AF=0.47;MQM=60	FANCD2,FANCD2OS	synonymous,intron	FANCD2:NM_033084.3:synonymous:LOW:exon42/43:c.4098T>G:p.Leu1366Leu,FANCD2:NM_001018115.1:synonymous:LOW:exon42/44:c.4098T>G:p.Leu1366Leu,FANCD2OS:NM_173472.1:intron:MODIFIER:exon2/2:c.*43+7813A>C:		rs2272125	0.2422	0.1868	2695/850/1177	0.1836						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];		CM066071 [CLASS=DP MUT=ALT PHEN="Breast cancer increased risk association with" GENE=FANCD2]; 	COSM3759565, COSM3759566	75	723	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCD2 (inh=AR pLI=0.00), FANCD2OS (inh=n/a pLI=0.05)
chr3	10138189	10138189	T	C	het	off-target	QUAL=2797;DP=207;AF=0.53;MQM=60	FANCD2,FANCD2OS	intron	FANCD2:NM_033084.3:intron:MODIFIER:exon42/42:c.4185+33T>C:,FANCD2:NM_001018115.1:intron:MODIFIER:exon42/43:c.4185+33T>C:,FANCD2OS:NM_173472.1:intron:MODIFIER:exon2/2:c.*43+7693A>G:		rs2272124	0.2418	0.1869	2676/845/1171	0.1833						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];				9	89					FANCD2 (inh=AR pLI=0.00), FANCD2OS (inh=n/a pLI=0.05)
chr3	10140671	10140671	G	A	het	off-target	QUAL=10294;DP=680;AF=0.54;MQM=60	FANCD2,FANCD2OS	3'UTR,intron	FANCD2:NM_033084.3:3'UTR:MODIFIER:exon43/43:c.*37G>A:,FANCD2:NM_001018115.1:intron:MODIFIER:exon43/43:c.4281+172G>A:,FANCD2OS:NM_173472.1:intron:MODIFIER:exon2/2:c.*43+5211C>T:		rs7626117	0.3452	0.2285	4893/1088/2964	0.2213						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];				12	116					FANCD2 (inh=AR pLI=0.00), FANCD2OS (inh=n/a pLI=0.05)
chr3	37067097	37067097	A	T	het	off-target	QUAL=1702;DP=268;AF=0.31;MQM=59	MLH1	intron	MLH1:NM_000249.3:intron:MODIFIER:exon11/18:c.1039-31A>T:,MLH1:NM_001258271.1:intron:MODIFIER:exon11/16:c.1039-31A>T:,MLH1:NM_001258273.1:intron:MODIFIER:exon10/17:c.316-31A>T:,MLH1:NM_001167617.1:intron:MODIFIER:exon11/18:c.745-31A>T:,MLH1:NM_001167618.1:intron:MODIFIER:exon11/18:c.316-31A>T:,MLH1:NM_001167619.1:intron:MODIFIER:exon10/17:c.316-31A>T:,MLH1:NM_001258274.1:intron:MODIFIER:exon12/19:c.316-31A>T:	(TA)n	rs59684491	0.0000	0.0613	2/0/0	0.0036						120436 [MLH1 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 2|Mismatch repair cancer syndrome|Muir-Torre syndrome];				0	0					MLH1 (inh=n/a pLI=0.74)
chr3	37067099	37067099	A	T	het	off-target	QUAL=1702;DP=268;AF=0.31;MQM=59	MLH1	intron	MLH1:NM_000249.3:intron:MODIFIER:exon11/18:c.1039-29A>T:,MLH1:NM_001258271.1:intron:MODIFIER:exon11/16:c.1039-29A>T:,MLH1:NM_001258273.1:intron:MODIFIER:exon10/17:c.316-29A>T:,MLH1:NM_001167617.1:intron:MODIFIER:exon11/18:c.745-29A>T:,MLH1:NM_001167618.1:intron:MODIFIER:exon11/18:c.316-29A>T:,MLH1:NM_001167619.1:intron:MODIFIER:exon10/17:c.316-29A>T:,MLH1:NM_001258274.1:intron:MODIFIER:exon12/19:c.316-29A>T:	(TA)n	rs6771325	0.0000	0.0185	14/4/0	0.0076						120436 [MLH1 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 2|Mismatch repair cancer syndrome|Muir-Torre syndrome];				0	0					MLH1 (inh=n/a pLI=0.74)
chr3	142168331	142168331	C	T	hom		QUAL=1594;DP=49;AF=1.00;MQM=60	ATR	synonymous	ATR:NM_001184.3:synonymous:LOW:exon47/47:c.7875G>A:p.Gln2625Gln		rs1802904	0.9163	0.8646	45665/23944/4913	0.8579						601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];	RCV000079601.6 [other]; 			1934	612	1	[1] Ilnaz Sepahi 29-03-2016 batch import			ATR (inh=AR pLI=0.70)
chr3	142178144	142178144	C	T	het		QUAL=1052;DP=77;AF=0.55;MQM=60	ATR	missense	ATR:NM_001184.3:missense:MODERATE:exon43/47:c.7274G>A:p.Arg2425Gln		rs2229032	0.1022	0.1328	1212/874/28	0.1324	0.0440	T	T,T	B	B	601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];	RCV000145330.2 [benign]; 		COSM149485	61	661	1	[1] Ilnaz Sepahi 29-03-2016 batch import			ATR (inh=AR pLI=0.70)
chr3	142188337	142188337	A	C	het	phylop_high;pred_pathogenic_1	QUAL=9942;DP=682;AF=0.56;MQM=60	ATR	missense	ATR:NM_001184.3:missense:MODERATE:exon38/47:c.6394T>G:p.Tyr2132Asp		rs28910273	0.0020	0.0033	2/1/0	0.0035	2.3460	T	T,D	B	B	601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];	RCV000145327.1 [uncertain significance]; 			0	20	2	[2] Ilnaz Sepahi 29-03-2016 batch import			ATR (inh=AR pLI=0.70)
chr3	142215171	142215171	T	C	het	off-target;low_DP	QUAL=124;DP=8;AF=0.75;MQM=60	ATR	intron	ATR:NM_001184.3:intron:MODIFIER:exon34/46:c.5898+32A>G:	(TA)n	rs11719960	0.0000	0.0594	291/230/2	0.0172						601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];	RCV000145325.1 [likely benign]; 			9	49					ATR (inh=AR pLI=0.70)
chr3	142215178	142215178	A	C	het	off-target;low_DP	QUAL=124;DP=8;AF=0.75;MQM=60	ATR	intron	ATR:NM_001184.3:intron:MODIFIER:exon34/46:c.5898+25T>G:	(TA)n	rs7620648	0.0000	0.0000	0/0/0	0.0398						601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];	RCV000145324.1 [likely benign]; 			195	257					ATR (inh=AR pLI=0.70)
chr3	142217537	142217537	A	G	het		QUAL=3564;DP=350;AF=0.51;MQM=60	ATR	synonymous	ATR:NM_001184.3:synonymous:LOW:exon32/47:c.5460T>C:p.Tyr1820Tyr		rs2227932	0.0669	0.0942	705/391/2	0.0915						601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];	RCV000145320.2 [other]; 			32	419	1	[1] Ilnaz Sepahi 29-03-2016 batch import			ATR (inh=AR pLI=0.70)
chr3	142255090	142255090	T	C	het	off-target	QUAL=1306;DP=111;AF=0.46;MQM=60	ATR	intron	ATR:NM_001184.3:intron:MODIFIER:exon19/46:c.3726-47A>G:		rs73240314	0.1172	0.1374	1200/832/62	0.1333						601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];	RCV000145305.1 [likely benign]; 		COSN167032	0	0					ATR (inh=AR pLI=0.70)
chr3	142259707	142259707	A	-	het	off-target	QUAL=9268;DP=903;AF=0.44;MQM=60	ATR	intron	ATR:NM_001184.3:intron:MODIFIER:exon18/46:c.3581+39delT:		rs201551475	0.0000	0.4574	74/42/18	0.1266						601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];				0	0					ATR (inh=AR pLI=0.70)
chr3	142277427	142277427	A	G	het	off-target	QUAL=6988;DP=587;AF=0.48;MQM=60	ATR	intron	ATR:NM_001184.3:intron:MODIFIER:exon8/46:c.1885+39T>C:	(TAGA)n	rs73240318	0.1122	0.0745	414/288/4	0.0174						601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];	RCV000145293.1 [likely benign]; 			7	34					ATR (inh=AR pLI=0.70)
chr3	142277575	142277575	A	T	het		QUAL=3151;DP=274;AF=0.47;MQM=60	ATR	synonymous	ATR:NM_001184.3:synonymous:LOW:exon8/47:c.1776T>A:p.Gly592Gly		rs2227930	0.5980	0.5529	19239/11031/3356	0.5329						601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];	RCV000145291.5 [other]; 		COSM149486	910	1230	1	[1] Ilnaz Sepahi 29-03-2016 batch import			ATR (inh=AR pLI=0.70)
chr3	142281612	142281612	A	G	het		QUAL=6583;DP=530;AF=0.49;MQM=60	ATR	missense	ATR:NM_001184.3:missense:MODERATE:exon4/47:c.632T>C:p.Met211Thr		rs2227928	0.5974	0.5540	19098/10972/3300	0.5505	1.2730	T	T,T	B	B	601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];	RCV000079600.6 [other]; 		COSM149487	909	1228	1	[1] Ilnaz Sepahi 29-03-2016 batch import			ATR (inh=AR pLI=0.70)
chr3	156413615	156413615	C	T	hom	off-target	QUAL=1862;DP=218;AF=0.26;MQM=53	TIPARP	intron	TIPARP:NM_001184717.1:intron:MODIFIER:exon3/5:c.1087-39C>T:,TIPARP:NM_015508.4:intron:MODIFIER:exon3/5:c.1087-39C>T:,TIPARP:NM_001184718.1:intron:MODIFIER:exon3/5:c.1087-39C>T:			0.0000	0.0000	0/0/0	0.0001										0	0					TIPARP (inh=n/a pLI=1.00)
chr3	156421525	156421525	G	T	het	off-target	QUAL=5995;DP=480;AF=0.51;MQM=60	TIPARP	intron	TIPARP:NM_001184717.1:intron:MODIFIER:exon5/5:c.1526+34G>T:,TIPARP:NM_015508.4:intron:MODIFIER:exon5/5:c.1526+34G>T:,TIPARP:NM_001184718.1:intron:MODIFIER:exon5/5:c.1526+34G>T:	AluYm1	rs34277251	0.3832	0.4306	10742/5291/26	0.3948										0	0					TIPARP (inh=n/a pLI=1.00)
chr3	178917005	178917005	A	G	het	off-target	QUAL=850;DP=54;AF=0.63;MQM=60	PIK3CA	intron	PIK3CA:NM_006218.2:intron:MODIFIER:exon2/20:c.352+40A>G:		rs3729674	0.2734	0.2156	2868/1297/889	0.1982						171834 [PIK3CA (provisional) Ovarian cancer,somatic|Breast cancer,somatic|Colorectal cancer,somatic|Gastric cancer,somatic|Hepatocellular carcinoma,somatic|Nonsmall cell lung cancer,somatic|Keratosis,seborrheic,somatic|Nevus,epidermal,somatic|CLOVE syndrome,somatic|Megalencephaly-capillary malformation-polymicrogyria syndrome,somatic|Cowden syndrome 5];				0	0					PIK3CA (inh=n/a pLI=1.00)
chr3	178922274	178922274	C	A	hom	off-target	QUAL=13692;DP=480;AF=1.00;MQM=60	PIK3CA	splice_region&intron	PIK3CA:NM_006218.2:splice_region&intron:LOW:exon5/20:c.1060-17C>A:		rs2699896	0.5847	0.5614	20164/11339/3659	0.5448						171834 [PIK3CA (provisional) Ovarian cancer,somatic|Breast cancer,somatic|Colorectal cancer,somatic|Gastric cancer,somatic|Hepatocellular carcinoma,somatic|Nonsmall cell lung cancer,somatic|Keratosis,seborrheic,somatic|Nevus,epidermal,somatic|CLOVE syndrome,somatic|Megalencephaly-capillary malformation-polymicrogyria syndrome,somatic|Cowden syndrome 5];				354	464					PIK3CA (inh=n/a pLI=1.00)
chr3	178922430	178922430	A	G	hom	off-target	QUAL=1931;DP=64;AF=1.00;MQM=60	PIK3CA	intron	PIK3CA:NM_006218.2:intron:MODIFIER:exon6/20:c.1145+54A>G:		rs3729679	0.5180	0.0000	0/0/0	0.0975						171834 [PIK3CA (provisional) Ovarian cancer,somatic|Breast cancer,somatic|Colorectal cancer,somatic|Gastric cancer,somatic|Hepatocellular carcinoma,somatic|Nonsmall cell lung cancer,somatic|Keratosis,seborrheic,somatic|Nevus,epidermal,somatic|CLOVE syndrome,somatic|Megalencephaly-capillary malformation-polymicrogyria syndrome,somatic|Cowden syndrome 5];			COSN167081	0	0					PIK3CA (inh=n/a pLI=1.00)
chr3	178938747	178938747	A	T	het	off-target	QUAL=4435;DP=376;AF=0.47;MQM=55	PIK3CA	intron	PIK3CA:NM_006218.2:intron:MODIFIER:exon13/20:c.2016-27A>T:		rs6443625	0.2730	0.2911	1131/461/300	0.1736						171834 [PIK3CA (provisional) Ovarian cancer,somatic|Breast cancer,somatic|Colorectal cancer,somatic|Gastric cancer,somatic|Hepatocellular carcinoma,somatic|Nonsmall cell lung cancer,somatic|Keratosis,seborrheic,somatic|Nevus,epidermal,somatic|CLOVE syndrome,somatic|Megalencephaly-capillary malformation-polymicrogyria syndrome,somatic|Cowden syndrome 5];				31	112					PIK3CA (inh=n/a pLI=1.00)
chr3	178942431	178942431	C	G	hom	off-target;low_DP	QUAL=183;DP=7;AF=1.00;MQM=60	PIK3CA	intron	PIK3CA:NM_006218.2:intron:MODIFIER:exon15/20:c.2295-57C>G:		rs2699889	0.6294	0.0000	0/0/0	0.1074						171834 [PIK3CA (provisional) Ovarian cancer,somatic|Breast cancer,somatic|Colorectal cancer,somatic|Gastric cancer,somatic|Hepatocellular carcinoma,somatic|Nonsmall cell lung cancer,somatic|Keratosis,seborrheic,somatic|Nevus,epidermal,somatic|CLOVE syndrome,somatic|Megalencephaly-capillary malformation-polymicrogyria syndrome,somatic|Cowden syndrome 5];				63	59					PIK3CA (inh=n/a pLI=1.00)
chr4	185999587	185999587	T	A	het	off-target	QUAL=686;DP=71;AF=0.46;MQM=60	HELT-SLC25A4	intergenic_region	HELT-SLC25A4:HELT-SLC25A4:intergenic_region:MODIFIER::n.185999587T>A:		rs6818170	0.6675	0.6436	23810/13741/2802	0.5995										160	115					HELT-SLC25A4 (inh=n/a pLI=n/a)
chr5	57617403	57617403	G	C	het		QUAL=11921;DP=940;AF=0.50;MQM=60	LOC101928569-PLK2	intergenic_region	LOC101928569-PLK2:LOC101928569-PLK2:intergenic_region:MODIFIER::n.57617403G>C:	MLT1E1A	rs37535	0.5719	0.0000	0/0/0	0.5688										187	263					LOC101928569-PLK2 (inh=n/a pLI=n/a)
chr5	79950508	79950508	C	T	hom	off-target	QUAL=2919;DP=109;AF=1.00;MQM=60	MSH3,DHFR	5'UTR_premature_start_codon_gain,5'UTR,non_coding_exon	MSH3:NM_002439.4:5'UTR_premature_start_codon_gain:LOW:exon1/24:c.-39C>T:,DHFR:NM_000791.3:5'UTR:MODIFIER:exon1/6:c.-200G>A:,MSH3:NM_002439.4:5'UTR:MODIFIER:exon1/24:c.-39C>T:,DHFR:NM_001290354.1:5'UTR:MODIFIER:exon1/5:c.-306G>A:,DHFR:NM_001290357.1:5'UTR:MODIFIER:exon1/5:c.-200G>A:,DHFR:NR_110936.1:non_coding_exon:MODIFIER:exon1/4:n.293G>A:		rs1105525	0.1230	0.1997	1596/914/9	0.1309						126060 [DHFR (confirmed) Megaloblastic anemia due to dihydrofolate reductase deficiency];				19	91					MSH3 (inh=n/a pLI=0.00), DHFR (inh=n/a pLI=0.28)
chr5	79950512	79950512	A	G	hom	off-target	QUAL=2919;DP=109;AF=1.00;MQM=60	DHFR,MSH3	5'UTR,non_coding_exon	DHFR:NM_000791.3:5'UTR:MODIFIER:exon1/6:c.-204T>C:,MSH3:NM_002439.4:5'UTR:MODIFIER:exon1/24:c.-35A>G:,DHFR:NM_001290354.1:5'UTR:MODIFIER:exon1/5:c.-310T>C:,DHFR:NM_001290357.1:5'UTR:MODIFIER:exon1/5:c.-204T>C:,DHFR:NR_110936.1:non_coding_exon:MODIFIER:exon1/4:n.289T>C:		rs1105524	0.7043	0.6744	22308/11896/3085	0.5697						126060 [DHFR (confirmed) Megaloblastic anemia due to dihydrofolate reductase deficiency];				187	127					DHFR (inh=n/a pLI=0.28), MSH3 (inh=n/a pLI=0.00)
chr5	79950781	79950781	A	G	het		QUAL=420;DP=38;AF=0.47;MQM=60	MSH3,DHFR	missense&splice_region,5'UTR,non_coding_exon	MSH3:NM_002439.4:missense&splice_region:MODERATE:exon1/24:c.235A>G:p.Ile79Val,DHFR:NM_000791.3:5'UTR:MODIFIER:exon1/6:c.-473T>C:,DHFR:NM_001290354.1:5'UTR:MODIFIER:exon1/5:c.-579T>C:,DHFR:NM_001290357.1:5'UTR:MODIFIER:exon1/5:c.-473T>C:,DHFR:NR_110936.1:non_coding_exon:MODIFIER:exon1/4:n.20T>C:		rs1650697	0.7686	0.9029	4978/2224/393	0.4128	-0.4930	T	T,T	B	B	126060 [DHFR (confirmed) Megaloblastic anemia due to dihydrofolate reductase deficiency]:600887 [MSH3 (provisional) Endometrial carcinoma,somatic];		CM003459 [CLASS=DP MUT=REF PHEN="Colon cancer association with" GENE=MSH3]; 	COSM4160035	1329	878	1	[1] Ilnaz Sepahi 29-03-2016 batch import			MSH3 (inh=n/a pLI=0.00), DHFR (inh=n/a pLI=0.28)
chr5	79966178	79966178	G	A	het	off-target	QUAL=5449;DP=416;AF=0.50;MQM=60	MSH3	intron	MSH3:NM_002439.4:intron:MODIFIER:exon4/23:c.792+50G>A:		rs6151630	0.0232	0.0419	129/87/1	0.0403						600887 [MSH3 (provisional) Endometrial carcinoma,somatic];				0	0					MSH3 (inh=n/a pLI=0.00)
chr5	80149981	80149981	A	G	hom		QUAL=28046;DP=904;AF=1.00;MQM=60	MSH3	missense	MSH3:NM_002439.4:missense:MODERATE:exon21/24:c.2846A>G:p.Gln949Arg		rs184967	0.9022	0.8731	46317/23581/4199	0.8489	0.4010	T	T,T	B	B	600887 [MSH3 (provisional) Endometrial carcinoma,somatic];		CM076322 [CLASS=DP MUT=REF PHEN="Proximal colon cancer increased risk association with" GENE=MSH3]; 	COSM4160036	1695	646	1	[1] Ilnaz Sepahi 29-03-2016 batch import			MSH3 (inh=n/a pLI=0.00)
chr5	80160597	80160600	AATG	-	het	off-target;low_DP	QUAL=58;DP=16;AF=0.38;MQM=60	MSH3	intron	MSH3:NM_002439.4:intron:MODIFIER:exon21/23:c.3001-33_3001-30delTGAA:		rs34486413	0.4030	0.5059	13685/8991/244	0.4481						600887 [MSH3 (provisional) Endometrial carcinoma,somatic];				42	74					MSH3 (inh=n/a pLI=0.00)
chr5	80168937	80168937	G	A	hom		QUAL=3771;DP=114;AF=1.00;MQM=60	MSH3	missense&splice_region	MSH3:NM_002439.4:missense&splice_region:MODERATE:exon23/24:c.3133G>A:p.Ala1045Thr		rs26279	0.7202	0.7305	32457/17163/2349	0.7223	1.0140	T	T,T	B	B	600887 [MSH3 (provisional) Endometrial carcinoma,somatic];		CM076321 [CLASS=DP MUT=REF PHEN="Colorectal cancer increased risk association with" GENE=MSH3]; 		1192	999	1	[1] Ilnaz Sepahi 29-03-2016 batch import			MSH3 (inh=n/a pLI=0.00)
chr5	112162854	112162854	T	C	het		QUAL=1678;DP=184;AF=0.42;MQM=60	APC	synonymous	APC:NM_000038.5:synonymous:LOW:exon12/16:c.1458T>C:p.Tyr486Tyr,APC:NM_001127511.2:synonymous:LOW:exon10/14:c.1404T>C:p.Tyr468Tyr,APC:NM_001127510.2:synonymous:LOW:exon13/17:c.1458T>C:p.Tyr486Tyr		rs2229992	0.5100	0.5780	21255/11677/216	0.5753						611731 [APC (confirmed) Adenomatous polyposis coli|Gastric cancer,somatic|Adenoma,periampullary,somatic|Hepatoblastoma,somatic|Desmoid disease,hereditary|Colorectal cancer,somatic|Brain tumor-polyposis syndrome 2|Gardner syndrome];	RCV000035064.7 [benign]; RCV000074147.1 [other]; RCV000131423.2 [benign]; 		COSM1432175	822	1190	1	[1] old entry - no details available			APC (inh=n/a pLI=1.00)
chr5	112164561	112164561	G	A	het		QUAL=2531;DP=179;AF=0.51;MQM=60	APC	synonymous	APC:NM_000038.5:synonymous:LOW:exon14/16:c.1635G>A:p.Ala545Ala,APC:NM_001127511.2:synonymous:LOW:exon12/14:c.1581G>A:p.Ala527Ala,APC:NM_001127510.2:synonymous:LOW:exon15/17:c.1635G>A:p.Ala545Ala		rs351771	0.6661	0.6481	25918/12755/1477	0.6434						611731 [APC (confirmed) Adenomatous polyposis coli|Gastric cancer,somatic|Adenoma,periampullary,somatic|Hepatoblastoma,somatic|Desmoid disease,hereditary|Colorectal cancer,somatic|Brain tumor-polyposis syndrome 2|Gardner syndrome];	RCV000035066.7 [benign]; RCV000074153.1 [other]; RCV000162371.1 [benign]; 		COSM3760868	942	1134	1	[1] old entry - no details available			APC (inh=n/a pLI=1.00)
chr5	112175770	112175770	G	A	het		QUAL=5170;DP=423;AF=0.49;MQM=60	APC	synonymous	APC:NM_000038.5:synonymous:LOW:exon16/16:c.4479G>A:p.Thr1493Thr,APC:NM_001127511.2:synonymous:LOW:exon14/14:c.4425G>A:p.Thr1475Thr,APC:NM_001127510.2:synonymous:LOW:exon17/17:c.4479G>A:p.Thr1493Thr		rs41115	0.6655	0.6486	25933/12779/1447	0.6435						611731 [APC (confirmed) Adenomatous polyposis coli|Gastric cancer,somatic|Adenoma,periampullary,somatic|Hepatoblastoma,somatic|Desmoid disease,hereditary|Colorectal cancer,somatic|Brain tumor-polyposis syndrome 2|Gardner syndrome];	RCV000035071.7 [benign]; RCV000074234.1 [other]; RCV000162372.1 [benign]; 		COSM3760869	943	1140	1	[1] old entry - no details available			APC (inh=n/a pLI=1.00)
chr5	112176325	112176325	G	A	het		QUAL=233;DP=26;AF=0.50;MQM=60	APC	synonymous	APC:NM_000038.5:synonymous:LOW:exon16/16:c.5034G>A:p.Gly1678Gly,APC:NM_001127511.2:synonymous:LOW:exon14/14:c.4980G>A:p.Gly1660Gly,APC:NM_001127510.2:synonymous:LOW:exon17/17:c.5034G>A:p.Gly1678Gly		rs42427	0.6667	0.6514	26051/12877/1489	0.6444						611731 [APC (confirmed) Adenomatous polyposis coli|Gastric cancer,somatic|Adenoma,periampullary,somatic|Hepatoblastoma,somatic|Desmoid disease,hereditary|Colorectal cancer,somatic|Brain tumor-polyposis syndrome 2|Gardner syndrome];	RCV000035074.7 [benign]; RCV000074235.1 [other]; RCV000162373.1 [benign]; 		COSM3760870	951	1125	1	[1] old entry - no details available			APC (inh=n/a pLI=1.00)
chr5	112176559	112176559	T	G	het		QUAL=3246;DP=262;AF=0.49;MQM=60	APC	synonymous	APC:NM_000038.5:synonymous:LOW:exon16/16:c.5268T>G:p.Ser1756Ser,APC:NM_001127511.2:synonymous:LOW:exon14/14:c.5214T>G:p.Ser1738Ser,APC:NM_001127510.2:synonymous:LOW:exon17/17:c.5268T>G:p.Ser1756Ser		rs866006	0.6669	0.6508	26034/12847/1478	0.6435						611731 [APC (confirmed) Adenomatous polyposis coli|Gastric cancer,somatic|Adenoma,periampullary,somatic|Hepatoblastoma,somatic|Desmoid disease,hereditary|Colorectal cancer,somatic|Brain tumor-polyposis syndrome 2|Gardner syndrome];	RCV000166360.1 [likely benign]; RCV000035076.7 [benign]; RCV000074236.1 [other]; RCV000162374.1 [benign]; 			945	1122	1	[1] old entry - no details available			APC (inh=n/a pLI=1.00)
chr5	112176756	112176756	T	A	het	phylop_high	QUAL=4289;DP=382;AF=0.45;MQM=60	APC	missense	APC:NM_000038.5:missense:MODERATE:exon16/16:c.5465T>A:p.Val1822Asp,APC:NM_001127511.2:missense:MODERATE:exon14/14:c.5411T>A:p.Val1804Asp,APC:NM_001127510.2:missense:MODERATE:exon17/17:c.5465T>A:p.Val1822Asp		rs459552	0.8654	0.7981	38872/19648/4738	0.7914	3.6530	T	T,T,T	B,B	B,B	611731 [APC (confirmed) Adenomatous polyposis coli|Gastric cancer,somatic|Adenoma,periampullary,somatic|Hepatoblastoma,somatic|Desmoid disease,hereditary|Colorectal cancer,somatic|Brain tumor-polyposis syndrome 2|Gardner syndrome];	RCV000020089.2 [benign]; RCV000034393.1 [benign]; RCV000035078.8 [benign]; RCV000074239.1 [other]; RCV000132160.2 [benign]; RCV000216852.1 [uncertain significance]; 	CM990164 [CLASS=DP MUT=REF PHEN="Adenomatous polyposis coli association with" GENE=APC]; 	COSM3760871	1462	862	1	[1] old entry - no details available			APC (inh=n/a pLI=1.00)
chr5	112177171	112177171	G	A	het		QUAL=9897;DP=815;AF=0.48;MQM=60	APC	synonymous	APC:NM_000038.5:synonymous:LOW:exon16/16:c.5880G>A:p.Pro1960Pro,APC:NM_001127511.2:synonymous:LOW:exon14/14:c.5826G>A:p.Pro1942Pro,APC:NM_001127510.2:synonymous:LOW:exon17/17:c.5880G>A:p.Pro1960Pro		rs465899	0.6665	0.6488	25923/12754/1497	0.6438						611731 [APC (confirmed) Adenomatous polyposis coli|Gastric cancer,somatic|Adenoma,periampullary,somatic|Hepatoblastoma,somatic|Desmoid disease,hereditary|Colorectal cancer,somatic|Brain tumor-polyposis syndrome 2|Gardner syndrome];	RCV000035080.7 [benign]; RCV000074242.1 [other]; RCV000162375.1 [benign]; 		COSM3760872	941	1135	1	[1] old entry - no details available			APC (inh=n/a pLI=1.00)
chr5	131892979	131892979	G	A	hom	off-target	QUAL=1592;DP=66;AF=0.98;MQM=60	RAD50	5'UTR	RAD50:NM_005732.3:5'UTR:MODIFIER:exon1/25:c.-38G>A:		rs4526098	0.9249	0.9752	57988/33161/2994	0.9411							RCV000160912.1 [benign]; 			384	6					RAD50 (inh=n/a pLI=0.00)
chr5	131915213	131915213	G	A	het	off-target	QUAL=1499;DP=145;AF=0.46;MQM=60	RAD50	splice_region&intron	RAD50:NM_005732.3:splice_region&intron:LOW:exon4/24:c.551+19G>A:		rs17166050	0.1677	0.1988	2524/1547/69	0.1936						604040 [RAD50 (provisional) Nijmegen breakage syndrome-like disorder];		CS139954 [CLASS=DFP MUT=ALT PHEN="Acute lymphoblastic leukaemia decreased risk" GENE=RAD50]; 		46	300					RAD50 (inh=n/a pLI=0.00)
chr5	131925483	131925483	G	C	het	phylop_high	QUAL=814;DP=67;AF=0.49;MQM=60	RAD50	missense	RAD50:NM_005732.3:missense:MODERATE:exon9/25:c.1406G>C:p.Gly469Ala		rs55653181	0.0002	0.0001	0/0/0	0.0001	6.3310	T	T,T,T	P	B	604040 [RAD50 (provisional) Nijmegen breakage syndrome-like disorder];	RCV000199031.1 [uncertain significance]; 			0	2					RAD50 (inh=n/a pLI=0.00)
chr5	176334195	176334195	C	T	het	off-target	QUAL=11593;DP=625;AF=0.69;MQM=60	UIMC1	splice_region&intron	UIMC1:NM_001199297.2:splice_region&intron:LOW:exon13/15:c.1849-17G>A:,UIMC1:NM_016290.4:splice_region&intron:LOW:exon12/14:c.1849-17G>A:,UIMC1:NM_001199298.1:splice_region&intron:LOW:exon12/14:c.1849-17G>A:,UIMC1:NM_001317961.1:splice_region&intron:LOW:exon12/14:c.1351-17G>A:		rs2292255	0.5905	0.5247	15293/7868/3362	0.5016										204	326					UIMC1 (inh=n/a pLI=0.03)
chr5	176338288	176338288	C	T	het	off-target	QUAL=3679;DP=323;AF=0.48;MQM=60	UIMC1	intron	UIMC1:NM_001199297.2:intron:MODIFIER:exon12/15:c.1676+24G>A:,UIMC1:NM_016290.4:intron:MODIFIER:exon11/14:c.1676+24G>A:,UIMC1:NM_001199298.1:intron:MODIFIER:exon11/14:c.1676+24G>A:,UIMC1:NM_001317961.1:intron:MODIFIER:exon11/14:c.1178+24G>A:		rs17078630	0.0092	0.0238	52/45/0	0.0235										1	31					UIMC1 (inh=n/a pLI=0.03)
chr6	35420628	35420628	A	C	het	off-target;low_DP	QUAL=67;DP=8;AF=0.50;MQM=60	FANCE	intron	FANCE:NM_021922.2:intron:MODIFIER:exon1/9:c.248+58A>C:		rs9470029	0.6172	0.0000	0/0/0	0.1057						613976 [FANCE (provisional) Fanconi anemia,complementation group E];				57	74					FANCE (inh=AR pLI=0.00)
chr6	35423489	35423489	A	G	het	off-target	QUAL=7904;DP=636;AF=0.49;MQM=60	FANCE	intron	FANCE:NM_021922.2:intron:MODIFIER:exon1/9:c.249-35A>G:		rs7757405	0.7766	0.7201	31745/15391/3873	0.7056						613976 [FANCE (provisional) Fanconi anemia,complementation group E];				0	0					FANCE (inh=AR pLI=0.00)
chr6	35423662	35423662	A	C	het		QUAL=884;DP=100;AF=0.41;MQM=60	FANCE	synonymous	FANCE:NM_021922.2:synonymous:LOW:exon2/10:c.387A>C:p.Pro129Pro		rs4713867	0.7780	0.7211	31791/15371/3918	0.7107						613976 [FANCE (provisional) Fanconi anemia,complementation group E];				1201	1117	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCE (inh=AR pLI=0.00)
chr6	35424188	35424188	A	G	het	off-target	QUAL=1441;DP=106;AF=0.53;MQM=60	FANCE	intron	FANCE:NM_021922.2:intron:MODIFIER:exon2/9:c.855+58A>G:		rs3800377	0.7191	0.0000	0/0/0	0.1337						613976 [FANCE (provisional) Fanconi anemia,complementation group E];				159	137					FANCE (inh=AR pLI=0.00)
chr6	35425416	35425416	A	G	het	off-target	QUAL=10912;DP=832;AF=0.50;MQM=60	FANCE	intron	FANCE:NM_021922.2:intron:MODIFIER:exon3/9:c.900+39A>G:		rs13214239	0.3596	0.4966	15583/9793/110	0.4840						613976 [FANCE (provisional) Fanconi anemia,complementation group E];				98	150					FANCE (inh=AR pLI=0.00)
chr6	131148863	131148863	A	T	het		QUAL=4396;DP=373;AF=0.52;MQM=60	SMLR1	intron	SMLR1:NM_001195597.1:intron:MODIFIER:exon1/1:c.238+72A>T:		rs9388856	0.4794	0.0000	0/0/0	0.3918										59	256					SMLR1 (inh=n/a pLI=n/a)
chr6	131148891	131148891	-	AT	het	off-target	QUAL=6756;DP=703;AF=0.41;MQM=60	SMLR1	intron	SMLR1:NM_001195597.1:intron:MODIFIER:exon1/1:c.238+113_238+114dupAT:		rs113795427;rs753973009	0.4884	0.0000	0/0/0	0.2629										9	52					SMLR1 (inh=n/a pLI=n/a)
chr7	6026775	6026775	T	C	hom	anno_pathogenic_hgmd	QUAL=527;DP=22;AF=1.00;MQM=60	PMS2	missense,non_coding_exon	PMS2:NM_000535.5:missense:MODERATE:exon11/15:c.1621A>G:p.Lys541Glu,PMS2:NR_003085.2:non_coding_exon:MODIFIER:exon11/15:n.1703A>G:		rs2228006	0.8832	0.8514	44055/24216/4305	0.8176	1.4430	T	T,T,T,T	B,B,B	B,B,B	600259 [PMS2 (confirmed) Mismatch repair cancer syndrome|Colorectal cancer,hereditary nonpolyposis,type 4];	RCV000030365.3 [benign]; RCV000034619.3 [benign]; RCV000121840.3 [benign]; 	BM1497492 [CLASS=DM? MUT=REF PHEN="Colorectal cancer non-polyposis" GENE=PMS2]; 	COSM4162329	2091	710	1	[1] Tanja Benkert 16.04.2015			PMS2 (inh=n/a pLI=0.00)
chr7	6036980	6036980	G	C	hom		QUAL=751;DP=25;AF=1.00;MQM=60	PMS2	synonymous,non_coding_exon	PMS2:NM_000535.5:synonymous:LOW:exon7/15:c.780C>G:p.Ser260Ser,PMS2:NR_003085.2:non_coding_exon:MODIFIER:exon7/15:n.862C>G:		rs1805319	0.8313	0.8109	39906/22309/3695	0.7970						600259 [PMS2 (confirmed) Mismatch repair cancer syndrome|Colorectal cancer,hereditary nonpolyposis,type 4];	RCV000162392.1 [benign]; RCV000030372.3 [benign]; RCV000079112.5 [benign]; RCV000131484.2 [benign]; 		COSM4162330	1924	839	1	[1] Ilnaz Sepahi 29-03-2016 batch import			PMS2 (inh=n/a pLI=0.00)
chr7	6037057	6037057	-	A	het		QUAL=186;DP=27;AF=0.48;MQM=60	PMS2	splice_region&intron	PMS2:NM_000535.5:splice_region&intron:LOW:exon6/14:c.706-4dupT:,PMS2:NR_003085.2:splice_region&intron:LOW:exon6/14:n.788-4dupT:		rs570998668;rs61373265;rs774538869	0.0264	0.0393	0/0/0	0.0302						600259 [PMS2 (confirmed) Mismatch repair cancer syndrome|Colorectal cancer,hereditary nonpolyposis,type 4];	RCV000179768.1 [benign]; RCV000202996.1 [benign]; 		COSM1735804	4	213					PMS2 (inh=n/a pLI=0.00)
chr7	128843169	128843169	C	T	hom	off-target;low_DP	QUAL=315;DP=12;AF=1.00;MQM=60	SMO	intron	SMO:NM_005631.4:intron:MODIFIER:exon1/11:c.332-56C>T:		rs2566871	0.4615	0.0000	0/0/0	0.4787						601500 [SMO (provisional) Basal cell carcinoma,somatic];				0	0					SMO (inh=n/a pLI=0.06)
chr7	128845018	128845018	C	T	hom	off-target	QUAL=6716;DP=206;AF=1.00;MQM=60	SMO	intron	SMO:NM_005631.4:intron:MODIFIER:exon2/11:c.538-26C>T:		rs2703091	0.7524	0.7960	38561/23420/2469	0.7884						601500 [SMO (provisional) Basal cell carcinoma,somatic];				244	78					SMO (inh=n/a pLI=0.06)
chr7	128845277	128845277	G	C	hom	off-target	QUAL=1590;DP=55;AF=1.00;MQM=60	SMO	intron	SMO:NM_005631.4:intron:MODIFIER:exon3/11:c.747+24G>C:		rs2075777	0.7520	0.8012	30520/18440/1802	0.7500						601500 [SMO (provisional) Basal cell carcinoma,somatic];				168	57					SMO (inh=n/a pLI=0.06)
chr7	128846328	128846328	G	C	hom		QUAL=28451;DP=909;AF=1.00;MQM=60	SMO	synonymous	SMO:NM_005631.4:synonymous:LOW:exon6/12:c.1164G>C:p.Gly388Gly		rs2228617	0.7562	0.7975	38862/23503/2520	0.7922						601500 [SMO (provisional) Basal cell carcinoma,somatic];			COSM4004294	1461	440					SMO (inh=n/a pLI=0.06)
chr7	128846469	128846469	A	G	hom	off-target	QUAL=27652;DP=857;AF=1.00;MQM=60	SMO	intron	SMO:NM_005631.4:intron:MODIFIER:exon6/11:c.1264+41A>G:		rs2735842	0.7532	0.7971	38446/23377/2515	0.7832						601500 [SMO (provisional) Basal cell carcinoma,somatic];				8	4					SMO (inh=n/a pLI=0.06)
chr7	142458371	142458371	T	C	het	off-target	QUAL=14853;DP=1540;AF=0.41;MQM=59	PRSS1	intron	PRSS1:NM_002769.4:intron:MODIFIER:exon1/4:c.41-35T>C:		rs367779270	0.0000	0.4958	0/0/0	0.0032						276000 [PRSS1 (confirmed) Pancreatitis,hereditary|Trypsinogen deficiency];				4	182					PRSS1 (inh=n/a pLI=0.00)
chr7	142460226	142460226	C	T	het	off-target;low_MQM	QUAL=865;DP=72;AF=0.67;MQM=40	PRSS1	intron	PRSS1:NM_002769.4:intron:MODIFIER:exon3/4:c.455-56C>T:		rs770654296	0.0000	0.0000	0/0/0	0.0001						276000 [PRSS1 (confirmed) Pancreatitis,hereditary|Trypsinogen deficiency];				0	171					PRSS1 (inh=n/a pLI=0.00)
chr7	142460238	142460238	G	A	het	off-target;low_MQM	QUAL=603;DP=116;AF=0.41;MQM=40	PRSS1	intron	PRSS1:NM_002769.4:intron:MODIFIER:exon3/4:c.455-44G>A:		rs749152254	0.0000	0.0180	0/0/0	0.0010						276000 [PRSS1 (confirmed) Pancreatitis,hereditary|Trypsinogen deficiency];				0	171					PRSS1 (inh=n/a pLI=0.00)
chr7	142460249	142460251	CTA	-	het	off-target;low_MQM	QUAL=531;DP=117;AF=0.41;MQM=40	PRSS1	intron	PRSS1:NM_002769.4:intron:MODIFIER:exon3/4:c.455-31_455-29delACT:		rs371688105	0.0000	0.0000	0/0/0	0.0100						276000 [PRSS1 (confirmed) Pancreatitis,hereditary|Trypsinogen deficiency];				0	171					PRSS1 (inh=n/a pLI=0.00)
chr7	142460255	142460255	C	T	het	off-target;low_MQM	QUAL=657;DP=117;AF=0.41;MQM=40	PRSS1	intron	PRSS1:NM_002769.4:intron:MODIFIER:exon3/4:c.455-27C>T:		rs754595466	0.0000	0.0001	0/0/0	0.0003						276000 [PRSS1 (confirmed) Pancreatitis,hereditary|Trypsinogen deficiency];				0	171					PRSS1 (inh=n/a pLI=0.00)
chr7	142460261	142460261	T	A	het	off-target	QUAL=1659;DP=117;AF=0.59;MQM=60	PRSS1	intron	PRSS1:NM_002769.4:intron:MODIFIER:exon3/4:c.455-21T>A:		rs201825825	0.9980	0.5815	9485/5327/520	0.0863						276000 [PRSS1 (confirmed) Pancreatitis,hereditary|Trypsinogen deficiency];				10	372					PRSS1 (inh=n/a pLI=0.00)
chr7	142460313	142460313	T	C	hom		QUAL=4913;DP=167;AF=0.99;MQM=60	PRSS1	synonymous	PRSS1:NM_002769.4:synonymous:LOW:exon4/5:c.486T>C:p.Asp162Asp		rs6666	0.3966	0.3693	0/0/0	0.0368						276000 [PRSS1 (confirmed) Pancreatitis,hereditary|Trypsinogen deficiency];		CM086253 [CLASS=DP MUT=REF PHEN="Pancreatitis chronic association with" GENE=PRSS1]; 	COSM4161889	274	1613	1	[1] Ilnaz Sepahi 29-03-2016 batch import			PRSS1 (inh=n/a pLI=0.00)
chr7	142460865	142460865	T	C	hom		QUAL=10142;DP=357;AF=1.00;MQM=60	PRSS1	synonymous	PRSS1:NM_002769.4:synonymous:LOW:exon5/5:c.738T>C:p.Asn246Asn		rs6667	0.3938	0.5041	16344/11218/985	0.4946						276000 [PRSS1 (confirmed) Pancreatitis,hereditary|Trypsinogen deficiency];				772	1174	1	[1] Ilnaz Sepahi 29-03-2016 batch import			PRSS1 (inh=n/a pLI=0.00)
chr8	90955624	90955624	T	A	het	off-target	QUAL=411;DP=31;AF=0.55;MQM=60	NBN	intron	NBN:NM_002485.4:intron:MODIFIER:exon13/15:c.2071-30A>T:,NBN:NM_001024688.2:intron:MODIFIER:exon14/16:c.1825-30A>T:		rs3736639	0.3792	0.3535	7667/3557/535	0.3451						602667 [NBN (confirmed) Nijmegen breakage syndrome|Aplastic anemia|Leukemia,acute lymphoblastic];				0	0					NBN (inh=AR pLI=0.00)
chr8	90958422	90958422	T	C	het		QUAL=584;DP=47;AF=0.55;MQM=60	NBN	synonymous	NBN:NM_002485.4:synonymous:LOW:exon13/16:c.2016A>G:p.Pro672Pro,NBN:NM_001024688.2:synonymous:LOW:exon14/17:c.1770A>G:p.Pro590Pro		rs1061302	0.3528	0.3451	7411/3552/277	0.3422						602667 [NBN (confirmed) Nijmegen breakage syndrome|Aplastic anemia|Leukemia,acute lymphoblastic];	RCV000162357.1 [benign]; 		COSM3763441	300	1290	1	[1] Alexandra Doehring 27.08.2015			NBN (inh=AR pLI=0.00)
chr8	90958530	90958530	T	C	het		QUAL=377;DP=36;AF=0.44;MQM=60	NBN	splice_region&intron	NBN:NM_002485.4:splice_region&intron:LOW:exon12/15:c.1915-7A>G:,NBN:NM_001024688.2:splice_region&intron:LOW:exon13/16:c.1669-7A>G:		rs2308962	0.3790	0.3529	7684/3567/522	0.3497						602667 [NBN (confirmed) Nijmegen breakage syndrome|Aplastic anemia|Leukemia,acute lymphoblastic];				301	1297	1	[1] Alexandra Doehring 27.08.2015			NBN (inh=AR pLI=0.00)
chr8	90967711	90967711	A	G	het		QUAL=349;DP=37;AF=0.43;MQM=60	NBN	synonymous	NBN:NM_002485.4:synonymous:LOW:exon10/16:c.1197T>C:p.Asp399Asp,NBN:NM_001024688.2:synonymous:LOW:exon11/17:c.951T>C:p.Asp317Asp		rs709816	0.6086	0.4676	14308/4457/3067	0.4608						602667 [NBN (confirmed) Nijmegen breakage syndrome|Aplastic anemia|Leukemia,acute lymphoblastic];	RCV000162376.1 [benign]; RCV000173761.1 [benign]; 		COSM3763442	383	1356	1	[1] Alexandra Doehring 27.08.2015			NBN (inh=AR pLI=0.00)
chr8	90970935	90970935	G	A	het	off-target	QUAL=463;DP=48;AF=0.42;MQM=60	NBN	splice_region&intron	NBN:NM_002485.4:splice_region&intron:LOW:exon9/15:c.1124+18C>T:,NBN:NM_001024688.2:splice_region&intron:LOW:exon10/16:c.878+18C>T:		rs2234744	0.3530	0.3446	7405/3556/278	0.3420						602667 [NBN (confirmed) Nijmegen breakage syndrome|Aplastic anemia|Leukemia,acute lymphoblastic];	RCV000180586.1 [benign]; 			90	455					NBN (inh=AR pLI=0.00)
chr8	90990479	90990479	C	G	het	phylop_high	QUAL=10738;DP=828;AF=0.50;MQM=60	NBN	missense	NBN:NM_002485.4:missense:MODERATE:exon5/16:c.553G>C:p.Glu185Gln,NBN:NM_001024688.2:missense:MODERATE:exon6/17:c.307G>C:p.Glu103Gln		rs1805794	0.3570	0.3453	7417/3546/292	0.3425	2.1330	T	T,T,T,T	B	B	602667 [NBN (confirmed) Nijmegen breakage syndrome|Aplastic anemia|Leukemia,acute lymphoblastic];	RCV000121620.2 [benign]; RCV000162358.1 [benign]; 	CM034886 [CLASS=DP MUT=ALT PHEN="Lung cancer association with" GENE=NBN]; 	COSM3763443	296	1297	1	[1] Christopher Schroeder 27.04.2015			NBN (inh=AR pLI=0.00)
chr8	90995019	90995019	C	T	het	low_DP	QUAL=99;DP=19;AF=0.37;MQM=60	NBN	synonymous,5'UTR	NBN:NM_002485.4:synonymous:LOW:exon2/16:c.102G>A:p.Leu34Leu,NBN:NM_001024688.2:5'UTR:MODIFIER:exon2/17:c.-195G>A:		rs1063045	0.3792	0.3527	7704/3573/531	0.3497						602667 [NBN (confirmed) Nijmegen breakage syndrome|Aplastic anemia|Leukemia,acute lymphoblastic];	RCV000162359.1 [benign]; 		COSM3763444	303	1277	1	[1] Alexandra Doehring 27.08.2015			NBN (inh=AR pLI=0.00)
chr8	107236280	107236280	G	T	hom		QUAL=20602;DP=650;AF=1.00;MQM=60	ZFPM2-AS1-OXR1	intergenic_region	ZFPM2-AS1-OXR1:ZFPM2-AS1-OXR1:intergenic_region:MODIFIER::n.107236280G>T:	LTR33	rs1393978	0.6096	0.0000	0/0/0	0.6664										226	240					ZFPM2-AS1-OXR1 (inh=n/a pLI=n/a)
chr9	5921881	5921881	G	A	het	phylop_high;pred_pathogenic_1	QUAL=15214;DP=1060;AF=0.54;MQM=60	KIAA2026	missense	KIAA2026:NM_001017969.2:missense:MODERATE:exon8/8:c.4115C>T:p.Thr1372Ile		rs72697396	0.0002	0.0001	0/0/0	0.0001	1.9050	T	D,D	B	B					0	0					KIAA2026 (inh=n/a pLI=n/a)
chr9	17235643	17235643	T	-	het	off-target	QUAL=521;DP=40;AF=0.60;MQM=60	CNTLN	splice_region&intron	CNTLN:NM_017738.3:splice_region&intron:LOW:exon3/25:c.535-7delT:,CNTLN:NM_001114395.2:splice_region&intron:LOW:exon3/6:c.535-7delT:		rs397708736	0.9133	0.8147	40766/18442/4471	0.7579										429	180					CNTLN (inh=n/a pLI=n/a)
chr9	17273878	17273878	A	G	het		QUAL=1145;DP=64;AF=0.72;MQM=60	CNTLN	splice_region&intron	CNTLN:NM_017738.3:splice_region&intron:LOW:exon6/25:c.983+14A>G:,CNTLN:NM_001114395.2:splice_region&intron:LOW:exon6/6:c.983+14A>G:		rs12376938	0.2258	0.2539	4272/2504/149	0.2471										152	661					CNTLN (inh=n/a pLI=n/a)
chr9	17273926	17273926	C	G	het	off-target;low_DP	QUAL=173;DP=16;AF=0.50;MQM=60	CNTLN	intron	CNTLN:NM_017738.3:intron:MODIFIER:exon6/25:c.983+62C>G:,CNTLN:NM_001114395.2:intron:MODIFIER:exon6/6:c.983+62C>G:		rs12379655	0.3343	0.0000	0/0/0	0.0559										22	67					CNTLN (inh=n/a pLI=n/a)
chr9	17342383	17342383	C	T	hom		QUAL=983;DP=30;AF=1.00;MQM=60	CNTLN	synonymous	CNTLN:NM_017738.3:synonymous:LOW:exon12/26:c.1827C>T:p.Asp609Asp		rs1442527	0.9495	0.9865	58803/33327/3518	0.9181										1858	5					CNTLN (inh=n/a pLI=n/a)
chr9	17394536	17394536	C	T	hom		QUAL=1783;DP=56;AF=1.00;MQM=60	CNTLN	missense	CNTLN:NM_017738.3:missense:MODERATE:exon15/26:c.2084C>T:p.Thr695Ile		rs7035276	0.7806	0.8284	39183/24109/2187	0.8011	0.3250	T	T,T,T	B,B,B	B,B,B					1378	416					CNTLN (inh=n/a pLI=n/a)
chr9	17394996	17394996	T	C	hom		QUAL=3142;DP=98;AF=1.00;MQM=60	CNTLN	synonymous	CNTLN:NM_017738.3:synonymous:LOW:exon15/26:c.2544T>C:p.His848His		rs3739489	0.8411	0.8799	46938/28083/2939	0.8623										1577	287					CNTLN (inh=n/a pLI=n/a)
chr9	17395108	17395108	C	T	hom	off-target	QUAL=6825;DP=215;AF=1.00;MQM=60	CNTLN	intron	CNTLN:NM_017738.3:intron:MODIFIER:exon15/25:c.2615+41C>T:		rs3739488	0.7819	0.8306	38889/24447/2325	0.8030										106	44					CNTLN (inh=n/a pLI=n/a)
chr9	17409366	17409366	G	A	hom		QUAL=12154;DP=384;AF=1.00;MQM=60	CNTLN	synonymous	CNTLN:NM_017738.3:synonymous:LOW:exon16/26:c.2691G>A:p.Thr897Thr		rs2780211	0.8389	0.8747	46375/27819/2946	0.8566									COSM3982792	1557	305					CNTLN (inh=n/a pLI=n/a)
chr9	17457513	17457513	A	-	hom	low_DP;anno_high_impact	QUAL=104;DP=4;AF=1.00;MQM=60	CNTLN	splice_acceptor	CNTLN:NM_017738.3:splice_acceptor:HIGH:exon18/25:c.3115-2delA:	(TATATT)n	rs35399020;rs397766990	0.7342	0.8450	40782/25898/1543	0.7481										1373	276	1	[1] auto-classification 16.06.2016  ahdoeha1 21.04.2016 Artefakt ssHC			CNTLN (inh=n/a pLI=n/a)
chr9	17494875	17494877	TTT	-	het	off-target	QUAL=309;DP=63;AF=0.25;MQM=59	CNTLN	intron	CNTLN:NM_017738.3:intron:MODIFIER:exon25/25:c.4120-7655_4120-7653delTTT:	Tigger3b:AluSx	rs776507555	0.0000	0.0003	0/0/0	0.0165										0	0					CNTLN (inh=n/a pLI=n/a)
chr9	17494875	17494875	T	-	het	off-target	QUAL=309;DP=63;AF=0.17;MQM=60	CNTLN	intron	CNTLN:NM_017738.3:intron:MODIFIER:exon25/25:c.4120-7653delT:	Tigger3b:AluSx	rs35224903	0.0000	0.0003	0/0/0	0.0001										0	0					CNTLN (inh=n/a pLI=n/a)
chr9	35074917	35074917	T	C	hom		QUAL=3127;DP=99;AF=1.00;MQM=60	FANCG	splice_region&intron	FANCG:NM_004629.1:splice_region&intron:LOW:exon12/13:c.1636+7A>G:		rs587118	0.2202	0.3957	11389/8269/33	0.3923						602956 [FANCG (confirmed) Fanconi anemia,complementation group G];				626	1267	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCG (inh=n/a pLI=0.00)
chr9	35077441	35077441	T	C	hom	off-target	QUAL=6891;DP=209;AF=1.00;MQM=60	FANCG	intron	FANCG:NM_004629.1:intron:MODIFIER:exon4/13:c.511-45A>G:		rs554098	0.7015	0.7459	34313/20097/2882	0.7374						602956 [FANCG (confirmed) Fanconi anemia,complementation group G];			COSN168536	200	113					FANCG (inh=n/a pLI=0.00)
chr9	90062823	90062823	A	G	hom		QUAL=14896;DP=528;AF=1.00;MQM=60	C9orf170-DAPK1	intergenic_region	C9orf170-DAPK1:C9orf170-DAPK1:intergenic_region:MODIFIER::n.90062823A>G:		rs12682834	0.6368	0.6466	23839/12412/915	0.6054										377	382					C9orf170-DAPK1 (inh=n/a pLI=n/a)
chr9	98209594	98209594	G	A	het	phylop_high;pred_pathogenic_1	QUAL=1180;DP=71;AF=0.66;MQM=60	PTCH1	missense	PTCH1:NM_000264.3:missense:MODERATE:exon23/24:c.3944C>T:p.Pro1315Leu,PTCH1:NM_001083607.1:missense:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu,PTCH1:NM_001083606.1:missense:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu,PTCH1:NM_001083604.1:missense:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu,PTCH1:NM_001083605.1:missense:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu,PTCH1:NM_001083602.1:missense:MODERATE:exon23/24:c.3746C>T:p.Pro1249Leu,PTCH1:NM_001083603.1:missense:MODERATE:exon23/24:c.3941C>T:p.Pro1314Leu		rs357564	0.3968	0.3855	9126/3704/255	0.3700	9.4050	T	D,D,D,D,D,D,D,D	P,P,P	P,P,B	601309 [PTCH1 (confirmed) Basal cell nevus syndrome|Basal cell carcinoma,somatic|Holoprosencephaly-7];	RCV000034575.1 [benign]; RCV000078463.5 [benign]; 	CM056376 [CLASS=DP MUT=REF PHEN="Skin cancer association with" GENE=PTCH1]; 	COSM1638395, COSM1638394, COSM1638396, COSM1638397	286	1147	1	[1] Ilnaz Sepahi 29-03-2016 batch import			PTCH1 (inh=AD pLI=1.00)
chr9	98232224	98232224	A	-	het		QUAL=263;DP=59;AF=0.54;MQM=60	PTCH1,LOC100507346	splice_region&intron,non_coding_exon	PTCH1:NM_000264.3:splice_region&intron:LOW:exon12/23:c.1729-11delT:,PTCH1:NM_001083607.1:splice_region&intron:LOW:exon12/23:c.1276-11delT:,PTCH1:NM_001083606.1:splice_region&intron:LOW:exon12/23:c.1276-11delT:,PTCH1:NM_001083604.1:splice_region&intron:LOW:exon12/23:c.1276-11delT:,PTCH1:NM_001083605.1:splice_region&intron:LOW:exon12/23:c.1276-11delT:,PTCH1:NM_001083602.1:splice_region&intron:LOW:exon12/23:c.1531-11delT:,PTCH1:NM_001083603.1:splice_region&intron:LOW:exon12/23:c.1726-11delT:,LOC100507346:NR_038982.1:non_coding_exon:MODIFIER:exon4/4:n.1887delA:		rs779000277	0.0000	0.0014	2/2/0	0.0012						601309 [PTCH1 (confirmed) Basal cell nevus syndrome|Basal cell carcinoma,somatic|Holoprosencephaly-7];				0	11					PTCH1 (inh=AD pLI=1.00), LOC100507346 (inh=n/a pLI=n/a)
chr9	98239190	98239190	G	C	hom	off-target	QUAL=1285;DP=42;AF=1.00;MQM=60	PTCH1	intron	PTCH1:NM_000264.3:intron:MODIFIER:exon10/23:c.1504-51C>G:,PTCH1:NM_001083607.1:intron:MODIFIER:exon10/23:c.1051-51C>G:,PTCH1:NM_001083606.1:intron:MODIFIER:exon10/23:c.1051-51C>G:,PTCH1:NM_001083604.1:intron:MODIFIER:exon10/23:c.1051-51C>G:,PTCH1:NM_001083605.1:intron:MODIFIER:exon10/23:c.1051-51C>G:,PTCH1:NM_001083602.1:intron:MODIFIER:exon10/23:c.1306-51C>G:,PTCH1:NM_001083603.1:intron:MODIFIER:exon10/23:c.1501-51C>G:		rs574688	0.1627	0.2302	2455/1639/15	0.2105						601309 [PTCH1 (confirmed) Basal cell nevus syndrome|Basal cell carcinoma,somatic|Holoprosencephaly-7];				16	123					PTCH1 (inh=AD pLI=1.00)
chr10	43595968	43595968	A	G	hom		QUAL=16324;DP=535;AF=1.00;MQM=60	RET	synonymous	RET:NM_020975.4:synonymous:LOW:exon2/20:c.135A>G:p.Ala45Ala,RET:NM_020630.4:synonymous:LOW:exon2/19:c.135A>G:p.Ala45Ala		rs1800858	0.7536	0.7365	33200/17899/4676	0.7262						164761 [RET (confirmed) Multiple endocrine neoplasia IIA|Medullary thyroid carcinoma|Multiple endocrine neoplasia IIB|Central hypoventilation syndrome,congenital|Pheochromocytoma|Renal agenesis|Hirschsprung disease,susceptibility to,1];	RCV000014967.2 [other]; RCV000127776.1 [benign]; RCV000205827.1 [benign]; RCV000216697.1 [not provided]; RCV000153833.3 [benign]; 	CM020759 [CLASS=DP MUT=REF PHEN="Hirschsprung disease association with" GENE=RET]; 	COSM4144677, COSM4144678	1447	1011	1	[1] old entry - no details available			RET (inh=n/a pLI=1.00)
chr10	43612226	43612226	C	T	het	off-target	QUAL=2409;DP=326;AF=0.45;MQM=60	RET	intron	RET:NM_020975.4:intron:MODIFIER:exon12/19:c.2284+47C>T:,RET:NM_020630.4:intron:MODIFIER:exon12/18:c.2284+47C>T:		rs760466	0.1206	0.2144	3184/2585/13	0.1982						164761 [RET (confirmed) Multiple endocrine neoplasia IIA|Medullary thyroid carcinoma|Multiple endocrine neoplasia IIB|Central hypoventilation syndrome,congenital|Pheochromocytoma|Renal agenesis|Hirschsprung disease,susceptibility to,1];				0	0					RET (inh=n/a pLI=1.00)
chr10	43613843	43613843	G	T	hom		QUAL=37745;DP=1158;AF=1.00;MQM=60	RET	synonymous	RET:NM_020975.4:synonymous:LOW:exon13/20:c.2307G>T:p.Leu769Leu,RET:NM_020630.4:synonymous:LOW:exon13/19:c.2307G>T:p.Leu769Leu		rs1800861	0.7125	0.7419	33769/19608/4074	0.7333						164761 [RET (confirmed) Multiple endocrine neoplasia IIA|Medullary thyroid carcinoma|Multiple endocrine neoplasia IIB|Central hypoventilation syndrome,congenital|Pheochromocytoma|Renal agenesis|Hirschsprung disease,susceptibility to,1];	RCV000021844.1 [benign]; RCV000127779.1 [benign]; RCV000154625.1 [benign]; RCV000203706.1 [benign]; RCV000153835.3 [benign]; 	CM014825 [CLASS=DP MUT=REF PHEN="Hirschsprung disease association with" GENE=RET]; 		1521	971	1	[1] Ilnaz Sepahi 29-03-2016 batch import			RET (inh=n/a pLI=1.00)
chr10	43615505	43615505	G	A	het	off-target	QUAL=9231;DP=736;AF=0.51;MQM=60	RET	intron	RET:NM_020975.4:intron:MODIFIER:exon14/19:c.2608-24G>A:,RET:NM_020630.4:intron:MODIFIER:exon14/18:c.2608-24G>A:		rs2472737	0.1731	0.2127	2529/1606/104	0.2020						164761 [RET (confirmed) Multiple endocrine neoplasia IIA|Medullary thyroid carcinoma|Multiple endocrine neoplasia IIB|Central hypoventilation syndrome,congenital|Pheochromocytoma|Renal agenesis|Hirschsprung disease,susceptibility to,1];	RCV000021870.1 [benign]; RCV000082053.4 [benign]; 	CS116395 [CLASS=DP MUT=ALT PHEN="Hirschsprung disease association with" GENE=RET]; 		15	132					RET (inh=n/a pLI=1.00)
chr10	43622217	43622217	T	C	hom	off-target	QUAL=1163;DP=42;AF=1.00;MQM=60	RET	3'UTR,intron	RET:NM_020630.4:3'UTR:MODIFIER:exon19/19:c.*15T>C:,RET:NM_020975.4:intron:MODIFIER:exon19/19:c.3187+47T>C:		rs2075912	0.7550	0.8031	33460/19436/3910	0.7666						164761 [RET (confirmed) Multiple endocrine neoplasia IIA|Medullary thyroid carcinoma|Multiple endocrine neoplasia IIB|Central hypoventilation syndrome,congenital|Pheochromocytoma|Renal agenesis|Hirschsprung disease,susceptibility to,1];	RCV000151742.1 [benign]; 	CS032426 [CLASS=DP MUT=ALT PHEN="Hirschsprung disease association with" GENE=RET]; 		538	249					RET (inh=n/a pLI=1.00)
chr10	88635779	88635779	C	A	het	phylop_high	QUAL=850;DP=71;AF=0.56;MQM=52	BMPR1A	missense	BMPR1A:NM_004329.2:missense:MODERATE:exon3/13:c.4C>A:p.Pro2Thr		rs11528010	0.4998	0.3558	9160/2415/2340	0.3486	3.7680	T	T,T	B	B	601299 [BMPR1A (confirmed) Polyposis,juvenile intestinal|Polyposis syndrome,hereditary mixed,2|Juvenile polyposis syndrome,infantile form];	RCV000034703.1 [benign]; RCV000120253.1 [not provided]; RCV000131909.2 [benign]; 		COSM3752019, COSM3752020	219	936	1	[1] Ilnaz Sepahi 29-03-2016 batch import			BMPR1A (inh=n/a pLI=0.77)
chr10	88649763	88649763	C	T	het	off-target	QUAL=672;DP=53;AF=0.49;MQM=60	BMPR1A	intron	BMPR1A:NM_004329.2:intron:MODIFIER:exon3/12:c.68-56C>T:		rs7087358	0.5312	0.0000	0/0/0	0.0790						601299 [BMPR1A (confirmed) Polyposis,juvenile intestinal|Polyposis syndrome,hereditary mixed,2|Juvenile polyposis syndrome,infantile form];				0	0					BMPR1A (inh=n/a pLI=0.77)
chr10	88683122	88683122	T	C	het	off-target	QUAL=5568;DP=620;AF=0.45;MQM=60	BMPR1A	splice_region&intron	BMPR1A:NM_004329.2:splice_region&intron:LOW:exon11/12:c.1343-11T>C:		rs7074064	0.4966	0.3538	9075/2400/2368	0.3452						601299 [BMPR1A (confirmed) Polyposis,juvenile intestinal|Polyposis syndrome,hereditary mixed,2|Juvenile polyposis syndrome,infantile form];				79	242					BMPR1A (inh=n/a pLI=0.77)
chr10	89720907	89720907	T	G	het	off-target	QUAL=251;DP=29;AF=0.52;MQM=60	PTEN	intron	PTEN:NM_001304717.2:intron:MODIFIER:exon9/9:c.1545+32T>G:,PTEN:NM_000314.6:intron:MODIFIER:exon8/8:c.1026+32T>G:,PTEN:NM_001304718.1:intron:MODIFIER:exon8/8:c.435+32T>G:		rs555895	0.4325	0.3699	8381/3687/1202	0.3478						601728 [PTEN (confirmed) Cowden syndrome 1|Lhermitte-Duclos syndrome|Bannayan-Riley-Ruvalcaba syndrome|Meningioma|Glioma susceptibility 2|Macrocephaly/autism syndrome|PTEN hamartoma tumor syndrome|VATER association with macrocephaly and ventriculomegaly|Prostate cancer,somatic|Malignant melanoma,somatic|Endometrial carcinoma,somatic|Squamous cell carcinoma,head and neck,somatic];	RCV000078603.3 [benign]; 			0	4					PTEN (inh=AD pLI=0.98)
chr10	104264107	104264107	C	T	hom		QUAL=9942;DP=414;AF=1.00;MQM=60	SUFU	splice_region&intron	SUFU:NM_016169.3:splice_region&intron:LOW:exon1/11:c.182+16C>T:,SUFU:NM_001178133.1:splice_region&intron:LOW:exon1/10:c.182+16C>T:		rs2274351	0.3962	0.4857	14438/9985/516	0.4624						607035 [SUFU (confirmed) Medulloblastoma,desmoplastic|Meningioma,familial,susceptibility to|Basal cell nevus syndrome];				350	523					SUFU (inh=n/a pLI=1.00)
chr10	104356822	104356822	A	G	hom	off-target	QUAL=2286;DP=74;AF=1.00;MQM=60	SUFU	intron	SUFU:NM_016169.3:intron:MODIFIER:exon6/11:c.757-75A>G:,SUFU:NM_001178133.1:intron:MODIFIER:exon6/10:c.757-75A>G:		rs10786690	0.9902	0.0000	0/0/0	0.1534						607035 [SUFU (confirmed) Medulloblastoma,desmoplastic|Meningioma,familial,susceptibility to|Basal cell nevus syndrome];				332	1					SUFU (inh=n/a pLI=1.00)
chr10	104387019	104387019	T	C	het		QUAL=14824;DP=1200;AF=0.49;MQM=60	SUFU	splice_region&intron	SUFU:NM_016169.3:splice_region&intron:LOW:exon11/11:c.1365+19T>C:		rs12414407	0.7196	0.6628	26892/13897/2970	0.6569						607035 [SUFU (confirmed) Medulloblastoma,desmoplastic|Meningioma,familial,susceptibility to|Basal cell nevus syndrome];				534	490					SUFU (inh=n/a pLI=1.00)
chr10	104389932	104389932	T	G	hom		QUAL=59615;DP=1897;AF=1.00;MQM=60	SUFU	3'UTR	SUFU:NM_016169.3:3'UTR:MODIFIER:exon12/12:c.*20T>G:		rs4917980	0.9974	0.9994	60625/33359/5139	0.9284										1201	0					SUFU (inh=n/a pLI=1.00)
chr11	13102890	13102890	C	A	het	off-target	QUAL=22536;DP=1762;AF=0.50;MQM=60	RASSF10-ARNTL	intergenic_region	RASSF10-ARNTL:RASSF10-ARNTL:intergenic_region:MODIFIER::n.13102890C>A:		rs2727397	0.5050	0.0000	0/0/0	0.5410										0	1					RASSF10-ARNTL (inh=n/a pLI=n/a)
chr11	13102924	13102924	G	A	het		QUAL=293;DP=26;AF=0.54;MQM=60	RASSF10-ARNTL	intergenic_region	RASSF10-ARNTL:RASSF10-ARNTL:intergenic_region:MODIFIER::n.13102924G>A:		rs2583136	0.5052	0.0000	0/0/0	0.5376										171	251					RASSF10-ARNTL (inh=n/a pLI=n/a)
chr11	64572018	64572018	T	C	hom		QUAL=8209;DP=259;AF=1.00;MQM=60	MEN1	missense	MEN1:NM_000244.3:missense:MODERATE:exon10/10:c.1636A>G:p.Thr546Ala,MEN1:NM_130800.2:missense:MODERATE:exon10/10:c.1636A>G:p.Thr546Ala,MEN1:NM_130801.2:missense:MODERATE:exon10/10:c.1636A>G:p.Thr546Ala,MEN1:NM_130799.2:missense:MODERATE:exon10/10:c.1621A>G:p.Thr541Ala,MEN1:NM_130802.2:missense:MODERATE:exon10/10:c.1636A>G:p.Thr546Ala,MEN1:NM_130803.2:missense:MODERATE:exon10/10:c.1636A>G:p.Thr546Ala,MEN1:NM_130804.2:missense:MODERATE:exon11/11:c.1636A>G:p.Thr546Ala		rs2959656	0.8345	0.9378	54048/33008/2619	0.9289	0.1310	T	T,T,T,T,T,T,T,T,T,T	B,B,B	B,B,B	613733 [MEN1 (confirmed) Multiple endocrine neoplasia 1|Carcinoid tumor of lung|Parathyroid adenoma,somatic|Lipoma,somatic|Angiofibroma,somatic|Adrenal adenoma,somatic];	RCV000034785.3 [benign]; RCV000082334.5 [benign]; RCV000204881.1 [benign]; RCV000210359.1 [uncertain significance]; RCV000121334.3 [benign]; 	CM085535 [CLASS=DFP MUT=REF PHEN="Impaired sensitisation to apoptosis" GENE=MEN1]; 	COSM255213	2411	34	1	[1] Ilnaz Sepahi 29-03-2016 batch import			MEN1 (inh=n/a pLI=1.00)
chr11	64572557	64572557	A	G	hom		QUAL=6555;DP=204;AF=1.00;MQM=60	MEN1	synonymous	MEN1:NM_000244.3:synonymous:LOW:exon9/10:c.1314T>C:p.His438His,MEN1:NM_130800.2:synonymous:LOW:exon9/10:c.1314T>C:p.His438His,MEN1:NM_130801.2:synonymous:LOW:exon9/10:c.1314T>C:p.His438His,MEN1:NM_130799.2:synonymous:LOW:exon9/10:c.1299T>C:p.His433His,MEN1:NM_130802.2:synonymous:LOW:exon9/10:c.1314T>C:p.His438His,MEN1:NM_130803.2:synonymous:LOW:exon9/10:c.1314T>C:p.His438His,MEN1:NM_130804.2:synonymous:LOW:exon10/11:c.1314T>C:p.His438His		rs540012	0.9760	0.9927	59759/33299/4389	0.9387						613733 [MEN1 (confirmed) Multiple endocrine neoplasia 1|Carcinoid tumor of lung|Parathyroid adenoma,somatic|Lipoma,somatic|Angiofibroma,somatic|Adrenal adenoma,somatic];	RCV000205798.1 [benign]; RCV000153486.2 [benign]; 			2451	4	1	[1] Ilnaz Sepahi 29-03-2016 batch import			MEN1 (inh=n/a pLI=1.00)
chr11	64577620	64577620	G	C	het	off-target	QUAL=269;DP=43;AF=0.49;MQM=60	MEN1	splice_region&intron	MEN1:NM_000244.3:splice_region&intron:LOW:exon1/9:c.-23-16C>G:,MEN1:NM_130800.2:splice_region&intron:LOW:exon1/9:c.-23-16C>G:,MEN1:NM_130801.2:splice_region&intron:LOW:exon1/9:c.-23-16C>G:,MEN1:NM_130799.2:splice_region&intron:LOW:exon1/9:c.-23-16C>G:,MEN1:NM_130802.2:splice_region&intron:LOW:exon1/9:c.-23-16C>G:,MEN1:NM_130803.2:splice_region&intron:LOW:exon1/9:c.-23-16C>G:,MEN1:NM_130804.2:splice_region&intron:LOW:exon2/10:c.-23-16C>G:		rs509606	0.1749	0.3084	333/73/6	0.0960										0	0					MEN1 (inh=n/a pLI=1.00)
chr11	108100105	108100105	-	TT	het	off-target	QUAL=406;DP=50;AF=0.20;MQM=60	ATM	intron	ATM:NM_000051.3:intron:MODIFIER:exon4/62:c.331+68_331+69dupTT:		rs11390378	0.0000	0.1206	5/4/0	0.0430						607585 [ATM (confirmed) Ataxia-telangiectasia|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to|Lymphoma,mantle cell|T-cell prolymphocytic leukemia,somatic];				0	15					ATM (inh=AR+AD pLI=0.00)
chr11	108100105	108100105	-	T	het	off-target	QUAL=406;DP=50;AF=0.44;MQM=60	ATM	intron	ATM:NM_000051.3:intron:MODIFIER:exon4/62:c.331+69dupT:		rs11390378;rs397713128	0.4848	0.4396	391/165/25	0.2464						607585 [ATM (confirmed) Ataxia-telangiectasia|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to|Lymphoma,mantle cell|T-cell prolymphocytic leukemia,somatic];				3	45					ATM (inh=AR+AD pLI=0.00)
chr11	108119616	108119616	A	-	het	off-target;low_QUAL	QUAL=11;DP=36;AF=0.14;MQM=60	ATM	intron	ATM:NM_000051.3:intron:MODIFIER:exon8/62:c.1066-31delA:	AluSp	rs35813860	0.0000	0.3608	0/0/0	0.0744						607585 [ATM (confirmed) Ataxia-telangiectasia|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to|Lymphoma,mantle cell|T-cell prolymphocytic leukemia,somatic];				1	28					ATM (inh=AR+AD pLI=0.00)
chr11	108129657	108129657	A	G	het	off-target;low_DP	QUAL=38;DP=16;AF=0.25;MQM=60	ATM	intron	ATM:NM_000051.3:intron:MODIFIER:exon15/62:c.2377-56A>G:		rs672655	0.4764	0.0000	0/0/0	0.1079						607585 [ATM (confirmed) Ataxia-telangiectasia|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to|Lymphoma,mantle cell|T-cell prolymphocytic leukemia,somatic];				160	175					ATM (inh=AR+AD pLI=0.00)
chr11	108141956	108141956	T	-	het	off-target	QUAL=426;DP=192;AF=0.22;MQM=60	ATM	splice_region&intron	ATM:NM_000051.3:splice_region&intron:LOW:exon19/62:c.2922-8delT:		rs373881770	0.0000	0.4363	1/0/0	0.0023						607585 [ATM (confirmed) Ataxia-telangiectasia|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to|Lymphoma,mantle cell|T-cell prolymphocytic leukemia,somatic];				0	796					ATM (inh=AR+AD pLI=0.00)
chr11	108150208	108150208	T	-	het		QUAL=889;DP=98;AF=0.39;MQM=60	ATM	splice_region&intron	ATM:NM_000051.3:splice_region&intron:LOW:exon22/62:c.3285-9delT:	(TTTG)n	rs397779715	0.0675	0.1845	730/488/5	0.0989						607585 [ATM (confirmed) Ataxia-telangiectasia|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to|Lymphoma,mantle cell|T-cell prolymphocytic leukemia,somatic];	RCV000159613.2,RCV000159613.2 [benign,benign]; 			46	505					ATM (inh=AR+AD pLI=0.00)
chr11	108151707	108151707	-	A	het	off-target	QUAL=1048;DP=77;AF=0.53;MQM=60	ATM	splice_region&intron	ATM:NM_000051.3:splice_region&intron:LOW:exon23/62:c.3403-13dupA:		rs3218681;rs587781368	0.5421	0.5675	18905/10528/1022	0.4947						607585 [ATM (confirmed) Ataxia-telangiectasia|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to|Lymphoma,mantle cell|T-cell prolymphocytic leukemia,somatic];	RCV000159614.2 [benign]; RCV000192572.1,RCV000159614.2 [likely benign,benign]; RCV000192572.1,RCV000159614.2 [likely benign,benign]; RCV000192572.1 [likely benign]; 			823	1040					ATM (inh=AR+AD pLI=0.00)
chr11	108175394	108175394	T	C	het	low_DP	QUAL=161;DP=14;AF=0.57;MQM=60	ATM	splice_region&intron	ATM:NM_000051.3:splice_region&intron:LOW:exon36/62:c.5497-8T>C:		rs3092829	0.0132	0.0230	38/34/0	0.0228						607585 [ATM (confirmed) Ataxia-telangiectasia|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to|Lymphoma,mantle cell|T-cell prolymphocytic leukemia,somatic];	RCV000119146.2 [benign]; RCV000128919.2 [benign]; 			8	277	1	[1] Ilnaz Sepahi 29-03-2016 batch import			ATM (inh=AR+AD pLI=0.00)
chr11	108175462	108175462	G	A	het	phylop_high	QUAL=388;DP=30;AF=0.53;MQM=60	ATM	missense	ATM:NM_000051.3:missense:MODERATE:exon37/63:c.5557G>A:p.Asp1853Asn		rs1801516	0.0669	0.1101	953/666/5	0.1094	6.3420	T	T,T	B	B	607585 [ATM (confirmed) Ataxia-telangiectasia|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to|Lymphoma,mantle cell|T-cell prolymphocytic leukemia,somatic];	RCV000116427.4 [other]; RCV000131720.2 [benign]; 	CM077896 [CLASS=DP MUT=ALT PHEN="Breast cancer bilateral association with" GENE=ATM]; 	COSM41596, COSM3736031	94	933	2	[2] Christopher Schroeder 27.04.2015			ATM (inh=AR+AD pLI=0.00)
chr11	108183167	108183167	A	G	hom		QUAL=14178;DP=445;AF=1.00;MQM=60	ATM	missense	ATM:NM_000051.3:missense:MODERATE:exon40/63:c.5948A>G:p.Asn1983Ser		rs659243	1.0000	1.0000	60654/33353/5170	0.9355	-1.0580	T	T,T	B,B	B,B	607585 [ATM (confirmed) Ataxia-telangiectasia|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to|Lymphoma,mantle cell|T-cell prolymphocytic leukemia,somatic];	RCV000128947.1 [benign]; RCV000120149.2 [benign]; 			4227	0	1	[3] Ilnaz Sepahi 29-03-2016 batch import [1] ahdoeha1 31.03.2016: GC-HBOC class 1 [n/a] harmuth 02.09.2016; observed base G is the wildtype base (hg38) which means that we sequenced the wildtype 			ATM (inh=AR+AD pLI=0.00)
chr11	108225483	108225483	C	T	het	off-target	QUAL=1990;DP=159;AF=0.48;MQM=60	ATM	intron	ATM:NM_000051.3:intron:MODIFIER:exon60/62:c.8787-55C>T:		rs664982	0.5351	0.0000	0/0/0	0.1116						607585 [ATM (confirmed) Ataxia-telangiectasia|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to|Lymphoma,mantle cell|T-cell prolymphocytic leukemia,somatic];				96	94					ATM (inh=AR+AD pLI=0.00)
chr11	108225661	108225661	A	G	het	off-target	QUAL=4410;DP=275;AF=0.58;MQM=60	ATM	intron	ATM:NM_000051.3:intron:MODIFIER:exon61/62:c.8850+60A>G:		rs664143	0.6282	0.0000	0/0/0	0.1168						607585 [ATM (confirmed) Ataxia-telangiectasia|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to|Lymphoma,mantle cell|T-cell prolymphocytic leukemia,somatic];				176	180					ATM (inh=AR+AD pLI=0.00)
chr11	125497466	125497466	G	T	het	off-target	QUAL=1071;DP=108;AF=0.49;MQM=60	CHEK1	intron	CHEK1:NM_001114121.2:intron:MODIFIER:exon2/13:c.66-36G>T:,CHEK1:NM_001114122.2:intron:MODIFIER:exon2/12:c.66-36G>T:,CHEK1:NM_001244846.1:intron:MODIFIER:exon2/11:c.66-36G>T:,CHEK1:NR_045204.1:intron:MODIFIER:exon2/11:n.962+738G>T:,CHEK1:NR_045205.1:intron:MODIFIER:exon2/12:n.500-36G>T:,CHEK1:NM_001274.5:intron:MODIFIER:exon2/12:c.66-36G>T:		rs491528	0.3530	0.3481	4414/2078/588	0.2884										49	131					CHEK1 (inh=n/a pLI=0.00)
chr11	125514573	125514573	G	A	het	off-target	QUAL=843;DP=107;AF=0.42;MQM=60	CHEK1	intron	CHEK1:NM_001114121.2:intron:MODIFIER:exon11/13:c.1233+35G>A:,CHEK1:NM_001114122.2:intron:MODIFIER:exon11/12:c.1233+35G>A:,CHEK1:NM_001244846.1:intron:MODIFIER:exon11/11:c.1233+35G>A:,CHEK1:NR_045204.1:intron:MODIFIER:exon10/11:n.1906+35G>A:,CHEK1:NR_045205.1:intron:MODIFIER:exon11/12:n.1667+35G>A:,CHEK1:NM_001274.5:intron:MODIFIER:exon11/12:c.1233+35G>A:		rs521102	0.4361	0.5059	15784/8765/412	0.4953										1	1					CHEK1 (inh=n/a pLI=0.00)
chr11	125525195	125525195	A	G	hom		QUAL=1962;DP=59;AF=1.00;MQM=60	CHEK1	missense,non_coding_exon	CHEK1:NM_001114121.2:missense:MODERATE:exon13/14:c.1411A>G:p.Ile471Val,CHEK1:NM_001114122.2:missense:MODERATE:exon13/13:c.1411A>G:p.Ile471Val,CHEK1:NM_001244846.1:missense:MODERATE:exon12/12:c.1309A>G:p.Ile437Val,CHEK1:NM_001274.5:missense:MODERATE:exon13/13:c.1411A>G:p.Ile471Val,CHEK1:NR_045204.1:non_coding_exon:MODIFIER:exon12/12:n.2084A>G:,CHEK1:NR_045205.1:non_coding_exon:MODIFIER:exon13/13:n.1845A>G:		rs506504	0.9858	0.9726	57363/30871/5146	0.9409	1.1780	T	T,T,T,T,T,T,T	B,B,B	B,B,B					1880	126	1	[1] Ilnaz Sepahi 29-03-2016 batch import			CHEK1 (inh=n/a pLI=0.00)
chr12	58144665	58144665	C	T	het	off-target	QUAL=1951;DP=162;AF=0.49;MQM=60	CDK4	intron	CDK4:NM_000075.3:intron:MODIFIER:exon4/7:c.522+41G>A:		rs2069502	0.3367	0.3541	8775/3639/30	0.3459						123829 [CDK4 (confirmed) Melanoma,cutaneous malignant,3];				12	64					CDK4 (inh=n/a pLI=0.93)
chr12	58145156	58145156	C	T	het	off-target	QUAL=5464;DP=416;AF=0.58;MQM=60	CDK4	intron	CDK4:NM_000075.3:intron:MODIFIER:exon2/7:c.219-31G>A:		rs2270777	0.2480	0.3392	7925/6306/137	0.3383						123829 [CDK4 (confirmed) Melanoma,cutaneous malignant,3];				32	73					CDK4 (inh=n/a pLI=0.93)
chr13	32890572	32890572	G	A	het	off-target	QUAL=1359;DP=118;AF=0.45;MQM=60	BRCA2	5'UTR	BRCA2:NM_000059.3:5'UTR:MODIFIER:exon2/27:c.-26G>A:		rs1799943	0.2093	0.2465	3755/2063/51	0.2438							RCV000112977.3 [benign]; RCV000114981.1 [not provided]; RCV000112978.1 [benign]; RCV000112979.1 [benign]; 	CR068211 [CLASS=DFP MUT=ALT PHEN="Breast cancer sporadic protection against" GENE=BRCA2]; 		48	271					BRCA2 (inh=AR+AD pLI=0.00)
chr13	32903685	32903685	C	T	het	off-target	QUAL=606;DP=44;AF=0.55;MQM=60	BRCA2	intron	BRCA2:NM_000059.3:intron:MODIFIER:exon8/26:c.681+56C>T:		rs2126042	0.1859	0.0000	0/0/0	0.0343						600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2|Fanconi anemia,complementation group D1|Prostate cancer|Breast cancer,male,susceptibility to|Wilms tumor|Medulloblastoma|Glioblastoma 3|Pre-B-cell acute lymphoblastic leukemia|Pancreatic cancer];	RCV000045058.2 [not provided]; RCV000114010.1 [uncertain significance]; RCV000114007.2 [benign]; 			6	151					BRCA2 (inh=AR+AD pLI=0.00)
chr13	32905219	32905219	-	T	het	off-target	QUAL=103;DP=107;AF=0.17;MQM=60	BRCA2	intron	BRCA2:NM_000059.3:intron:MODIFIER:exon9/26:c.793+64dupT:		rs760080447	0.0000	0.0825	0/0/0	0.0225						600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2|Fanconi anemia,complementation group D1|Prostate cancer|Breast cancer,male,susceptibility to|Wilms tumor|Medulloblastoma|Glioblastoma 3|Pre-B-cell acute lymphoblastic leukemia|Pancreatic cancer];				0	0					BRCA2 (inh=AR+AD pLI=0.00)
chr13	32911888	32911888	A	G	het		QUAL=826;DP=75;AF=0.49;MQM=60	BRCA2	synonymous	BRCA2:NM_000059.3:synonymous:LOW:exon11/27:c.3396A>G:p.Lys1132Lys		rs1801406	0.2668	0.2945	5391/3115/273	0.2927						600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2|Fanconi anemia,complementation group D1|Prostate cancer|Breast cancer,male,susceptibility to|Wilms tumor|Medulloblastoma|Glioblastoma 3|Pre-B-cell acute lymphoblastic leukemia|Pancreatic cancer];	RCV000113169.1 [benign]; RCV000113170.4 [benign]; RCV000114982.2 [benign]; RCV000130987.2 [benign]; RCV000152873.3 [benign]; 			284	1291	1	[1] Ulrike Faust 13.06.2015			BRCA2 (inh=AR+AD pLI=0.00)
chr13	32913055	32913055	A	G	hom		QUAL=32057;DP=994;AF=1.00;MQM=60	BRCA2	synonymous	BRCA2:NM_000059.3:synonymous:LOW:exon11/27:c.4563A>G:p.Leu1521Leu		rs206075	0.9740	0.9931	59672/33182/4417	0.9551						600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2|Fanconi anemia,complementation group D1|Prostate cancer|Breast cancer,male,susceptibility to|Wilms tumor|Medulloblastoma|Glioblastoma 3|Pre-B-cell acute lymphoblastic leukemia|Pancreatic cancer];	RCV000113321.1 [benign]; RCV000160224.1 [benign]; RCV000164515.1 [likely benign]; RCV000198429.1 [likely benign]; RCV000119245.2 [benign]; RCV000132170.2 [benign]; RCV000152875.5 [benign]; 			2954	11	1	[1] Ulrike Faust 13.06.2015			BRCA2 (inh=AR+AD pLI=0.00)
chr13	32915005	32915005	G	C	hom		QUAL=857;DP=26;AF=1.00;MQM=60	BRCA2	synonymous	BRCA2:NM_000059.3:synonymous:LOW:exon11/27:c.6513G>C:p.Val2171Val		rs206076	0.9736	0.9930	59677/33272/4398	0.9628						600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2|Fanconi anemia,complementation group D1|Prostate cancer|Breast cancer,male,susceptibility to|Wilms tumor|Medulloblastoma|Glioblastoma 3|Pre-B-cell acute lymphoblastic leukemia|Pancreatic cancer];	RCV000113602.1 [not provided]; RCV000119246.2 [benign]; RCV000152878.5 [benign]; RCV000162377.1 [benign]; RCV000163332.1 [likely benign]; RCV000168590.2 [other]; RCV000173959.1 [uncertain significance]; RCV000195987.2 [likely benign]; 		COSM4147690, COSM4147689	2955	14	1	[1] old entry - no details available			BRCA2 (inh=AR+AD pLI=0.00)
chr13	32929232	32929232	A	G	het		QUAL=437;DP=38;AF=0.50;MQM=60	BRCA2	synonymous	BRCA2:NM_000059.3:synonymous:LOW:exon14/27:c.7242A>G:p.Ser2414Ser		rs1799955	0.2326	0.2244	3228/1556/231	0.2239						600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2|Fanconi anemia,complementation group D1|Prostate cancer|Breast cancer,male,susceptibility to|Wilms tumor|Medulloblastoma|Glioblastoma 3|Pre-B-cell acute lymphoblastic leukemia|Pancreatic cancer];	RCV000113739.4 [benign]; RCV000123992.2 [benign]; RCV000130994.2 [benign]; RCV000152882.3 [benign]; 			142	1065	1	[1] Ulrike Faust 13.06.2015			BRCA2 (inh=AR+AD pLI=0.00)
chr13	32929387	32929387	T	C	hom	phylop_high;anno_pathogenic_hgmd	QUAL=19363;DP=598;AF=1.00;MQM=60	BRCA2	missense	BRCA2:NM_000059.3:missense:MODERATE:exon14/27:c.7397T>C:p.Val2466Ala		rs169547	0.9758	0.9937	59912/33304/4522	0.9638	2.3530	T	T,T			600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2|Fanconi anemia,complementation group D1|Prostate cancer|Breast cancer,male,susceptibility to|Wilms tumor|Medulloblastoma|Glioblastoma 3|Pre-B-cell acute lymphoblastic leukemia|Pancreatic cancer];	RCV000045197.4 [benign]; RCV000113751.2 [benign]; RCV000168597.1 [benign]; RCV000203672.1 [benign]; RCV000120357.5 [benign]; RCV000207137.1 [uncertain significance]; 	CM960194 [CLASS=DM? MUT=REF PHEN="Breast cancer" GENE=BRCA2]; 		2966	11	2	[2] old entry - no details available			BRCA2 (inh=AR+AD pLI=0.00)
chr13	32936646	32936646	T	C	hom	off-target	QUAL=2098;DP=63;AF=1.00;MQM=60	BRCA2	splice_region&intron	BRCA2:NM_000059.3:splice_region&intron:LOW:exon16/26:c.7806-14T>C:		rs9534262	0.5316	0.5208	16490/8840/1661	0.5132						600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2|Fanconi anemia,complementation group D1|Prostate cancer|Breast cancer,male,susceptibility to|Wilms tumor|Medulloblastoma|Glioblastoma 3|Pre-B-cell acute lymphoblastic leukemia|Pancreatic cancer];	RCV000113823.3 [benign]; RCV000124004.2 [benign]; RCV000132168.1 [benign]; RCV000152883.3 [benign]; 	CS147979 [CLASS=FP MUT=ALT PHEN="Alternative splicing" GENE=BRCA2]; 		284	533	1	[1] Ulrike Faust 13.06.2015			BRCA2 (inh=AR+AD pLI=0.00)
chr13	79766188	79766188	A	G	het		QUAL=10953;DP=825;AF=0.52;MQM=60	LINC00331-RBM26	intergenic_region	LINC00331-RBM26:LINC00331-RBM26:intergenic_region:MODIFIER::n.79766188A>G:		rs2988039	0.5066	0.3571	7871/1863/1908	0.3276										72	347					LINC00331-RBM26 (inh=n/a pLI=n/a)
chr14	45606387	45606387	A	G	het	pred_pathogenic_3	QUAL=593;DP=53;AF=0.47;MQM=60	FANCM	missense	FANCM:NM_020937.3:missense:MODERATE:exon2/23:c.624A>G:p.Ile208Met,FANCM:NM_001308134.1:missense:MODERATE:exon2/11:c.624A>G:p.Ile208Met,FANCM:NM_001308133.1:missense:MODERATE:exon2/22:c.624A>G:p.Ile208Met		rs45547534	0.0054	0.0107	9/6/0	0.0111	0.1250	T	D,D,D	D,D,P	D,D,P				COSM3753963	0	55	2	[2] Ilnaz Sepahi 12-10-2016 batch import			FANCM (inh=n/a pLI=0.00)
chr14	68290372	68290372	T	G	het	off-target	QUAL=6800;DP=523;AF=0.50;MQM=60	RAD51B	intron	RAD51B:NM_133509.3:intron:MODIFIER:exon2/10:c.84+28T>G:,RAD51B:NM_133510.3:intron:MODIFIER:exon2/10:c.84+28T>G:,RAD51B:NM_002877.5:intron:MODIFIER:exon2/10:c.84+28T>G:		rs17783124	0.2504	0.3030	5813/4121/633	0.2920										21	69					RAD51B (inh=n/a pLI=0.00)
chr14	68301767	68301767	-	A	het	off-target	QUAL=2995;DP=253;AF=0.49;MQM=60	RAD51B	intron	RAD51B:NM_133509.3:intron:MODIFIER:exon3/10:c.199-22dupA:,RAD51B:NM_133510.3:intron:MODIFIER:exon3/10:c.199-22dupA:,RAD51B:NM_002877.5:intron:MODIFIER:exon3/10:c.199-22dupA:		rs34564590;rs397897257;rs531055380	0.3195	0.3203	6502/4087/1269	0.2985										24	67					RAD51B (inh=n/a pLI=0.00)
chr14	68331675	68331675	A	T	hom	off-target	QUAL=12268;DP=483;AF=0.98;MQM=60	RAD51B	intron	RAD51B:NM_133509.3:intron:MODIFIER:exon4/10:c.316-45A>T:,RAD51B:NM_133510.3:intron:MODIFIER:exon4/10:c.316-45A>T:,RAD51B:NM_002877.5:intron:MODIFIER:exon4/10:c.316-45A>T:		rs1474939	0.0000	0.9998	9038/3595/1015	0.3552										0	0					RAD51B (inh=n/a pLI=0.00)
chr14	68944344	68944344	T	-	het	off-target	QUAL=901;DP=396;AF=0.20;MQM=60	RAD51B	splice_region&intron,intron	RAD51B:NM_133510.3:splice_region&intron:LOW:exon10/10:c.1037-8delT:,RAD51B:NM_133509.3:intron:MODIFIER:exon10/10:c.1036+9390delT:,RAD51B:NM_002877.5:intron:MODIFIER:exon10/10:c.1036+9390delT:	(T)n	rs567396898;rs768547850	0.2957	0.3406	2/0/2	0.1985										2	24					RAD51B (inh=n/a pLI=0.00)
chr14	104165753	104165753	G	A	het		QUAL=12801;DP=968;AF=0.51;MQM=60	XRCC3,KLC1	missense,intron	XRCC3:NM_001100118.1:missense:MODERATE:exon7/9:c.722C>T:p.Thr241Met,XRCC3:NM_001100119.1:missense:MODERATE:exon8/10:c.722C>T:p.Thr241Met,XRCC3:NM_005432.3:missense:MODERATE:exon8/10:c.722C>T:p.Thr241Met,KLC1:NM_001130107.1:intron:MODIFIER:exon14/15:c.1782-1239G>A:,KLC1:NM_182923.3:intron:MODIFIER:exon13/14:c.1651-1239G>A:		rs861539	0.2169	0.3075	5751/4513/219	0.2913	0.6420	T	T,T,T,T,T,T	P	B	600675 [XRCC3 (provisional) Melanoma,cutaneous malignant,6|Breast cancer,susceptibility to];	RCV000009500.2 [other]; 	CM003625 [CLASS=DFP MUT=ALT PHEN="Melanoma association with" GENE=XRCC3]; 	COSM1128325	350	1142	1	[1] old entry - no details available			XRCC3 (inh=n/a pLI=0.00), KLC1 (inh=n/a pLI=0.51)
chr14	105242966	105242966	T	C	het	off-target	QUAL=1980;DP=134;AF=0.61;MQM=60	AKT1	intron	AKT1:NM_001014431.1:intron:MODIFIER:exon4/13:c.287+30A>G:,AKT1:NM_005163.2:intron:MODIFIER:exon4/13:c.287+30A>G:,AKT1:NM_001014432.1:intron:MODIFIER:exon5/14:c.287+30A>G:		rs2494735	0.5964	0.4648	13485/4174/2524	0.4407						164730 [AKT1 (confirmed) Breast cancer,somatic|Colorectal cancer,somatic|Ovarian cancer,somatic|Schizophrenia,susceptibility to|Proteus syndrome,somatic|Cowden syndrome 6];				60	142					AKT1 (inh=n/a pLI=0.98)
chr14	105258892	105258892	C	T	hom	off-target	QUAL=3612;DP=111;AF=1.00;MQM=60	AKT1	intron	AKT1:NM_001014431.1:intron:MODIFIER:exon2/13:c.46+43G>A:,AKT1:NM_005163.2:intron:MODIFIER:exon2/13:c.46+43G>A:,AKT1:NM_001014432.1:intron:MODIFIER:exon3/14:c.46+43G>A:		rs2494748	0.3562	0.5107	16940/12430/349	0.4751						164730 [AKT1 (confirmed) Breast cancer,somatic|Colorectal cancer,somatic|Ovarian cancer,somatic|Schizophrenia,susceptibility to|Proteus syndrome,somatic|Cowden syndrome 6];				108	171					AKT1 (inh=n/a pLI=0.98)
chr14	105258893	105258893	A	G	hom	off-target	QUAL=3612;DP=111;AF=1.00;MQM=60	AKT1	intron	AKT1:NM_001014431.1:intron:MODIFIER:exon2/13:c.46+42T>C:,AKT1:NM_005163.2:intron:MODIFIER:exon2/13:c.46+42T>C:,AKT1:NM_001014432.1:intron:MODIFIER:exon3/14:c.46+42T>C:		rs2494749	0.7093	0.8237	42310/27943/4018	0.7770						164730 [AKT1 (confirmed) Breast cancer,somatic|Colorectal cancer,somatic|Ovarian cancer,somatic|Schizophrenia,susceptibility to|Proteus syndrome,somatic|Cowden syndrome 6];				258	70					AKT1 (inh=n/a pLI=0.98)
chr15	40998342	40998342	T	G	het	off-target	QUAL=1309;DP=99;AF=0.56;MQM=60	RAD51	intron	RAD51:NM_001164269.1:intron:MODIFIER:exon4/9:c.347-2881T>G:,RAD51:NM_001164270.1:intron:MODIFIER:exon3/8:c.226-33T>G:,RAD51:NM_002875.4:intron:MODIFIER:exon3/9:c.226-33T>G:,RAD51:NM_133487.3:intron:MODIFIER:exon4/9:c.347-2881T>G:		rs45457497	0.3542	0.2652	6006/1024/329	0.2597						179617 [RAD51 (confirmed) Breast cancer,susceptibility to|Mirror movements 2];				7	42					RAD51 (inh=n/a pLI=0.99)
chr15	43701947	43701947	A	-	het		QUAL=368;DP=58;AF=0.43;MQM=60	TP53BP1	splice_region&intron	TP53BP1:NM_001141980.1:splice_region&intron:LOW:exon24/27:c.5306-8delT:,TP53BP1:NM_001141979.1:splice_region&intron:LOW:exon24/27:c.5300-8delT:,TP53BP1:NM_005657.2:splice_region&intron:LOW:exon24/27:c.5291-8delT:		rs397711844;rs56813954	0.2502	0.3694	2441/1310/43	0.2272									COSM1608394	186	888	1	[1] old entry - no details available			TP53BP1 (inh=n/a pLI=1.00)
chr15	43707808	43707808	A	T	het		QUAL=1611;DP=136;AF=0.46;MQM=60	TP53BP1	synonymous	TP53BP1:NM_001141980.1:synonymous:LOW:exon23/28:c.5073T>A:p.Ser1691Ser,TP53BP1:NM_001141979.1:synonymous:LOW:exon23/28:c.5073T>A:p.Ser1691Ser,TP53BP1:NM_005657.2:synonymous:LOW:exon23/28:c.5058T>A:p.Ser1686Ser		rs2230451	0.1286	0.1634	1830/1156/143	0.1616									COSM3754329	117	778	1	[1] Ilnaz Sepahi 29-03-2016 batch import			TP53BP1 (inh=n/a pLI=1.00)
chr15	43720156	43720156	A	-	het	off-target	QUAL=1129;DP=391;AF=0.18;MQM=60	TP53BP1	intron	TP53BP1:NM_001141980.1:intron:MODIFIER:exon18/27:c.3828+58delT:,TP53BP1:NM_001141979.1:intron:MODIFIER:exon18/27:c.3828+58delT:,TP53BP1:NM_005657.2:intron:MODIFIER:exon18/27:c.3813+58delT:	AluJb		0.0000	0.0000	0/0/0	0.0009										0	0					TP53BP1 (inh=n/a pLI=1.00)
chr15	43720197	43720197	C	T	het	off-target	QUAL=4140;DP=350;AF=0.55;MQM=60	TP53BP1	splice_region&intron	TP53BP1:NM_001141980.1:splice_region&intron:LOW:exon18/27:c.3828+17G>A:,TP53BP1:NM_001141979.1:splice_region&intron:LOW:exon18/27:c.3828+17G>A:,TP53BP1:NM_005657.2:splice_region&intron:LOW:exon18/27:c.3813+17G>A:		rs550239	0.3804	0.2075	4173/527/2160	0.1992										8	144					TP53BP1 (inh=n/a pLI=1.00)
chr15	43724646	43724646	T	G	hom	phylop_high	QUAL=20028;DP=634;AF=1.00;MQM=60	TP53BP1	missense	TP53BP1:NM_001141980.1:missense:MODERATE:exon17/28:c.3421A>C:p.Lys1141Gln,TP53BP1:NM_001141979.1:missense:MODERATE:exon17/28:c.3421A>C:p.Lys1141Gln,TP53BP1:NM_005657.2:missense:MODERATE:exon17/28:c.3406A>C:p.Lys1136Gln		rs2602141	0.5264	0.3750	10244/3163/3807	0.3694	3.2610	T	T,T,T,T	B,B,B,B	B,B,B,B			CM067476 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=TP53BP1]; 	COSM3754330	285	1024	1	[1] Ilnaz Sepahi 29-03-2016 batch import			TP53BP1 (inh=n/a pLI=1.00)
chr15	43730486	43730486	A	G	het	off-target	QUAL=11449;DP=895;AF=0.49;MQM=60	TP53BP1	intron	TP53BP1:NM_001141980.1:intron:MODIFIER:exon16/27:c.3191+36T>C:,TP53BP1:NM_001141979.1:intron:MODIFIER:exon16/27:c.3191+36T>C:,TP53BP1:NM_005657.2:intron:MODIFIER:exon16/27:c.3176+36T>C:		rs16957730	0.1368	0.1665	1818/1126/187	0.1616										19	134					TP53BP1 (inh=n/a pLI=1.00)
chr15	43748304	43748304	A	G	hom		QUAL=30186;DP=958;AF=1.00;MQM=60	TP53BP1	synonymous	TP53BP1:NM_001141980.1:synonymous:LOW:exon12/28:c.2502T>C:p.Asp834Asp,TP53BP1:NM_001141979.1:synonymous:LOW:exon12/28:c.2502T>C:p.Asp834Asp,TP53BP1:NM_005657.2:synonymous:LOW:exon12/28:c.2487T>C:p.Asp829Asp		rs690367	0.5262	0.3739	10243/3157/3934	0.3685									COSM3754331	286	1018	1	[1] Ilnaz Sepahi 29-03-2016 batch import			TP53BP1 (inh=n/a pLI=1.00)
chr15	43762196	43762196	C	T	het	pred_pathogenic_1	QUAL=3267;DP=207;AF=0.57;MQM=60	TP53BP1	missense	TP53BP1:NM_001141980.1:missense:MODERATE:exon11/28:c.1249G>A:p.Gly417Ser,TP53BP1:NM_001141979.1:missense:MODERATE:exon11/28:c.1249G>A:p.Gly417Ser,TP53BP1:NM_005657.2:missense:MODERATE:exon11/28:c.1234G>A:p.Gly412Ser		rs689647	0.3824	0.2064	4213/530/2154	0.2014	1.1390	T	D,D,D,D,T	B,B,B,B	B,B,B,B			CM107902 [CLASS=DP MUT=ALT PHEN="Basal cell carcinoma reduced risk association with" GENE=TP53BP1]; 	COSM3754332	42	493	1	[1] Ilnaz Sepahi 29-03-2016 batch import			TP53BP1 (inh=n/a pLI=1.00)
chr15	43767774	43767774	G	C	hom		QUAL=3605;DP=116;AF=1.00;MQM=60	TP53BP1	missense	TP53BP1:NM_001141980.1:missense:MODERATE:exon9/28:c.1074C>G:p.Asp358Glu,TP53BP1:NM_001141979.1:missense:MODERATE:exon9/28:c.1074C>G:p.Asp358Glu,TP53BP1:NM_005657.2:missense:MODERATE:exon9/28:c.1059C>G:p.Asp353Glu		rs560191	0.5258	0.3737	10224/3146/3930	0.3679	0.2260	T	T,T,T,T,T	B,B,B,B	B,B,B,B			CM067475 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=TP53BP1]; 	COSM3744615	287	1018	1	[1] Ilnaz Sepahi 29-03-2016 batch import			TP53BP1 (inh=n/a pLI=1.00)
chr15	43773036	43773036	A	C	het	off-target	QUAL=10479;DP=864;AF=0.48;MQM=60	TP53BP1	intron	TP53BP1:NM_001141980.1:intron:MODIFIER:exon5/27:c.499+57T>G:,TP53BP1:NM_001141979.1:intron:MODIFIER:exon5/27:c.499+57T>G:,TP53BP1:NM_005657.2:intron:MODIFIER:exon5/27:c.484+57T>G:		rs7173383	0.1368	0.0000	0/0/0	0.0330										0	2					TP53BP1 (inh=n/a pLI=1.00)
chr15	43784000	43784000	C	T	hom	off-target	QUAL=26780;DP=852;AF=1.00;MQM=60	TP53BP1	intron	TP53BP1:NM_001141980.1:intron:MODIFIER:exon3/27:c.287-49G>A:,TP53BP1:NM_001141979.1:intron:MODIFIER:exon3/27:c.287-49G>A:,TP53BP1:NM_005657.2:intron:MODIFIER:exon3/27:c.272-49G>A:		rs555252	0.9515	0.9843	58805/33322/3976	0.9410										0	0					TP53BP1 (inh=n/a pLI=1.00)
chr15	75643615	75643615	-	T	hom	off-target	QUAL=502;DP=129;AF=0.19;MQM=60	NEIL1	intron	NEIL1:NM_001256552.1:intron:MODIFIER:exon2/9:c.693-818dupT:,NEIL1:NM_024608.3:intron:MODIFIER:exon2/9:c.435-818dupT:,NEIL1:NR_046311.1:intron:MODIFIER:exon3/10:n.1064-818dupT:		rs11422837;rs397739988;rs768966115	0.0000	0.0644	13/2/0	0.0316										0	1					NEIL1 (inh=n/a pLI=0.00)
chr16	3639139	3639139	A	G	het		QUAL=1344;DP=102;AF=0.52;MQM=60	SLX4	synonymous	SLX4:NM_032444.2:synonymous:LOW:exon12/15:c.4500T>C:p.Asn1500Asn		rs3810812	0.7396	0.6116	23691/8817/3963	0.5995						613278 [SLX4 (provisional) Fanconi anemia,complementation group P];				658	1149	1	[1] Ilnaz Sepahi 29-03-2016 batch import			SLX4 (inh=n/a pLI=0.00)
chr16	3639230	3639230	G	A	het	anno_pathogenic_hgmd	QUAL=1417;DP=112;AF=0.49;MQM=60	SLX4	missense	SLX4:NM_032444.2:missense:MODERATE:exon12/15:c.4409C>T:p.Pro1470Leu		rs72778139	0.0002	0.0001	0/0/0	0.0001	0.3390	T	T	P	B	613278 [SLX4 (provisional) Fanconi anemia,complementation group P];		CM136925 [CLASS=DM MUT=ALT PHEN="Breast and/or ovarian cancer" GENE=SLX4]; 		0	3					SLX4 (inh=n/a pLI=0.00)
chr16	23625463	23625463	A	T	hom	off-target	QUAL=1216;DP=38;AF=1.00;MQM=60	PALB2	intron	PALB2:NM_024675.3:intron:MODIFIER:exon10/12:c.3114-51T>A:		rs249936	0.9968	0.9975	37488/19526/3750	0.9173						610355 [PALB2 (provisional) Fanconi anemia,complementation group N|Breast cancer,susceptibility to|Pancreatic cancer,susceptibility to,3];	RCV000114594.1 [likely benign]; 			0	0					PALB2 (inh=AR+AD pLI=0.00)
chr16	23640467	23640467	G	A	het	off-target	QUAL=249;DP=23;AF=0.48;MQM=60	PALB2	intron	PALB2:NM_024675.3:intron:MODIFIER:exon6/12:c.2586+58C>T:		rs249954	0.3500	0.0000	0/0/0	0.0534						610355 [PALB2 (provisional) Fanconi anemia,complementation group N|Breast cancer,susceptibility to|Pancreatic cancer,susceptibility to,3];	RCV000114539.1 [benign]; 			0	0					PALB2 (inh=AR+AD pLI=0.00)
chr16	68771372	68771372	C	T	hom		QUAL=4027;DP=129;AF=0.99;MQM=60	CDH1	splice_region&intron	CDH1:NM_004360.4:splice_region&intron:LOW:exon1/15:c.48+6C>T:,CDH1:NM_001317184.1:splice_region&intron:LOW:exon1/14:c.48+6C>T:,CDH1:NM_001317185.1:splice_region&intron:LOW:exon1/15:c.-1568+6C>T:,CDH1:NM_001317186.1:splice_region&intron:LOW:exon1/14:c.-1772+6C>T:		rs3743674	0.7634	0.8111	5304/2436/102	0.5523						192090 [CDH1 (confirmed) Endometrial carcinoma,somatic|Ovarian carcinoma,somatic|Breast cancer,lobular|Gastric cancer,familial diffuse,with or without cleft lip and/or palate|Prostate cancer,susceptibility to];	RCV000132163.3 [benign]; RCV000173339.1 [benign]; 			2095	553	1	[1] Ilnaz Sepahi 29-03-2016 batch import			CDH1 (inh=AD pLI=0.34)
chr16	68771418	68771418	-	GCCCCAGCCCCGT	hom	off-target	QUAL=2621;DP=102;AF=1.00;MQM=60	CDH1	intron	CDH1:NM_004360.4:intron:MODIFIER:exon1/15:c.48+62_48+63insCGTGCCCCAGCCC:,CDH1:NM_001317184.1:intron:MODIFIER:exon1/14:c.48+62_48+63insCGTGCCCCAGCCC:,CDH1:NM_001317185.1:intron:MODIFIER:exon1/15:c.-1568+62_-1568+63insCGTGCCCCAGCCC:,CDH1:NM_001317186.1:intron:MODIFIER:exon1/14:c.-1772+62_-1772+63insCGTGCCCCAGCCC:		rs147838237;rs74406246	0.6887	0.8100	3615/1177/49	0.3004						192090 [CDH1 (confirmed) Endometrial carcinoma,somatic|Ovarian carcinoma,somatic|Breast cancer,lobular|Gastric cancer,familial diffuse,with or without cleft lip and/or palate|Prostate cancer,susceptibility to];				205	80					CDH1 (inh=AD pLI=0.34)
chr16	68857441	68857441	T	C	het		QUAL=14801;DP=1164;AF=0.52;MQM=60	CDH1	synonymous	CDH1:NM_004360.4:synonymous:LOW:exon13/16:c.2076T>C:p.Ala692Ala,CDH1:NM_001317184.1:synonymous:LOW:exon12/15:c.1893T>C:p.Ala631Ala,CDH1:NM_001317185.1:synonymous:LOW:exon13/16:c.528T>C:p.Ala176Ala,CDH1:NM_001317186.1:synonymous:LOW:exon12/15:c.111T>C:p.Ala37Ala		rs1801552	0.7187	0.6548	26404/13014/4084	0.6414						192090 [CDH1 (confirmed) Endometrial carcinoma,somatic|Ovarian carcinoma,somatic|Breast cancer,lobular|Gastric cancer,familial diffuse,with or without cleft lip and/or palate|Prostate cancer,susceptibility to];	RCV000132164.2 [benign]; 	CM1414917 [CLASS=DP MUT=ALT PHEN="Gastric cancer early-onset diffuse association with" GENE=CDH1]; 	COSM3755010	1102	1308	1	[1] Ilnaz Sepahi 29-03-2016 batch import			CDH1 (inh=AD pLI=0.34)
chr16	81816733	81816733	C	T	het		QUAL=4992;DP=430;AF=0.51;MQM=60	PLCG2	intron	PLCG2:NM_002661.4:intron:MODIFIER:exon1/32:c.-47-2815C>T:		rs8045964	0.4241	0.5194	6242/2864/337	0.3767										160	415					PLCG2 (inh=n/a pLI=1.00)
chr16	81816787	81816787	T	A	hom	off-target	QUAL=24041;DP=746;AF=1.00;MQM=60	PLCG2	intron	PLCG2:NM_002661.4:intron:MODIFIER:exon1/32:c.-47-2761T>A:		rs4476171	0.9980	0.0000	0/0/0	0.1531										491	0					PLCG2 (inh=n/a pLI=1.00)
chr16	89805261	89805261	A	G	hom	off-target	QUAL=18058;DP=580;AF=1.00;MQM=60	ZNF276,FANCA	3'UTR,intron,non_coding_exon	ZNF276:NM_001113525.1:3'UTR:MODIFIER:exon11/11:c.*607A>G:,ZNF276:NM_152287.3:3'UTR:MODIFIER:exon11/11:c.*607A>G:,FANCA:NM_000135.2:intron:MODIFIER:exon42/42:c.4260+29T>C:,FANCA:NM_001286167.1:intron:MODIFIER:exon42/42:c.4264+29T>C:,ZNF276:NR_110128.1:non_coding_exon:MODIFIER:exon11/11:n.2430A>G:,ZNF276:NR_110122.1:non_coding_exon:MODIFIER:exon11/11:n.2624A>G:,ZNF276:NR_110126.1:non_coding_exon:MODIFIER:exon11/11:n.2507A>G:,ZNF276:NR_110129.1:non_coding_exon:MODIFIER:exon11/11:n.2519A>G:		rs1800359	0.8508	0.7044	31320/11656/4512	0.6775						607139 [FANCA (confirmed) Fanconi anemia,complementation group A];				179	192					ZNF276 (inh=n/a pLI=0.00), FANCA (inh=AR pLI=0.00)
chr16	89805977	89805977	G	A	het	off-target	QUAL=2205;DP=181;AF=0.48;MQM=60	FANCA,ZNF276	splice_region&intron,3'UTR,non_coding_exon	FANCA:NM_000135.2:splice_region&intron:LOW:exon39/42:c.3935-16C>T:,FANCA:NM_001286167.1:splice_region&intron:LOW:exon39/42:c.3935-16C>T:,ZNF276:NM_001113525.1:3'UTR:MODIFIER:exon11/11:c.*1323G>A:,ZNF276:NM_152287.3:3'UTR:MODIFIER:exon11/11:c.*1323G>A:,ZNF276:NR_110128.1:non_coding_exon:MODIFIER:exon11/11:n.3146G>A:,ZNF276:NR_110122.1:non_coding_exon:MODIFIER:exon11/11:n.3340G>A:,ZNF276:NR_110126.1:non_coding_exon:MODIFIER:exon11/11:n.3223G>A:,ZNF276:NR_110129.1:non_coding_exon:MODIFIER:exon11/11:n.3235G>A:		rs1061646	0.5381	0.4098	1784/308/375	0.1691						607139 [FANCA (confirmed) Fanconi anemia,complementation group A];				108	407					FANCA (inh=AR pLI=0.00), ZNF276 (inh=n/a pLI=0.00)
chr16	89806347	89806347	A	T	het	off-target	QUAL=873;DP=48;AF=0.71;MQM=60	ZNF276,FANCA	3'UTR,intron	ZNF276:NM_001113525.1:3'UTR:MODIFIER:exon11/11:c.*1693A>T:,ZNF276:NM_152287.3:3'UTR:MODIFIER:exon11/11:c.*1693A>T:,FANCA:NM_000135.2:intron:MODIFIER:exon39/42:c.3934+55T>A:,FANCA:NM_001286167.1:intron:MODIFIER:exon39/42:c.3934+55T>A:		rs7195906	0.7065	0.5227	18679/4716/3149	0.4969	-0.5840	T		B	B	607139 [FANCA (confirmed) Fanconi anemia,complementation group A];	RCV000122401.1 [not provided]; 			164	408					ZNF276 (inh=n/a pLI=0.00), FANCA (inh=AR pLI=0.00)
chr16	89815217	89815217	C	T	het	off-target	QUAL=1919;DP=159;AF=0.51;MQM=60	FANCA	intron	FANCA:NM_000135.2:intron:MODIFIER:exon32/42:c.3240-42G>A:,FANCA:NM_001286167.1:intron:MODIFIER:exon32/42:c.3240-42G>A:		rs1800345	0.5449	0.4311	8845/2051/1234	0.3927						607139 [FANCA (confirmed) Fanconi anemia,complementation group A];		CS137887 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA]; 		16	64					FANCA (inh=AR pLI=0.00)
chr16	89818491	89818491	T	C	het	off-target	QUAL=9378;DP=751;AF=0.49;MQM=60	FANCA	intron	FANCA:NM_000135.2:intron:MODIFIER:exon31/42:c.3066+55A>G:,FANCA:NM_001286167.1:intron:MODIFIER:exon31/42:c.3066+55A>G:		rs3743860	0.5865	0.0000	0/0/0	0.0872						607139 [FANCA (confirmed) Fanconi anemia,complementation group A];				0	0					FANCA (inh=AR pLI=0.00)
chr16	89831510	89831510	C	A	het	off-target	QUAL=11990;DP=972;AF=0.48;MQM=60	FANCA	intron	FANCA:NM_000135.2:intron:MODIFIER:exon27/42:c.2602-36G>T:,FANCA:NM_001286167.1:intron:MODIFIER:exon27/42:c.2602-36G>T:		rs2159116	0.0933	0.1518	1622/1173/10	0.1451						607139 [FANCA (confirmed) Fanconi anemia,complementation group A];				27	93					FANCA (inh=AR pLI=0.00)
chr16	89836323	89836323	C	T	het		QUAL=835;DP=96;AF=0.41;MQM=60	FANCA	missense	FANCA:NM_000135.2:missense:MODERATE:exon26/43:c.2426G>A:p.Gly809Asp,FANCA:NM_001286167.1:missense:MODERATE:exon26/43:c.2426G>A:p.Gly809Asp		rs7195066	0.6667	0.4690	16070/3144/2387	0.4485	0.3050	T	T	B,B	B,B	607139 [FANCA (confirmed) Fanconi anemia,complementation group A];	RCV000120927.1 [not provided]; 	CM137288 [CLASS=R MUT=ALT PHEN="Fanconi anaemia A" GENE=FANCA]; 	COSM435949	346	1174	2	[2] old entry - no details available			FANCA (inh=AR pLI=0.00)
chr16	89838078	89838078	A	G	het		QUAL=12861;DP=1060;AF=0.48;MQM=60	FANCA	splice_region&intron	FANCA:NM_000135.2:splice_region&intron:LOW:exon23/42:c.2151+8T>C:,FANCA:NM_001286167.1:splice_region&intron:LOW:exon23/42:c.2151+8T>C:		rs1800340	0.5599	0.4315	12977/3039/1411	0.4236						607139 [FANCA (confirmed) Fanconi anemia,complementation group A];				295	1170	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCA (inh=AR pLI=0.00)
chr16	89845194	89845194	A	G	het	off-target	QUAL=6225;DP=616;AF=0.53;MQM=60	FANCA	splice_region&intron	FANCA:NM_000135.2:splice_region&intron:LOW:exon20/42:c.1826+15T>C:,FANCA:NM_001286167.1:splice_region&intron:LOW:exon20/42:c.1826+15T>C:		rs1800337	0.6825	0.5115	18057/4737/2484	0.4942						607139 [FANCA (confirmed) Fanconi anemia,complementation group A];				155	439					FANCA (inh=AR pLI=0.00)
chr16	89849480	89849480	C	T	hom		QUAL=6739;DP=202;AF=1.00;MQM=60	FANCA	missense	FANCA:NM_000135.2:missense:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser,FANCA:NM_001286167.1:missense:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser		rs2239359	0.6240	0.4995	16447/5298/2452	0.4917	-0.0380	T	T	B,B	B,B	607139 [FANCA (confirmed) Fanconi anemia,complementation group A];	RCV000120917.1 [not provided]; 	CM137880 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA]; 		482	1320	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCA (inh=AR pLI=0.00)
chr16	89857964	89857964	T	C	het	off-target	QUAL=14528;DP=1042;AF=0.53;MQM=60	FANCA	splice_region&intron	FANCA:NM_000135.2:splice_region&intron:LOW:exon13/42:c.1226-20A>G:,FANCA:NM_001286167.1:splice_region&intron:LOW:exon13/42:c.1226-20A>G:		rs1800330	0.5719	0.4370	13077/2988/1621	0.4273						607139 [FANCA (confirmed) Fanconi anemia,complementation group A];				99	384					FANCA (inh=AR pLI=0.00)
chr16	89858505	89858505	T	C	het	off-target	QUAL=4325;DP=304;AF=0.51;MQM=60	FANCA	intron	FANCA:NM_000135.2:intron:MODIFIER:exon12/42:c.1084-29A>G:,FANCA:NM_001286167.1:intron:MODIFIER:exon12/42:c.1084-29A>G:		rs6500452	0.5317	0.4118	11866/2863/1375	0.4083						607139 [FANCA (confirmed) Fanconi anemia,complementation group A];				39	128					FANCA (inh=AR pLI=0.00)
chr16	89858525	89858525	C	G	het	off-target	QUAL=4352;DP=307;AF=0.51;MQM=60	FANCA	intron	FANCA:NM_000135.2:intron:MODIFIER:exon12/42:c.1084-49G>C:,FANCA:NM_001286167.1:intron:MODIFIER:exon12/42:c.1084-49G>C:		rs1800287	0.7027	0.5175	18504/4730/2990	0.4955						607139 [FANCA (confirmed) Fanconi anemia,complementation group A];				60	140					FANCA (inh=AR pLI=0.00)
chr16	89859008	89859008	G	A	het	off-target	QUAL=930;DP=105;AF=0.40;MQM=60	FANCA	intron	FANCA:NM_000135.2:intron:MODIFIER:exon11/42:c.1007-53C>T:,FANCA:NM_001286167.1:intron:MODIFIER:exon11/42:c.1007-53C>T:		rs3856	0.5302	0.0000	0/0/0	0.0807						607139 [FANCA (confirmed) Fanconi anemia,complementation group A];				17	64					FANCA (inh=AR pLI=0.00)
chr16	89859016	89859016	T	-	het	off-target	QUAL=875;DP=105;AF=0.40;MQM=60	FANCA	intron	FANCA:NM_000135.2:intron:MODIFIER:exon11/42:c.1007-61delA:,FANCA:NM_001286167.1:intron:MODIFIER:exon11/42:c.1007-61delA:		rs869077718	0.6430	0.0000	0/0/0	0.4539						607139 [FANCA (confirmed) Fanconi anemia,complementation group A];				26	70					FANCA (inh=AR pLI=0.00)
chr16	89866043	89866043	T	C	het		QUAL=9337;DP=734;AF=0.49;MQM=60	FANCA	missense	FANCA:NM_000135.2:missense:MODERATE:exon9/43:c.796A>G:p.Thr266Ala,FANCA:NM_001286167.1:missense:MODERATE:exon9/43:c.796A>G:p.Thr266Ala,FANCA:NM_001018112.1:missense:MODERATE:exon9/11:c.796A>G:p.Thr266Ala		rs7190823	0.6905	0.5166	18422/4824/2761	0.4992	0.4020	T	T,T,T,T	B,B,B,B,B,B	B,B,B,B,B,B	607139 [FANCA (confirmed) Fanconi anemia,complementation group A];	RCV000120967.1 [not provided]; 	CM137879 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA]; 		466	1271	1	[1] Ilnaz Sepahi 29-03-2016 batch import			FANCA (inh=AR pLI=0.00)
chr16	89869761	89869761	T	C	hom	off-target	QUAL=3854;DP=115;AF=1.00;MQM=60	FANCA	splice_region&intron	FANCA:NM_000135.2:splice_region&intron:LOW:exon7/42:c.710-12A>G:,FANCA:NM_001286167.1:splice_region&intron:LOW:exon7/42:c.710-12A>G:,FANCA:NM_001018112.1:splice_region&intron:LOW:exon7/10:c.710-12A>G:		rs1800286	0.8429	0.7013	31090/11644/4387	0.6775						607139 [FANCA (confirmed) Fanconi anemia,complementation group A];				364	438					FANCA (inh=AR pLI=0.00)
chr17	7572980	7572980	T	G	het	pred_pathogenic_1	QUAL=42;DP=222;AF=0.35;MQM=60	TP53	missense,3'UTR	TP53:NM_000546.5:missense:MODERATE:exon11/11:c.1129A>C:p.Thr377Pro,TP53:NM_001126115.1:missense:MODERATE:exon7/7:c.733A>C:p.Thr245Pro,TP53:NM_001276697.1:missense:MODERATE:exon7/7:c.652A>C:p.Thr218Pro,TP53:NM_001126112.2:missense:MODERATE:exon11/11:c.1129A>C:p.Thr377Pro,TP53:NM_001126118.1:missense:MODERATE:exon10/10:c.1012A>C:p.Thr338Pro,TP53:NM_001276760.1:missense:MODERATE:exon11/11:c.1012A>C:p.Thr338Pro,TP53:NM_001276761.1:missense:MODERATE:exon11/11:c.1012A>C:p.Thr338Pro,TP53:NM_001126116.1:3'UTR:MODIFIER:exon8/8:c.*236A>C:,TP53:NM_001126117.1:3'UTR:MODIFIER:exon8/8:c.*148A>C:,TP53:NM_001276698.1:3'UTR:MODIFIER:exon8/8:c.*236A>C:,TP53:NM_001276699.1:3'UTR:MODIFIER:exon8/8:c.*148A>C:,TP53:NM_001126113.2:3'UTR:MODIFIER:exon12/12:c.*148A>C:,TP53:NM_001126114.2:3'UTR:MODIFIER:exon12/12:c.*236A>C:,TP53:NM_001276695.1:3'UTR:MODIFIER:exon12/12:c.*148A>C:,TP53:NM_001276696.1:3'UTR:MODIFIER:exon12/12:c.*236A>C:		rs774269719	0.0000	0.0006	0/0/0	0.0001	0.4640	D	T,T,T,.	B	B	191170 [TP53 (confirmed) Colorectal cancer|Li-Fraumeni syndrome|Hepatocellular carcinoma|Osteosarcoma|Choroid plexus papilloma|Nasopharyngeal carcinoma|Pancreatic cancer|Adrenal cortical carcinoma|Breast cancer|Basal cell carcinoma 7|Glioma susceptibility 1];			COSM1658764, COSM1658763	0	0					TP53 (inh=AD pLI=0.91)
chr17	7579472	7579472	G	C	het		QUAL=7662;DP=573;AF=0.54;MQM=60	TP53	missense	TP53:NM_000546.5:missense:MODERATE:exon4/11:c.215C>G:p.Pro72Arg,TP53:NM_001126112.2:missense:MODERATE:exon4/11:c.215C>G:p.Pro72Arg,TP53:NM_001126113.2:missense:MODERATE:exon4/12:c.215C>G:p.Pro72Arg,TP53:NM_001126114.2:missense:MODERATE:exon4/12:c.215C>G:p.Pro72Arg,TP53:NM_001126118.1:missense:MODERATE:exon3/10:c.98C>G:p.Pro33Arg,TP53:NM_001276695.1:missense:MODERATE:exon4/12:c.98C>G:p.Pro33Arg,TP53:NM_001276696.1:missense:MODERATE:exon4/12:c.98C>G:p.Pro33Arg,TP53:NM_001276760.1:missense:MODERATE:exon4/11:c.98C>G:p.Pro33Arg,TP53:NM_001276761.1:missense:MODERATE:exon4/11:c.98C>G:p.Pro33Arg		rs1042522	0.5429	0.6600	27306/18000/773	0.6429	1.0150	T	T,T,T,T,T,T,T,T,T	B,B,B,B,P	B,B,B,B,B	191170 [TP53 (confirmed) Colorectal cancer|Li-Fraumeni syndrome|Hepatocellular carcinoma|Osteosarcoma|Choroid plexus papilloma|Nasopharyngeal carcinoma|Pancreatic cancer|Adrenal cortical carcinoma|Breast cancer|Basal cell carcinoma 7|Glioma susceptibility 1];	RCV000152112.1 [benign]; RCV000013144.2 [benign]; RCV000034639.1 [benign]; RCV000079202.5 [benign]; RCV000132165.2 [benign]; RCV000144668.1 [uncertain significance]; RCV000211157.1 [drug response]; RCV000211212.1 [drug response]; RCV000211311.1 [drug response]; RCV000211338.1 [drug response]; RCV000211395.1 [drug response]; RCV000164487.1 [uncertain significance]; 	CM961374 [CLASS=DFP MUT=REF PHEN="Lung cancer association with" GENE=TP53]; 	COSM250061, COSM3766192, COSM3766191, COSM3766190, COSM3766193	1524	1121	1	[1] old entry - no details available			TP53 (inh=AD pLI=0.91)
chr17	7579644	7579659	CCCCAGCCCTCCAGGT	-	het	off-target	QUAL=103;DP=25;AF=0.56;MQM=59	TP53	intron	TP53:NM_000546.5:intron:MODIFIER:exon3/10:c.96+41_97-54delACCTGGAGGGCTGGGG:,TP53:NM_001126112.2:intron:MODIFIER:exon3/10:c.96+41_97-54delACCTGGAGGGCTGGGG:,TP53:NM_001126113.2:intron:MODIFIER:exon3/11:c.96+41_97-54delACCTGGAGGGCTGGGG:,TP53:NM_001126114.2:intron:MODIFIER:exon3/11:c.96+41_97-54delACCTGGAGGGCTGGGG:,TP53:NM_001126118.1:intron:MODIFIER:exon2/9:c.-22+41_-21-54delACCTGGAGGGCTGGGG:,TP53:NM_001276695.1:intron:MODIFIER:exon3/11:c.-22+41_-21-54delACCTGGAGGGCTGGGG:,TP53:NM_001276696.1:intron:MODIFIER:exon3/11:c.-22+41_-21-54delACCTGGAGGGCTGGGG:,TP53:NM_001276760.1:intron:MODIFIER:exon3/10:c.-22+41_-21-54delACCTGGAGGGCTGGGG:,TP53:NM_001276761.1:intron:MODIFIER:exon3/10:c.-22+41_-21-54delACCTGGAGGGCTGGGG:		rs150200764	0.5865	0.0000	0/0/0	0.1174						191170 [TP53 (confirmed) Colorectal cancer|Li-Fraumeni syndrome|Hepatocellular carcinoma|Osteosarcoma|Choroid plexus papilloma|Nasopharyngeal carcinoma|Pancreatic cancer|Adrenal cortical carcinoma|Breast cancer|Basal cell carcinoma 7|Glioma susceptibility 1];	RCV000161045.1 [benign]; 			13	293					TP53 (inh=AD pLI=0.91)
chr17	29553485	29553485	G	A	hom		QUAL=2535;DP=86;AF=1.00;MQM=60	NF1	synonymous	NF1:NM_001042492.2:synonymous:LOW:exon18/58:c.2034G>A:p.Pro678Pro,NF1:NM_000267.3:synonymous:LOW:exon18/57:c.2034G>A:p.Pro678Pro		rs2285892	0.4968	0.3827	9925/3078/2462	0.3658						613113 [NF1 (confirmed) Neurofibromatosis,type 1|Leukemia,juvenile myelomonocytic|Neurofibromatosis,familial spinal|Neurofibromatosis-Noonan syndrome|Watson syndrome];	RCV000162648.1 [benign]; RCV000219876.1 [benign]; 			224	1036					NF1 (inh=AD pLI=1.00)
chr17	29559061	29559061	-	T	het	off-target	QUAL=507;DP=156;AF=0.24;MQM=60	NF1	splice_region&intron	NF1:NM_001042492.2:splice_region&intron:LOW:exon24/57:c.3198-4dupT:,NF1:NM_000267.3:splice_region&intron:LOW:exon24/56:c.3198-4dupT:		rs371047262	0.0000	0.0052	21/6/0	0.0001						613113 [NF1 (confirmed) Neurofibromatosis,type 1|Leukemia,juvenile myelomonocytic|Neurofibromatosis,familial spinal|Neurofibromatosis-Noonan syndrome|Watson syndrome];				0	0					NF1 (inh=AD pLI=1.00)
chr17	29559932	29559932	C	A	hom	off-target	QUAL=1030;DP=35;AF=1.00;MQM=60	NF1	intron	NF1:NM_001042492.2:intron:MODIFIER:exon26/57:c.3496+33C>A:,NF1:NM_000267.3:intron:MODIFIER:exon26/56:c.3496+33C>A:		rs2066736	0.4581	0.3676	8780/2982/1958	0.3586						613113 [NF1 (confirmed) Neurofibromatosis,type 1|Leukemia,juvenile myelomonocytic|Neurofibromatosis,familial spinal|Neurofibromatosis-Noonan syndrome|Watson syndrome];				29	109					NF1 (inh=AD pLI=1.00)
chr17	29563073	29563073	-	TG	hom	off-target	QUAL=11392;DP=408;AF=0.98;MQM=60	NF1	intron	NF1:NM_001042492.2:intron:MODIFIER:exon29/57:c.3974+36_3974+37dupGT:,NF1:NM_000267.3:intron:MODIFIER:exon29/56:c.3974+36_3974+37dupGT:	(T)n	rs371036783;rs59745739	0.0016	0.0010	0/0/0	0.0263						613113 [NF1 (confirmed) Neurofibromatosis,type 1|Leukemia,juvenile myelomonocytic|Neurofibromatosis,familial spinal|Neurofibromatosis-Noonan syndrome|Watson syndrome];				25	119					NF1 (inh=AD pLI=1.00)
chr17	29563085	29563085	T	G	hom	off-target	QUAL=10302;DP=390;AF=0.99;MQM=60	NF1	intron	NF1:NM_001042492.2:intron:MODIFIER:exon29/57:c.3974+46T>G:,NF1:NM_000267.3:intron:MODIFIER:exon29/56:c.3974+46T>G:	(T)n	rs72813695	0.0988	0.0054	2/0/0	0.0199						613113 [NF1 (confirmed) Neurofibromatosis,type 1|Leukemia,juvenile myelomonocytic|Neurofibromatosis,familial spinal|Neurofibromatosis-Noonan syndrome|Watson syndrome];				9	60					NF1 (inh=AD pLI=1.00)
chr17	29663625	29663625	-	A	hom	off-target	QUAL=840;DP=41;AF=0.78;MQM=60	NF1	splice_region&intron	NF1:NM_001042492.2:splice_region&intron:LOW:exon41/57:c.6148-17dupA:,NF1:NM_000267.3:splice_region&intron:LOW:exon40/56:c.6085-17dupA:		rs33925668;rs553817239	0.3437	0.2734	758/301/165	0.2008						613113 [NF1 (confirmed) Neurofibromatosis,type 1|Leukemia,juvenile myelomonocytic|Neurofibromatosis,familial spinal|Neurofibromatosis-Noonan syndrome|Watson syndrome];				0	0					NF1 (inh=AD pLI=1.00)
chr17	29670190	29670190	C	G	hom	off-target	QUAL=5223;DP=163;AF=1.00;MQM=60	NF1	intron	NF1:NM_001042492.2:intron:MODIFIER:exon48/57:c.7189+37C>G:,NF1:NM_000267.3:intron:MODIFIER:exon47/56:c.7126+37C>G:		rs7405740	0.8738	0.9069	47463/26412/3102	0.8764						613113 [NF1 (confirmed) Neurofibromatosis,type 1|Leukemia,juvenile myelomonocytic|Neurofibromatosis,familial spinal|Neurofibromatosis-Noonan syndrome|Watson syndrome];				2	0					NF1 (inh=AD pLI=1.00)
chr17	33433487	33433487	C	T	hom		QUAL=2531;DP=85;AF=1.00;MQM=60	RAD51D,RAD51L3-RFFL	missense,non_coding_exon	RAD51D:NM_001142571.1:missense:MODERATE:exon6/10:c.554G>A:p.Arg185Gln,RAD51D:NM_002878.3:missense:MODERATE:exon6/10:c.494G>A:p.Arg165Gln,RAD51D:NM_133629.2:missense:MODERATE:exon3/7:c.158G>A:p.Arg53Gln,RAD51L3-RFFL:NR_037714.1:non_coding_exon:MODIFIER:exon2/7:n.246G>A:,RAD51D:NR_037711.1:non_coding_exon:MODIFIER:exon5/9:n.631G>A:,RAD51D:NR_037712.1:non_coding_exon:MODIFIER:exon4/8:n.496G>A:		rs4796033	0.0950	0.1593	1568/680/7	0.1412	1.3260	T	T,T,T,T,T,T,T	B,B,B,B	B,B,B,B	602954 [RAD51D (provisional) Breast-ovarian cancer,familial,susceptibility to,4];	RCV000131069.2 [benign]; 			55	653	1	[1] Christopher Schroeder 27.04.2015			RAD51D (inh=AD pLI=0.00), RAD51L3-RFFL (inh=n/a pLI=n/a)
chr17	33445549	33445549	G	A	het		QUAL=1637;DP=132;AF=0.55;MQM=60	RAD51D,RAD51L3-RFFL	synonymous,intron	RAD51D:NM_002878.3:synonymous:LOW:exon3/10:c.234C>T:p.Ser78Ser,RAD51L3-RFFL:NR_037714.1:intron:MODIFIER:exon1/6:n.232+2761C>T:,RAD51D:NM_001142571.1:intron:MODIFIER:exon2/9:c.144+581C>T:,RAD51D:NM_133629.2:intron:MODIFIER:exon2/6:c.144+581C>T:,RAD51D:NR_037711.1:intron:MODIFIER:exon2/8:n.400+581C>T:,RAD51D:NR_037712.1:intron:MODIFIER:exon2/7:n.400+581C>T:		rs9901455	0.1875	0.1184	1176/263/469	0.1175						602954 [RAD51D (provisional) Breast-ovarian cancer,familial,susceptibility to,4];	RCV000162563.1 [benign]; 			33	481	1	[1] Ilnaz Sepahi 29-03-2016 batch import			RAD51D (inh=AD pLI=0.00), RAD51L3-RFFL (inh=n/a pLI=n/a)
chr17	41223094	41223094	T	C	het	pred_pathogenic_1	QUAL=4395;DP=434;AF=0.47;MQM=60	BRCA1	missense,non_coding_exon	BRCA1:NM_007300.3:missense:MODERATE:exon16/24:c.4900A>G:p.Ser1634Gly,BRCA1:NM_007298.3:missense:MODERATE:exon14/22:c.1525A>G:p.Ser509Gly,BRCA1:NM_007297.3:missense:MODERATE:exon14/22:c.4696A>G:p.Ser1566Gly,BRCA1:NM_007299.3:missense:MODERATE:exon15/22:c.1525A>G:p.Ser509Gly,BRCA1:NM_007294.3:missense:MODERATE:exon15/23:c.4837A>G:p.Ser1613Gly,BRCA1:NR_027676.1:non_coding_exon:MODIFIER:exon15/23:n.4973A>G:		rs1799966	0.3558	0.3496	7852/3646/290	0.3439	-0.1120	T	D,T,D,T,D,T,T,T,D,.,D,D,D	B,B,B,P,B,B,B,B	B,B,B,B,B,B,B,B	113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1|Pancreatic cancer,susceptibility to,4];	RCV000031194.5 [other]; RCV000048673.4 [likely benign]; RCV000130704.2 [likely benign]; RCV000167795.2 [likely benign]; RCV000034753.3 [benign]; RCV000048672.5 [benign]; RCV000112410.5 [benign]; RCV000119096.2 [benign]; RCV000120260.4 [benign]; RCV000128996.2 [benign]; 	CM1210129 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=BRCA1]; 	COSM3755560, COSM3755559	332	1239	2	[2] old entry - no details available			BRCA1 (inh=AD pLI=0.00)
chr17	41234470	41234470	A	G	het		QUAL=343;DP=34;AF=0.50;MQM=60	BRCA1	synonymous,non_coding_exon	BRCA1:NM_007300.3:synonymous:LOW:exon12/24:c.4308T>C:p.Ser1436Ser,BRCA1:NM_007298.3:synonymous:LOW:exon11/22:c.999T>C:p.Ser333Ser,BRCA1:NM_007297.3:synonymous:LOW:exon11/22:c.4167T>C:p.Ser1389Ser,BRCA1:NM_007299.3:synonymous:LOW:exon12/22:c.999T>C:p.Ser333Ser,BRCA1:NM_007294.3:synonymous:LOW:exon12/23:c.4308T>C:p.Ser1436Ser,BRCA1:NR_027676.1:non_coding_exon:MODIFIER:exon12/23:n.4444T>C:		rs1060915	0.3363	0.3431	7653/3619/159	0.3380	-0.1190	T				113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1|Pancreatic cancer,susceptibility to,4];	RCV000112313.5 [benign]; RCV000114988.2 [benign]; RCV000128938.2 [benign]; RCV000152866.4 [benign]; 			327	1236	1	[1] Ulrike Faust 13.06.2015			BRCA1 (inh=AD pLI=0.00)
chr17	41244000	41244000	T	C	het		QUAL=4694;DP=350;AF=0.49;MQM=60	BRCA1	missense,intron,non_coding_exon	BRCA1:NM_007300.3:missense:MODERATE:exon10/24:c.3548A>G:p.Lys1183Arg,BRCA1:NM_007297.3:missense:MODERATE:exon9/22:c.3407A>G:p.Lys1136Arg,BRCA1:NM_007294.3:missense:MODERATE:exon10/23:c.3548A>G:p.Lys1183Arg,BRCA1:NM_007298.3:intron:MODIFIER:exon9/21:c.788-951A>G:,BRCA1:NM_007299.3:intron:MODIFIER:exon10/21:c.788-951A>G:,BRCA1:NR_027676.1:non_coding_exon:MODIFIER:exon10/23:n.3684A>G:		rs16942	0.3526	0.3490	7768/3592/284	0.3419	-0.3650	T	T,T,T,T,T,T,T	B,B,B,B,B,B	B,B,B,B,B,B	113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1|Pancreatic cancer,susceptibility to,4];	RCV000034742.3 [benign]; RCV000048229.4 [benign]; RCV000112115.5 [benign]; RCV000120278.4 [benign]; RCV000128991.2 [benign]; RCV000157734.1 [benign]; 	CM058359 [CLASS=DP MUT=ALT PHEN="Breast cancer protection against association with" GENE=BRCA1]; 	COSM3755561, COSM148277	329	1235	1	[1] old entry - no details available			BRCA1 (inh=AD pLI=0.00)
chr17	41244435	41244435	T	C	het	pred_pathogenic_1	QUAL=10833;DP=980;AF=0.49;MQM=60	BRCA1	missense,intron,non_coding_exon	BRCA1:NM_007300.3:missense:MODERATE:exon10/24:c.3113A>G:p.Glu1038Gly,BRCA1:NM_007297.3:missense:MODERATE:exon9/22:c.2972A>G:p.Glu991Gly,BRCA1:NM_007294.3:missense:MODERATE:exon10/23:c.3113A>G:p.Glu1038Gly,BRCA1:NM_007298.3:intron:MODIFIER:exon9/21:c.788-1386A>G:,BRCA1:NM_007299.3:intron:MODIFIER:exon10/21:c.788-1386A>G:,BRCA1:NR_027676.1:non_coding_exon:MODIFIER:exon10/23:n.3249A>G:		rs16941	0.3357	0.3429	7641/3610/156	0.3259	-0.4800	T	D,D,D,D,D,D,D	B,B,B,B,P,B	B,B,B,B,P,B	113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1|Pancreatic cancer,susceptibility to,4];	RCV000034738.3 [benign]; RCV000112006.5 [benign]; RCV000114987.2 [benign]; RCV000120276.5 [benign]; RCV000128978.2 [benign]; 	CM032861 [CLASS=DP MUT=ALT PHEN="Endometriosis association with" GENE=BRCA1]; 	COSM3755563, COSM3755562	326	1235	1	[1] old entry - no details available			BRCA1 (inh=AD pLI=0.00)
chr17	41244936	41244936	G	A	het	phylop_high	QUAL=2131;DP=132;AF=0.58;MQM=60	BRCA1	missense,intron,non_coding_exon	BRCA1:NM_007300.3:missense:MODERATE:exon10/24:c.2612C>T:p.Pro871Leu,BRCA1:NM_007297.3:missense:MODERATE:exon9/22:c.2471C>T:p.Pro824Leu,BRCA1:NM_007294.3:missense:MODERATE:exon10/23:c.2612C>T:p.Pro871Leu,BRCA1:NM_007298.3:intron:MODIFIER:exon9/21:c.787+1825C>T:,BRCA1:NM_007299.3:intron:MODIFIER:exon10/21:c.787+1825C>T:,BRCA1:NR_027676.1:non_coding_exon:MODIFIER:exon10/23:n.2748C>T:		rs799917	0.5439	0.4100	11586/3799/3500	0.4022	4.2460	T	T,T,T,T,T,T,T	B,B,B,B,B,B	B,B,B,B,B,B	113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1|Pancreatic cancer,susceptibility to,4];	RCV000034735.3 [benign]; RCV000111903.5 [benign]; RCV000114986.2 [benign]; RCV000120285.4 [benign]; RCV000132149.2 [benign]; RCV000077111.2 [likely benign]; RCV000221093.1 [uncertain significance]; RCV000047899.2 [not provided]; RCV000111902.1 [uncertain significance]; 	CM096315 [CLASS=DFP MUT=ALT PHEN="Cervical cancer decreased risk association with" GENE=BRCA1]; 	COSM148278, COSM3755564	365	1254	1	[1] Christopher Schroeder 27.04.2015			BRCA1 (inh=AD pLI=0.00)
chr17	41245237	41245237	A	G	het		QUAL=1538;DP=127;AF=0.46;MQM=60	BRCA1	synonymous,intron,non_coding_exon	BRCA1:NM_007300.3:synonymous:LOW:exon10/24:c.2311T>C:p.Leu771Leu,BRCA1:NM_007297.3:synonymous:LOW:exon9/22:c.2170T>C:p.Leu724Leu,BRCA1:NM_007294.3:synonymous:LOW:exon10/23:c.2311T>C:p.Leu771Leu,BRCA1:NM_007298.3:intron:MODIFIER:exon9/21:c.787+1524T>C:,BRCA1:NM_007299.3:intron:MODIFIER:exon10/21:c.787+1524T>C:,BRCA1:NR_027676.1:non_coding_exon:MODIFIER:exon10/23:n.2447T>C:		rs16940	0.3353	0.3420	7603/3578/154	0.3276						113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1|Pancreatic cancer,susceptibility to,4];	RCV000111822.5 [benign]; RCV000114985.2 [benign]; RCV000128982.2 [benign]; RCV000152867.3 [benign]; 		COSM3755566, COSM3755565	323	1233	1	[1] Ulrike Faust 13.06.2015			BRCA1 (inh=AD pLI=0.00)
chr17	41245466	41245466	G	A	het		QUAL=460;DP=62;AF=0.44;MQM=60	BRCA1	synonymous,intron,non_coding_exon	BRCA1:NM_007300.3:synonymous:LOW:exon10/24:c.2082C>T:p.Ser694Ser,BRCA1:NM_007297.3:synonymous:LOW:exon9/22:c.1941C>T:p.Ser647Ser,BRCA1:NM_007294.3:synonymous:LOW:exon10/23:c.2082C>T:p.Ser694Ser,BRCA1:NM_007298.3:intron:MODIFIER:exon9/21:c.787+1295C>T:,BRCA1:NM_007299.3:intron:MODIFIER:exon10/21:c.787+1295C>T:,BRCA1:NR_027676.1:non_coding_exon:MODIFIER:exon10/23:n.2218C>T:		rs1799949	0.3365	0.3483	7796/3607/286	0.3388						113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1|Pancreatic cancer,susceptibility to,4];	RCV000111763.4 [benign]; RCV000114984.2 [benign]; RCV000128966.2 [benign]; RCV000152868.4 [benign]; 		COSM148280, COSM3755567	329	1234	1	[1] Ulrike Faust 13.06.2015			BRCA1 (inh=AD pLI=0.00)
chr17	41249364	41249364	A	-	het	off-target	QUAL=594;DP=70;AF=0.39;MQM=60	BRCA1	intron	BRCA1:NM_007300.3:intron:MODIFIER:exon7/23:c.548-58delT:,BRCA1:NM_007298.3:intron:MODIFIER:exon6/21:c.548-58delT:,BRCA1:NR_027676.1:intron:MODIFIER:exon7/22:n.684-58delT:,BRCA1:NM_007297.3:intron:MODIFIER:exon6/21:c.407-58delT:,BRCA1:NM_007299.3:intron:MODIFIER:exon7/21:c.548-58delT:,BRCA1:NM_007294.3:intron:MODIFIER:exon7/22:c.548-58delT:		rs273902772	0.3349	0.0000	0/0/0	0.3013						113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1|Pancreatic cancer,susceptibility to,4];	RCV000112738.3,RCV000112738.3 [benign,benign]; 			30	99					BRCA1 (inh=AD pLI=0.00)
chr17	41256101	41256103	AAG	-	het	off-target;low_QUAL;low_DP	QUAL=7;DP=11;AF=0.27;MQM=60	BRCA1	intron	BRCA1:NM_007300.3:intron:MODIFIER:exon6/23:c.441+36_441+38delCTT:,BRCA1:NM_007298.3:intron:MODIFIER:exon5/21:c.441+36_441+38delCTT:,BRCA1:NR_027676.1:intron:MODIFIER:exon6/22:n.580+36_580+38delCTT:,BRCA1:NM_007297.3:intron:MODIFIER:exon5/21:c.300+36_300+38delCTT:,BRCA1:NM_007299.3:intron:MODIFIER:exon6/21:c.441+36_441+38delCTT:,BRCA1:NM_007294.3:intron:MODIFIER:exon6/22:c.441+36_441+38delCTT:	(AAG)n	rs147856441;rs730881450	0.3948	0.0074	11/7/0	0.0276						113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1|Pancreatic cancer,susceptibility to,4];	RCV000210985.1,RCV000159863.1 [benign,benign]; 			11	48					BRCA1 (inh=AD pLI=0.00)
chr17	56769979	56769979	C	T	het	off-target	QUAL=11259;DP=987;AF=0.46;MQM=60	RAD51C	5'UTR,non_coding_exon	RAD51C:NM_058216.2:5'UTR:MODIFIER:exon1/9:c.-26C>T:,RAD51C:NM_002876.3:5'UTR:MODIFIER:exon1/2:c.-26C>T:,RAD51C:NR_103873.1:non_coding_exon:MODIFIER:exon1/2:n.46C>T:,RAD51C:NR_103872.1:non_coding_exon:MODIFIER:exon1/8:n.46C>T:		rs12946397	0.1583	0.1797	2089/1377/92	0.1795										2	22					RAD51C (inh=AR+AD pLI=0.00)
chr17	56798207	56798207	T	C	het	off-target	QUAL=203;DP=27;AF=0.44;MQM=60	RAD51C	intron	RAD51C:NM_058216.2:intron:MODIFIER:exon6/8:c.904+34T>C:,RAD51C:NR_103872.1:intron:MODIFIER:exon5/7:n.808+34T>C:		rs28363318	0.2053	0.2800	5250/3988/381	0.2674						602774 [RAD51C (provisional) Fanconi anemia,complementation group O|Breast-ovarian cancer,familial,susceptibility to,3];				0	0					RAD51C (inh=AR+AD pLI=0.00)
chr17	59760996	59760996	A	G	hom		QUAL=7621;DP=310;AF=1.00;MQM=60	BRIP1	synonymous	BRIP1:NM_032043.2:synonymous:LOW:exon20/20:c.3411T>C:p.Tyr1137Tyr		rs4986763	0.6208	0.5941	22043/11338/2201	0.5943						605882 [BRIP1 (confirmed) Breast cancer,early-onset|Fanconi anemia,complementation group J];	RCV000162378.1 [benign]; 			990	1357	1	[1] Ilnaz Sepahi 29-03-2016 batch import			BRIP1 (inh=n/a pLI=0.00)
chr17	59763347	59763347	A	G	hom	low_DP	QUAL=369;DP=12;AF=1.00;MQM=60	BRIP1	missense	BRIP1:NM_032043.2:missense:MODERATE:exon19/20:c.2755T>C:p.Ser919Pro		rs4986764	0.6278	0.5972	22365/11454/2344	0.5828	0.1360	T	T	B	B	605882 [BRIP1 (confirmed) Breast cancer,early-onset|Fanconi anemia,complementation group J];	RCV000120400.1 [not provided]; RCV000132148.2 [benign]; 	CM046104 [CLASS=DP MUT=REF PHEN="Breast cancer association with" GENE=BRIP1]; 		995	1358	1	[1] Ilnaz Sepahi 29-03-2016 batch import			BRIP1 (inh=n/a pLI=0.00)
chr17	59763465	59763465	T	C	hom		QUAL=3671;DP=114;AF=1.00;MQM=60	BRIP1	synonymous	BRIP1:NM_032043.2:synonymous:LOW:exon19/20:c.2637A>G:p.Glu879Glu		rs4986765	0.8151	0.7188	32088/14734/4248	0.7134						605882 [BRIP1 (confirmed) Breast cancer,early-onset|Fanconi anemia,complementation group J];	RCV000162379.1 [benign]; 		COSM437064, COSM1479821	1337	1213	1	[1] Ilnaz Sepahi 29-03-2016 batch import			BRIP1 (inh=n/a pLI=0.00)
chr17	59857600	59857600	A	-	het	off-target;low_QUAL	QUAL=14;DP=28;AF=0.21;MQM=60	BRIP1	intron	BRIP1:NM_032043.2:intron:MODIFIER:exon13/19:c.1935+22delT:		rs763913233	0.0000	0.0160	0/0/0	0.0126						605882 [BRIP1 (confirmed) Breast cancer,early-onset|Fanconi anemia,complementation group J];				0	0					BRIP1 (inh=n/a pLI=0.00)
chr17	59857809	59857809	C	G	het	off-target;low_DP	QUAL=183;DP=14;AF=0.64;MQM=60	BRIP1	intron	BRIP1:NM_032043.2:intron:MODIFIER:exon12/19:c.1795-47G>C:	AluJb	rs4988351	0.7897	0.7476	33638/18248/3568	0.7172						605882 [BRIP1 (confirmed) Breast cancer,early-onset|Fanconi anemia,complementation group J];			COSN165483	0	0					BRIP1 (inh=n/a pLI=0.00)
chr18	19995753	19995753	T	C	hom	low_DP	QUAL=461;DP=19;AF=1.00;MQM=60	CTAGE1	synonymous	CTAGE1:NM_172241.2:synonymous:LOW:exon1/1:c.2022A>G:p.Pro674Pro		rs9946145	0.6855	0.8453	44643/28030/667	0.8003										710	160					CTAGE1 (inh=n/a pLI=0.00)
chr18	19996011	19996011	G	A	het		QUAL=1512;DP=133;AF=0.46;MQM=60	CTAGE1	synonymous	CTAGE1:NM_172241.2:synonymous:LOW:exon1/1:c.1764C>T:p.Leu588Leu		rs61747184	0.4942	0.4999	15457/8071/1094	0.4627										236	461					CTAGE1 (inh=n/a pLI=0.00)
chr18	20555219	20555219	T	C	hom	off-target	QUAL=2177;DP=70;AF=1.00;MQM=60	RBBP8	intron	RBBP8:NM_002894.2:intron:MODIFIER:exon6/18:c.428+37T>C:,RBBP8:NM_203291.1:intron:MODIFIER:exon6/18:c.428+37T>C:,RBBP8:NM_203292.1:intron:MODIFIER:exon6/17:c.428+37T>C:		rs2336916	0.9157	0.9626	54138/30894/3453	0.9110						604124 [RBBP8 (provisional) Pancreatic carcinoma,somatic|Seckel syndrome 2|Jawad syndrome];				305	26					RBBP8 (inh=AR pLI=0.00)
chr18	20564801	20564803	TCA	-	het	off-target	QUAL=362;DP=32;AF=0.47;MQM=60	RBBP8	intron	RBBP8:NM_002894.2:intron:MODIFIER:exon7/18:c.605-41_605-39delCAT:,RBBP8:NM_203291.1:intron:MODIFIER:exon7/18:c.605-41_605-39delCAT:,RBBP8:NM_203292.1:intron:MODIFIER:exon7/17:c.605-41_605-39delCAT:		rs34354995	0.4517	0.5698	18103/12215/199	0.5118						604124 [RBBP8 (provisional) Pancreatic carcinoma,somatic|Seckel syndrome 2|Jawad syndrome];				0	0					RBBP8 (inh=AR pLI=0.00)
chr18	48584855	48584855	-	TT	het	off-target	QUAL=2452;DP=238;AF=0.40;MQM=58	SMAD4	intron	SMAD4:NM_005359.5:intron:MODIFIER:exon7/11:c.904+44_904+45dupTT:		rs397686427;rs57847829;rs760402978	0.0118	0.1541	617/388/11	0.1198						600993 [SMAD4 (confirmed) Pancreatic cancer,somatic|Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome|Myhre syndrome|Polyposis,juvenile intestinal];				0	0					SMAD4 (inh=AD pLI=0.97)
chr18	48584855	48584855	-	T	het	off-target	QUAL=2452;DP=238;AF=0.16;MQM=60	SMAD4	intron	SMAD4:NM_005359.5:intron:MODIFIER:exon7/11:c.904+45dupT:		rs57847829;rs760402978	0.0066	0.1914	355/191/19	0.1280						600993 [SMAD4 (confirmed) Pancreatic cancer,somatic|Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome|Myhre syndrome|Polyposis,juvenile intestinal];				0	0					SMAD4 (inh=AD pLI=0.97)
chr19	17379558	17379558	C	T	het	off-target	QUAL=1316;DP=109;AF=0.48;MQM=60	BABAM1	splice_region&intron,intron	BABAM1:NM_001033549.2:splice_region&intron:LOW:exon1/8:c.-51-7C>T:,BABAM1:NM_001288757.1:splice_region&intron:LOW:exon1/5:c.-51-7C>T:,BABAM1:NM_001288756.1:intron:MODIFIER:exon1/8:c.-13-45C>T:,BABAM1:NM_014173.3:intron:MODIFIER:exon1/8:c.-13-45C>T:		rs10424178	0.1727	0.3600	1239/714/323	0.1515										3	65					BABAM1 (inh=n/a pLI=0.73)
chr19	17382505	17382505	A	T	het	off-target	QUAL=331;DP=49;AF=0.37;MQM=60	BABAM1	intron	BABAM1:NM_001033549.2:intron:MODIFIER:exon3/8:c.344+41A>T:,BABAM1:NM_001288756.1:intron:MODIFIER:exon3/8:c.344+41A>T:,BABAM1:NM_001288757.1:intron:MODIFIER:exon3/5:c.344+41A>T:,BABAM1:NM_014173.3:intron:MODIFIER:exon3/8:c.344+41A>T:		rs10420922	0.4631	0.4367	10978/5948/2038	0.4150										0	0					BABAM1 (inh=n/a pLI=0.73)
chr19	17387254	17387254	G	A	het	off-target	QUAL=1375;DP=102;AF=0.52;MQM=60	BABAM1	intron	BABAM1:NM_001033549.2:intron:MODIFIER:exon6/8:c.570-50G>A:,BABAM1:NM_001288756.1:intron:MODIFIER:exon6/8:c.570-50G>A:,BABAM1:NM_001288757.1:intron:MODIFIER:exon3/5:c.345-50G>A:,BABAM1:NM_014173.3:intron:MODIFIER:exon6/8:c.570-50G>A:		rs61634114	0.0990	0.2372	483/299/39	0.1056										4	83					BABAM1 (inh=n/a pLI=0.73)
chr19	17389648	17389648	C	T	het		QUAL=1229;DP=109;AF=0.47;MQM=60	BABAM1	splice_region&intron	BABAM1:NM_001033549.2:splice_region&intron:LOW:exon8/8:c.787-6C>T:,BABAM1:NM_001288756.1:splice_region&intron:LOW:exon8/8:c.787-6C>T:,BABAM1:NM_001288757.1:splice_region&intron:LOW:exon5/5:c.562-6C>T:,BABAM1:NM_014173.3:splice_region&intron:LOW:exon8/8:c.787-6C>T:		rs10406920	0.1118	0.1798	1404/941/140	0.1450										50	539	1	[1] Ilnaz Sepahi 29-03-2016 batch import			BABAM1 (inh=n/a pLI=0.73)
chr19	17389704	17389704	G	A	het		QUAL=6312;DP=539;AF=0.47;MQM=60	BABAM1	synonymous	BABAM1:NM_001033549.2:synonymous:LOW:exon9/9:c.837G>A:p.Lys279Lys,BABAM1:NM_001288756.1:synonymous:LOW:exon9/9:c.837G>A:p.Lys279Lys,BABAM1:NM_001288757.1:synonymous:LOW:exon6/6:c.612G>A:p.Lys204Lys,BABAM1:NM_014173.3:synonymous:LOW:exon9/9:c.837G>A:p.Lys279Lys		rs8170	0.1124	0.1568	1581/1048/168	0.1486								CM1010189 [CLASS=DP MUT=ALT PHEN="Ovarian cancer susceptibility to" GENE=BABAM1]; 	COSM438891, COSM438892	50	540	1	[1] Ilnaz Sepahi 29-03-2016 batch import			BABAM1 (inh=n/a pLI=0.73)
chr20	14167283	14167283	A	G	hom		QUAL=905;DP=31;AF=1.00;MQM=60	MACROD2	intron	MACROD2:NM_080676.5:intron:MODIFIER:exon3/16:c.271+100909A>G:	L1PA16	rs6074704	0.4792	0.0000	0/0/0	0.5723										192	243					MACROD2 (inh=n/a pLI=0.01)
chr20	48301146	48301146	G	A	hom		QUAL=39629;DP=1210;AF=1.00;MQM=60	B4GALT5	intron	B4GALT5:NM_004776.3:intron:MODIFIER:exon1/8:c.116-27907C>T:		rs6512586	0.4681	0.5201	15518/8865/587	0.4853										257	399					B4GALT5 (inh=n/a pLI=0.99)
